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Whether the use be in household, industrial, medicinal, or agricultural 
situations, modern society relies heavily on the use of chemicals.  Unsurprisingly, 
many of these compounds are washed down the drain and have been detected in 
the wastewater treatment system.  Compounds such as pharmaceuticals and 
personal care products (PPCPs), flame retardants, surfactants, and plasticizers have 
all been consistently detected in samples collected from wastewater treatment plants 
(WWTPs).  Wastewater treatment is not designed specifically to remove these 
pollutants so they are oftentimes released into the environment via the discharge of 
WWTP effluent to local water bodies or the land application of treated sludge, also 
known as biosolids.  Once released into the environment, chemicals can influence 
environmental health due to toxicity, bioaccumulation, microbial resistance issues, 
etc.  Additionally, when degradation of these chemicals during treatment does take 
place, they are often not fully mineralized, leading to concerns regarding the 
environmental effects of transformation products. 
This research focuses on the impact that individual treatment systems have 
on concentrations of the antimicrobials triclosan (TCS) and triclocarban (TCC), 4 
phthalate plasticizers, and their transformation products.  The primary compounds 
studied have been shown to possess endocrine disrupting capabilities and to be 
present in biosolids at high concentrations due to extensive use.  Treatment systems 
studied included activated sludge, nitrification, anaerobic digestion, and Cambi 
Thermal Hydrolysis Process (CambiTHP) pretreatment.  Experiments were carried 
out in-lab using bioreactors to simulate treatment in a controlled manner as well as 
on-site at local WWTPs. The final goal of this research was the development of an 
extraction/analytical method for the detection of 27 compounds of concern in 
wastewater solids samples.  Experimental results indicate that aerobic, anaerobic, 
and physical treatment processes can have mixed impacts on compound 









INFLUENCE OF VARIOUS WASTEWATER TREATMENT PROCESSES ON 












Dissertation submitted to the Faculty of the Graduate School of the  
University of Maryland, College Park, in partial fulfillment  


















Professor Alba Torrents, Chair 
Dr. Natasha Andrade 
Professor Stephanie Lansing 




















© Copyright by 






Table of Contents 
 
Chapter 1:  Introduction………………………………………………….………………………………1 
1.1  Background…………………………………………………………………………………………….1 
1.1.1  Organic Compounds in Wastewater Treatment…………………………………………………1 
1.1.2  Health and Environmental Concerns of Organic Pollutants……………………………………4 
1.1.3  Overview of Study Wastewater Treatment Plant (DC Water, Blue Plains)…………………..6 
1.2  Research Objectives………………………………………………………………………………….7 
1.2.1  Objective #1:  Study the influence that aerobic treatment processes  
(activated sludge and nitrification) have on degradation of the antimicrobials TCS  
and TCC as well as the formation of their transformation products using  
benchtop bioreactors……………………………………………………………………………………….9 
1.2.2  Objective #2:  Determine how the TH-AD influences concentrations of TCC, TCS,  
and their transformation products as well as phthalic acid esters in-plant………………………….11 
1.2.3  Objective #3:  Influence of Aerobic and Anaerobic Treatment Processes on  
Concentrations of Phthalate Acid Esters……………………………………………………………….13 
1.2.4  Objective #4:  Simulate the anaerobic digestion process with and without thermal 
hydrolysis pretreatment using bioreactors to gauge the degradation of TCS, TCC, and  
PAEs and the formation of transformation products…………………………………………………..13 
1.2.5  Objective #5:  :  Analyze for 27 compounds of concern  
in sludge samples and determine the influence of wastewater treatment processes on 
concentrations of compounds……………………………………………………………………………14 
Chapter 2:  Degradation of Triclosan and Triclocarban and Formation of Transformation 
Products in Activated Sludge Using Benchtop Bioreactors…………………………………….17 
2.2  Introduction…………………………………………………………………………………………...18 
2.3  Materials and Methods………………………………………………………………………………21 
2.3.1  Standards and Reagents…………………………………………………………………………21 
2.3.2  Wastewater Treatment Plant Background and Sample Collection…………………….…….21 
2.3.3  Benchtop Bioreactors………………………………………………………………………….….22 
2.3.4  Solids Analysis……………………………………………………………………………………..23 
2.3.5  Microbial Activity…………………………………………………………………………………...24 
2.3.6  Chemical Oxygen Demand……………………………………………………………………….24 
2.3.7  Triclosan, Triclocarban, & Transformation Product Extraction and Analysis………………..25 
2.3.8  Quality Assurance and Quality Control………………………………….………………………27 
 iii 
2.4  Results and Discussion…………………………………………………….……………………….28 
2.4.1  Triclosan, Triclocarban, and Methyltriclosan……………………….….………………............28 
2.5  Conclusions…………………………………………………………………………………………..41 
Chapter 3:  Fate of Triclosan, Triclocarban, and Their Transformation Products in 
Wastewater Under Nitrifying Conditions……………………………………………………………42 
3.1  Abstract……………………………………………………………………………………………….42 
3.2  Introduction…………………………………………………………………………………………...43 
3.3  Materials and Methods………………………………………………………………………………45 
3.3.1  Target Analytes…………………………………………………………………………………….45 
3.3.2  Wastewater Treatment Plant Background………………………………………………………46 
3.3.3  Benchtop Bioreactor Experimental Setup………………………………………………………46 
3.3.4  Extraction and Analysis of Target Analytes…………………………………………………….48 
3.3.5  Secondary Analyses………………………………………………………………………………50 
3.3.6  Quality Assurance/Quality Control………….……………………………………………………51 
3.4  Results and Discussion……………………………………………………………………………..51 
3.4.1  Triclosan and Its Transformation Products………..……………………………………………52 
3.4.2  Triclocarban and Its Transformation Products…….……………………………………………58 
3.5  Conclusions……………………….………………………………………………………………….59 
3.6  Acknowledgements………………………………………………………………………………….61 
Chapter 4:  Influence of Thermal Hydrolysis-Anaerobic Digestion Treatment of Wastewater  
Solids on Concentrations of Triclosan, Triclocarban, and their Transformation Products in 
Biosolids…………………………………………………………………………………………………..62 
4.1  Abstract……………………………………………………………………………………………….62 
 
4.2  Introduction…………………………………………………………………………………………...63 
4.3  Materials and Methods………………………………………………………………………………65 
4.3.1  Target Analytes…………………………………………………………………………………….65 
4.3.2  Wastewater Treatment Plant……………………………………………………………………..67 
4.3.3  Sample Collection and Handling…………………………………………………………………68 
4.3.4  Standards and Reagents…………………………………………………………………………70 
4.3.5  Triclosan, Triclocarban, & Transformation Product Extraction and Analysis… …………….71 
 iv
4.4  Results and Discussion……………………….…………………………………………………….74 
4.4.1  Concentrations in the TH-AD Process…..………………………………………………………74 
4.4.2  Concentrations in Biosolids……………..………………………………………………………..76 
4.5  Conclusions………………………………………..…………………………………………………82 
4.6  Acknowledgements………………………………………………………………………………….83 
Chapter 5:  Effect of Cambi Thermal Hydrolysis Process-Anaerobic Digestion Treatment 
on Concentrations of Phthalate Plasticizers in Wastewater Sludge…………………………...84 
5.1  Abstract……………………………………………………………………………………………….84 
5.2  Introduction…………………………………………………………………………………………...85 
5.3  Materials and Methods………………………………………………………………………………87 
5.3.1  Target Analytes…………………………………………………………………………………….87 
5.3.2  Sample Collection and Handling…………………………………………………………………87 
5.3.3  Standards and Reagents…………………………………………………………………………90 
5.3.4  Extraction Method…………………………………………………………………………………90 
5.3.5  Instrument Analysis………………………………………………………………….…………….91 
5.3.6  Quality Assurance and Quality Control………………………………………….………………91 
5.4  Results and Discussion…………………………………………………………….……………….92 
5.4.1  Influence of TH-AD Treatment…………………………………………………..……………….92 
5.4.2  Comparison of plasticizers in Class A and Class B biosolids……………….………………..95 
5.4.3  Predicted Concentrations of Phthalate Plasticizers in Soil…………………………………..100 
5.5  Conclusions…………………………………………………………………………………………102 
5.6  Acknowledgements………………………………………………………………………………...102 
Chapter 6:  Fate of Four Phthalate Plasticizers Under Various Wastewater Treatment 
Processes…………………………….…………………………………………………………………103 
6.1  Abstract……………………………………………………………………………………………...103 
6.2  Introduction………………………………………………………………………………………….104 
6.3  Materials and Methods…………………………………………………………………………….106 
6.3.1  Sample Collection and Handling……………………………………………………………….106 
6.3.2  Study treatment facilities………………….……………………………………………………..107 
 v
6.3.3  Standards and Reagents………………………………………………………………………..107 
6.3.4  Extraction Method………………………………………………………………………………..107 
6.3.5  Instrumental Analysis……………………………………………………………………………109 
6.4  Results and Discussion……………………………………………………………………………109 
6.4.1  Di(2-ethylhexyl) Phthalate (DEHP)……………………………………………………………..109 
6.4.2  Diisononyl Phthalate (DiNP)…………………………………………………………………….113 
6.4.3  Diisodecyl Phthalate (DiDP)…………………………………………………………………….115 
6.4.4  Benzyl Butyl Phthalate (BBP)…………………………………………………………………..117 
6.4.5  Predicted Environmental Concentrations of PAEs in Soil and DEHP Risk………………..119 
6.5  Conclusions…………………………………………………………………………………………121 
6.6  Acknowledgements………………………………………………………………………………...123 
Chapter 7:  Influence of Anaerobic Digestion With and Without Thermal Hydrolysis 
Pretreatment on Concentrations of Endocrine Disrupting Compounds and Their 
Transformation Products in Wastewater Sludge………………………………………………...124 
7.1  Abstract……………………………………………………………………………………………...124 
7.2  Introduction………………………………………………………………………………………….125 
7.3  Materials and Methods…………………………………………………………………………….127 
7.3.1  Wastewater Treatment Plant Background…………………………………………………….127 
7.3.2  Sample Collection and Experimental Setup.………………………………………………….127 
7.3.3  Target Analytes…………………………………………………………………………………..129 
7.3.4  Substrate Characterization……………………………………………………………………...130 
7.3.5  Volatile Fatty Acid Analysis……………………………………………………………………..131 
7.3.6  Methane Biogas Characterization………………………………………………………….…..131 
7.3.7  Quality Assurance/Quality Control……………………………………………………………..131 
7.4  Results and Discussion……………………………………………………………………………132 
7.4.1  Antimicrobial Compounds……………………………………………………………………….132 
7.4.2  Phthalic Acid Esters……………………………………………………………………………...136 
7.5  Conclusions…………………………………………………………………………………………140 
7.6  Acknowledgements………………………………………………………………………………...140 
 vi
Chapter 8:  Impact of Various Wastewater Treatment Conditions on Concentrations of 27 
Emerging Contaminants and Their Estimated Concentrations in Soils……………………..141 
8.1  Abstract……………………………………………………………………………………………...141 
8.2  Introduction………………………………………………………………………………………….141 
8.3  Materials and Methods…………………………………………………………………………….144 
8.3.1  Target Analytes…………………………………………………………………………………..144 
8.3.2  Sample Collection and Handling……………………………………………………………….144 
8.3.3  Extraction Method………………………………………………………………………………..146 
8.3.4  Instrumental Analysis……………………………………………………………………………147 
8.3.5  Quality Assurance/Quality Control……………………………………………………………..148 
8.4  Results and Discussion……………………………………………………………………………149 
8.4.1  Pharmaceuticals and Personal Care Products (PPCPs)…………………………………….149 
8.4.2  Pesticides…………………………………………………………………………………………154 
8.4.3  Fire Retardants………….………………………………………………………………………..156 
8.4.4  Food Additives……………………………………………………………………………………158 
8.4.5  Surfactants………………………………………………………………………………………..160 
8.4.6  Predicted Environmental Concentrations in Soil……………………………………………...160 
8.5  Conclusions…………………………………………………………………………………………163 
Chapter 9:  Conclusions and Future Work……………………………………………………..…164 
9.1  Conclusions…………………………………………………………………………………………164 
9.2  Future Work…………………………………………………………………………………………166 






List of Tables 
Table 1-1:  Compounds for Method Development……………………………………………………16 
Table 2-1:  Compounds Analyzed and Their Structures……………………………………………..20 
Table 2-2:  Method detection limit (MDL), Relative Standard Deviation (RSD),  
Recoveries (Rec) and Quantification Limits (LOQ) (n=7)……………………………………..28 
Table 2-3:  Calculated TCS, TCC, and MeTCS Rates of Change During  
Activated Sludge Treatment………………………………………………………………………29 
Table 3-1:  Experimental Conditions for Bioreactor Runs……………………………………………48 
Table 3-2:  TCS. TCC, MeTCS Rates of Change in Nitrification and Activated Sludge………….55 
Table 4-1:  MDLs and Recoveries of Target Analytes………………………………………………..73 
Table 4-2:  Typical Nutrient Concentrations in Class A and Class B Biosolids……………………82 
Table 5-1:  Average Concentrations of Phthalate Plasticizers in Biosolids and  
their Predicted Environmental Concentrations………………………………………………..101 
Table 6-1: Treatment Details for the Six Study WWTPs……………………………………………108 
Table 6-2:  Concentrations and calculated percent changes of PAEs during  
each stage of treatment in WWTPs #1 – 6……………………………………………………111 
Table 6-3:  Predicted environmental concentrations of PAEs in soils for each  
WWTP after a single biosolids application…………………………………………………….120 
Table 6-4:  DEHP risk quotients for terrestrial organisms for each WWTP after  
a single biosolids application……………………………………………………………………122 
Table 7-1:  Compounds Analyzed and Their Descriptions, Recoveries, and LOQs…….……….129 
Table 7-2:  Phthalic Acid Ester Rates of Change During Anaerobic Digestion…………………..137 
Table 8-1:  Compounds Analyzed and Their Physiochemical Properties………………………...145 
Table 8-2:  Overall Changes in Detected PPCP Compound Concentrations…………………….150 




List of Figures 
 
Figure 1-1:  Worldwide projected population growth and chemical consumption…………………..1 
Figure 1-2:  Process Flow Diagram of DC Water’s Blue Plains WWTP……………………………..8 
Figure 2-1  Concentrations of TCS in a) Solids and b) Aqueous Factions of Activated  
Sludge Samples Over Time………………………………………………………………………30 
Figure:  2-2  Concentrations of TCC in a) Solids and b) Aqueous Factions of Activated  
Sludge Samples Over Time………………………………………………………………………34 
Figure 2-3:  Concentrations of MeTCS in the Solids Faction of Activated Sludge  
Samples at a) 21°C and b) 30°C Over Time……………………………………………………37 
Figure 3-1:  Concentrations of TCS in a) Solids and b) Aqueous Factions of  
Nitrification Samples Over Time………………………………………………………………….53 
Figure 3-2:  Concentrations of MeTCS in the Solids Fraction of Nitrification Samples…………..56 
Figure 3-3:  Concentrations of 2,4-DCP in the Solids Fraction of Nitrification Samples………….58 
Figure 3-4:  Concentrations of TCC in a) Solids and b) Aqueous Factions of  
Nitrification Samples Over Time………………………………………………………………….60 
Figure 4-1:  Structures of Triclosan, Triclocarban, and their Transformation Products…………..66 
Figure 4-2:  Diagram of the CambiTHP™ - Anaerobic Digestion Solids Treatment  
Process and Sampling Locations………………………………………………………………..69 
Figure 4-3:  Concentrations of TCC, TCS, MeTCS, and 2,4-DCP in Individual  
Stages of the TH-AD Treatment Process……………………………………………………….74 
Figure 4-4:  Concentrations of a) TCC, b) TCS, c) MeTCS, and d) 2,4-DCP in  
Class A and Class B Biosolids…………………………………………………………………...77 
Figure 4-5:  Concentrations of TCS, MeTCS, and 2,4-DCP in Class A Biosolids and  
Class B Biosolids (Corrected for Solids Concentration Losses)……………………………...81 
Figure 5-1:  Diagram of the Cambi THP™-Anaerobic Treatment Process………………………...89 
Figure 5-2:  Concentrations of DEHP, DiNP, and DiDP and BBP (x10) in Individual  
Stages of TH-AD Treatment……………………………………………………………………………..93 
 ix
Figure 5-3:  Concentrations of a) DEHP, b) DiNP, c) DiDP, and d) BBP in Class A  
and Class B Biosolids………………………….………………………………………………….96 
Figure 5-4:  Concentrations of Phthalate Plasticizers in Class A Biosolids and Class 
B Biosolids (Corrected for Solids Concentration Losses)……………………………………..99 
Figure 6-1:  Concentrations of a) DEHP, b) DiNP, c) DiDP, and d) BBP during each  
stage of treatment in WWTPs #1 – 6…………………………………………………………..110 
Figure 7-1:  Concentrations and Trends of a) TCS, b) MeTCS, c) 2,4-DCP, and  
d) TCC in Anaerobic Digestion Samples With and Without TH Pretreatment……………..133 
Figure 7-2:  Concentrations and Trends of a) DEHP/MEHP Without TH Pretreatment,  
b) DEHP/MEHP With TH Pretreatment, c) DiNP/MNP Without TH Pretreatment,  
d) DiNP/MNP With TH Pretreatment, e) BBP/MBuP/MBeP Without TH Pretreatment,  
and f) BBP/MBuP/MBeP With TH Pretreatment in Anaerobic Digestion Samples………..139 
Figure 8-1:  Concentrations of Detected PPCPs in Each WWTP Treatment Stage…………….151 
Figure 8-2:  Concentrations of Detected Pesticides in Each WWTP Treatment Stage...……….155 
Figure 8-3:  Concentrations of Detected Flame Retardants in Each WWTP  
Treatment Stage………………………………………………………………………………….157 
Figure 8-4:  Concentrations of Detected a) Food Additives and b) Surfactants in  
Each WWTP Treatment Stage…………………………………………………………………………159 
 
 1 
Chapter 1:  Introduction 
1.1  Background 
1.1.1  Organic Compounds in Wastewater Treatment 
 Modern society relies heavily on chemical use; whether the consumption is 
industrial, medicinal, agricultural, or household, the utilization of chemicals has 
become prolific in everyday human life.  Due to this heavy reliance, chemical use 
worldwide is expected to increase well beyond human population growth, as outlined 
in Figure 1-1 [1].  Unsurprisingly, this has resulted in the presence of numerous 
compounds within the wastewater treatment system.   
The primary objective of wastewater treatment is the reduction nutrients, pathogens, 
turbidity, and organics from raw sewage prior to release into local water bodies.  
Because treatment systems are not focused on removal of anthropogenic chemicals, 
their removal efficiencies can be varied depending on the treatment systems 
employed by individual wastewater treatment plants (WWTPs) [2]. 
Figure 1-1:  Worldwide projected population growth and chemical consumption [1] 
 2 
Pharmaceutical compounds, both prescribed and over the counter, can reach 
wastewater treatment systems through numerous sources, including consumer 
excretion via urine or feces, improper disposal (i.e. flushing of substances), 
manufacturing facility wastewater, hospital wastewater, and landfill leachate [3,4].  
Excreted compounds can take the form of untransformed pharmaceuticals or as 
various metabolites of the parent compound.  The rates of excretion can vary 
depending on the chemistry of the compound but are estimated to be as high as 70 - 
90% for antibiotics.  However, even pharmaceuticals with low excretion rates can be 
found at relatively high levels in wastewater if consumption of the compound is high 
[5].  Chemicals associated with personal care products, such as antimicrobials in 
soaps, fragrances, UV blockers in sunscreens, etc. [6,7], are typically washed down 
drains and into the wastewater treatment system due to the nature of their 
consumption [8].  Due to frequent daily use of pharmaceuticals and personal care 
products (PPCPs), compounds within this classification are commonly detected in 
wastewater samples.  A study of a Portuguese WWTP found a number of 
pharmaceuticals in influent samples, with anti-diabetics, analgesics/antipyretics, and 
psycho-stimulants detected at the highest concentrations.  Removal efficiency of 
detected compounds varied and was determined to rely on the efficiency of the 
secondary treatment method [9].  Furthermore, research focusing on 56 
pharmaceuticals and pharmaceutical metabolites at a German WWTP found that 
while significant aqueous phase removal occurred for 20 of the analyzed 
compounds, only 5 were removed more than 50%.  Additionally, concentrations of 5 
different compounds were found to increase during treatment [10].  Levels of the 
antimicrobials triclosan and triclocarban were found to decrease by over 97% during 
 3 
sewage treatment, but a majority of this removal was due to association with solids 
rather than actual degradation of the compounds [11]. 
 Phthalic acid esters (PAEs), also known as phthalate plasticizers can enter 
wastewater systems through the use of plastics (leaching), such as PVC piping, and 
urban runoff [12-14].  These compounds are produced in high volumes worldwide - 
over 4 million metric tons per year and > 90% of worldwide plasticizer production 
[13,15,16] and have been detected in wastewater treatment at high concentrations.  
During the treatment process, high molecular weight PAEs tend to sorb to solids, 
causing them to be present at notable levels in biosolids.  Dargnat et al. (2009) 
found that of the 78% removal of bis(2-ethylhexyl) phthalate (DEHP) during 
treatment, a significant portion of that was due to association with sludge rather than 
actual degradation of the compound [13].  A study of six PAEs in Austrian WWTPs, 
showed that DEHP, benzyl butyl phthalate (BBP), and dibutyl phthalate (DBP) 
predominantly associated with wastewater sludge rather than undergo 
biotransformation or discharge via liquid effluent.  Concentrations of DEHP were 
approximately two orders of magnitude higher in sludge samples than the other 
compounds analyzed and ranged from 20,00 to 29,000 µg/kg [17]. 
 Numerous compounds fall into the “flame retardant” category.  As with other 
discussed chemicals, their prolific use has caused them to be present in the 
wastewater treatment system.  Polybrominated diphenyl ethers (PBDEs), for 
example, can be released into waste treatment via the washing of textiles treated 
with the compounds or exposed to such compounds via indoor dust [18].  PBDE and 
polychlorinated biphenyl (PCB) congeners have been found to overwhelmingly 
associate with wastewater sludge during treatment, while flame retardants such as 
triphenyl phosphate (TPP) tend to associate with the aqueous faction [19].  In a 
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study focused on Swedish sewage sludge, Olofsson et al (2013) found that 
concentrations of 7 PCB compounds ranges from 23 – 100 µg/kg while PBDEs 
ranged from 390 – 870 µg/kg.  Both compound classifications were detected with 
100% frequency in collected sludge samples.  Additionally, organo phosphorus 
compounds, including TPP, ranged from 310 – 2800 µg/kg [20].  A study on the 
trends of PBDEs in limed biosolids over a 7-year period demonstrated that while 
concentrations of the congeners BDE-47 and BDE-99 decreased by 42%, likely due 
to phase-out, concentrations of BDE-209 generally remained steady during the 
sample period [21].    
 The presence of numerous anthropogenic compounds in the wastewater 
treatment system and the inability of treatment to consistently degrade compounds 
have drawn concern regarding the environmental health impacts.  Specifically since 
effects due to long-term exposure at trace concentrations is not well understood for 
many chemicals.  
1.1.2  Health and Environmental Concerns of Organic Pollutants 
 Varied removal efficiencies of anthropogenic organic pollutants by 
wastewater treatment leads to their presence in the environment primarily due to 
discharge of effluent into local water bodies or the land application of treated sewage 
sludge, known as biosolids [22].  Detection of pharmaceutical compounds in water 
bodies downstream of WWTPs is common.  A two-year study of the Huangpu River 
system in China detected ibuprofen, naproxen, ketoprofen, diclofenac and clofibric 
acid at various sample sites, with average concentrations ranging from 1.6 – 28.6 
ng/L.  A cause for concern not just for environmental health, but human health as 
well since the river system acts as a source of raw drinking water for Shanghai [23].  
Numerous PPCP compounds have been detected in tissue (brain, liver, kidney, and 
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muscle) and plasma samples of Japanese wild cyprinoid fish whose habitat entailed 
streams impacted by wastewater treatment [24].  Triclosan and its metabolite methyl 
triclosan have been demonstrated to persist in soils amended with wastewater 
biosolids, with half lives estimated to be 104 and 443 days, respectively [25].  Both 
compounds have been shown to possess endocrine disrupting capabilities [26,27].  
Uptake of carbamazepine by zucchini plants has been demonstrated to reduce plant 
biomass, both above and below ground, reduction of photosynthetic pigment in plant 
leaves, shifts in hormone concentrations within the plants, and leaf nutrient levels 
[28]. 
 Once present in environmental samples, PAEs have been found to migrate to 
living organisms.  For instance, studies have found that the compounds can transfer 
from soils to vegetation.  A cultivation study conducted using lettuce, strawberry, and 
carrots determined that DEHP, DBP, and their primary metabolites could be 
translocated into plant tissues, with bioconcentration factors ranging from 0.16 to 
4.78 [29].  A study regarding anthropogenic compounds and their concentrations in 
soils and earthworms after biosolids amendments to soils found soils levels for 
diethylhexyl phthalate to range from non detect (ND) to 2251 ng/g while earthworm 
concentrations ranged from ND to 288 ng/g [30].  While some compounds within the 
PAE classification may be rapidly degraded under the proper conditions [31], they 
still are of health concern.  The developmental effects of DEHP have been classified 
as “a serious concern” to critically ill children while the compound’s reproductive 
effects are classified as a “concern” to children under one year old and “some 
concern” for male fetuses during pregnancy and children over the age of one 
exposed to high doses [32].  Furthermore, it has been demonstrated that PAE 
metabolites can posses toxicological properties [31].    
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 Flame retardants have been found in environmental and biotic samples 
worldwide.  PBDEswere found in dolphin samples from Brazil ranging from 3 – 5960 
ng/, in US osprey eggs at concentrations of 98 – 897 ng/g, in United Kingdom (UK) 
harbor porpoises at 54.6 – 913 µg/kg, Korean blue mussels at 6.6 – 44 ng/g, etc.   
Polychlorinated biphenyls have been detected in Canadian sea lion samples from 
272 – 14280 µg/kg, Greenland polar bears at 10537 ng, UK otter livers from 1.8 – 
140000 ng/g, from 0.1 – 0.28 ng/g in clam samples collected in Fiji, etc. [33].  
Andrade et al (2010) found that after application of biosolids, average concentrations 
of PBDEs in soil ranged from 15.2 µg/kg in fields that had received one application to 
53.0 µg/kg in fields with multiple biosolids applications.  Of the congeners analyzed, 
BDE-209 was detected at the highest rate [34].  Flame retardants such as the 
PBDEs have demonstrated the ability to disrupt thyroid function (distorted 
functionality and reduction of hormone levels) and cause neurodevelopmental 
effects and cancer [35].  
 The environmental and health impacts of anthropogenic compounds, whether 
they are released into the environment via wastewater treatment or other 
mechanism, are still being understood.  However, current research indicates that the 
impacts of the vast numbers of compounds can have numerous effects, including 
bioconcentration/bioaccumulation, endocrine disruption, growth limitations, etc.  
Limiting the use of these compounds, where able, and understanding how 
wastewater treatment impacts these compounds and what treatments and changes 





1.1.3  Overview of Study Wastewater Treatment Plant (DC Water, Blue Plains) 
 DC Water’s Blue Plains Advanced WWTP serves a population of over 2 
million residents from Washington DC, Maryland, and Virginia.  A large-scale 
WWTP, Blue Plains treats an average of 1.14 million m3 of raw wastewater per day.  
Maximum treatment capacity is 1.4 million m3.  The Blue Plains facility achieves 
waste treatment via sedimentation, activated sludge, nitrification-denitrification, 
filtration, and disinfection.  Sludge is treated via the pretreatment by the Cambi 
Thermal Hydrolysis Process™ (CambiTHP) and mesophilic anaerobic digestion.  
Biosolids produced by this method are considered Class A biosolids by the US EPA.  
Prior to 2015, sludge waste treated by the addition of lime, on a 15 – 20% by weight 
basis.  Class B biosolids were produced from this method.  A majority of the 
biosolids produced by Blue Plains are land applied for agricultural use.  Figure 1-2 
outlines the current treatment system at Blue Plains. 
1.2  Research Objectives 
 WWTPs can employ an assortment of treatment methods, and as such, 
degradation and removal of anthropogenic organic pollutants can vary widely.  Even 
variations of the same treatment method can have significant influence on 
compound removal.  For instance, Badia-Fabregat et al. (2015) found that 
pharmaceutically active compounds were better removed via fungal degradation 
when external nutrients (glucose and ammonia tartrate) were added to the treatment 
process while an increase in aeration led to an increase in levels of several 
compounds, including salicylic acid and ketoprofen, among others [36].  Moreover, 
factors such as sludge “age”, hydraulic retention times, and ambient temperatures 




Figure 1-2:  Process Flow Diagram of DC Water’s Blue Plains WWTP 
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compound degradation [2].  Additionally, degradation effectiveness is influenced by 
the chemical properties of individual compounds [2]. 
Furthermore, degradation of a parent compound of concern does not 
guarantee that the pollutant is being fully mineralized.  Quite often the chemicals is 
transformed into numerous degradation products that may have environmental and 
health implications of its own.  Transformation products and pathways are often 
poorly characterized [2] and represent a gap in the research regarding the fate of 
organic pollutants in the wastewater treatment process.  A survey of scientists in the 
environmental field identified research priorities of PPCPs to include the questions 
“what effluent treatment methods are effective in reducing the effects of PPCPs in 
the environment whereas at the same time not increasing the toxicity of whole 
effluents?” and “how can the environmental risks of metabolites and environmental 
transformation products of PPCPs be assed?” [37].  Considering all this, the 
objective of this research project focus on the impact that amending in-place 
treatment can have on compounds of concern and their transformation products, 
how new treatment technologies effect compound and transformation product 
concentrations, and analysis of samples using a method that can detect for a large 
number of compounds at once, allowing for a more efficient analysis and more 
readily broadens the understanding of the fate of anthropogenic compounds in 
wastewater treatment. 
1.2.1  Objective #1:  Study the influence that aerobic treatment processes 
(activated sludge and nitrification) have on degradation of the antimicrobials 
TCS and TCC as well as the formation of their transformation products using 
benchtop bioreactors.  
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Hypothesis 1-1:  TCS will be degraded by both processes, resulting in formation of 
degradation products, but more effectively by activated sludge.  As TCS 
concentrations decrease, we expect higher concentrations of MeTCS. 
Hypothesis 1-2:  Degradation of TCC will be more limited than TCS but will occur; 
degradation will be more effective during nitrification. 
Experimental Approach/Tasks: 
Study the influence that aerobic treatment processes (activated sludge and 
nitrification) have on degradation of the antimicrobials TCS and TCC as well as the 
formation of their transformation products using benchtop bioreactors.  
New Brunswick BioFlo® 115  benchtop bioreactors will be used to simulate 
the activated sludge and nitrification processes.  Utilization of these bioreactors will 
allow for the simulation of the wastewater treatment processes (activated sludge and 
nitrification) under controlled laboratory conditions.   
Activated Sludge Experiments 
Activated sludge (AS) bioreactor experiments will be run for 122 hours to 
simulate extended hydraulic retention time.  Two bioreactors will be run 
simultaneously (under duplicate conditions) and experiments will be performed with 
5 L (per reactor) of mixed liquor collected from DC Water’s AS reactors (near reactor 
input, in an area where sufficient mixing was occurs).  Two reactor “runs” will be 
performed at different temperatures to understand temperature effects on compound 
degradation.  Reactor conditions are as follows: 
• Temperature:  21°C (Run #1) and 30°C (Run #2). 
• pH:  6.5 – 7.5 
• DO:  4 mg/L 
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Samples (160 mL) will be collected periodically from the reactors for TCS, TCC, 
and MeTCS analysis of both the aqueous and solid phase.  Additionally, activated 
sludge samples will be scanned (qualitatively) for the TCS and TCC transformation 
products: 2,4-DCP, TCS-o-sulfate (TCS-o-sulf), 3,4-DCA, 4-CA, 4,4’-
dichlorocarbanilide (DCC), 1-(3-chlorophenyl)-3-phenylurea (MCC), and carbanilide 
(NCC).   
Nitrification Experiments 
Nitrification bioreactor experiments will be run for 171 hours to, again, simulate 
extended hydraulic retention time.  As with the AS experiments, two bioreactors will 
be run concurrently under matching conditions with 5L of sample collected from DC 
Water’s nitrification reactors (in a well mixed area close to reactor input).  The two 
reactor “runs” will be performed at different pH ranges as this can influence the 
activity of nitrifying bacteria species.  Reactor conditions are as follows: 
• Temperature:  21°C 
• pH:  6.5 – 7.5 (Run #1) and 8.5 – 9.5 (Run #2) 
• DO:  2.5 mg/L 
Samples (200 mL) will be collected from the reactors periodically and analyzed 
quantitatively for TCS, TCC, MeTCS 2,4-DCP, TCS-o-sulf, 3,4-DCA, 4-CA, DCC, 
MCC, and NCC. This study will allow for the determination of TCS and TCC 
degradation rates as well as formation rates of detected transformation products. 
1.2.2  Objective #2:  Determine how the TH-AD influences concentrations of 
TCC, TCS, and their transformation products as well as phthalic acid esters in-
plant.  
Hypothesis 2-1:  The thermal hydrolysis process will have the ability to partially 
degrade TCS, TCC, and MeTCS and will result in the formation of 4-CA and 3,4-
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DCA due to hydrolysis of TCC.  Concentrations of DEHP, DiNP, DiDP, and BBP will 
also degrade during treatment. 
Hypothesis 2-2:  Remaining concentrations of TCS and TCC will be dechlorinated 
during anaerobic digestion and will result in the formation of the dechlorination 
products of TCC.  Concentrations of the phthalates DEHP, DiNP, DiDP, and BBP will 
be unaffected by anaerobic digestion treatment. 
Experimental Approach/Tasks: 
The second objective of this research project is to determine the influence 
that the TH-AD process has on concentrations of TCS, TCC and their degradation 
products as well as four phthalic acid ester compounds when compared to 
concentrations in limed (Class B) biosolids.  Class B biosolids have been collected 
routinely from the DC Water facility since 2005 as part of previous experiments on 
temporal trends of organic compounds in biosolids.  Samples were collected directly 
after the liming/mixing process (prior to on-site storage) and have been archived at -
20°C for future use.  Implementation of the TH-AD process began in 2014 and Class 
A biosolids from this process have also been collected regularly and archived at -
20°C for future analysis.  Class A biosolids (collected after January 2015) and Class 
B biosolids (collected between August 2011 and January 2015) will be analyzed for 
TCS, TCC, TCC/TCS transformation products, DEHP, DiNP, DiDP, and BBP to 
compare how concentrations of these compounds in the final biosolids product 
differs with change in sludge treatment processes.  Additionally, sludge samples will 
be collected throughout the TH-AD process, including the final cake (Class A 
biosolids) for compound analysis.  This will help to demonstrate the degree of 
degradation and transformation compound formation, if any, that occurs in each step 
of the TH-AD process.  This study will give insight into the ability of the TH-AD to 
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degrade these endocrine disrupting compounds as well as the influence that a major 
change in solids treatment has on final compound concentrations in biosolids prior to 
land-application. 
1.2.3  Objective #3:  Influence of Aerobic and Anaerobic Treatment Processes 
on Concentrations of Phthalate Acid Esters 
Hypothesis 3-1:  Anaerobic digestion processes will have no effect on concentrations 
of DEHP, DiNP, DiDP, and BBP while aerobic processes will degrade the 
compounds. 
Experimental Approach/Tasks: 
Research from this task will focus on the fate of four PAEs during solids 
treatment at six different WWTPs.  Grab samples will be collected prior to treatment, 
after treatment (including individual treatment steps), and from final solids processes 
in order to understand the impact that the individual solids treatment has on 
compound concentrations.  Samples will be collected from DC Water’s Blue Plains 
facility in Washington, DC, and the following Maryland WWTPs:  Marlay-Taylor, Sod 
Run, Back River, Tolchester, and Worton.  Samples will be analyzed for DEHP, 
DiNP, DiDP, and BBP.  The study WWTPs represent a mixture of large and small 
WWTPs located in urban and rural areas.  Four of the facilities employ anaerobic 
processes while the remaining two utilize aerobic processes.  This research will 
allow for a straightforward comparison of 1) how different treatment processes 
(aerobic and anaerobic) impact concentrations of PAEs and 2) how similar 
processes at different facilities can impact compound concentrations. 
1.2.4  Objective #4:  Simulate the anaerobic digestion process with and without 
thermal hydrolysis pretreatment using bioreactors to gauge the degradation of 
TCS, TCC, and PAEs and the formation of transformation products. 
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Hypothesis 4-1:  Concentrations of TCS, TCC will not readily degrade while 
transformation product formation will be minimal in anaerobically digested sludge 
pretreated with the thermal hydrolysis process. 
Hypothesis 4-2:  Concentrations of PAEs will increase while concentrations of 
transformation products will decrease in anaerobically digested sludge pretreated 
with the thermal hydrolysis process. 
Experimental Approach/Tasks: 
 Degradation studies will be conducted using sealed serum bottles shaken 
continuously in a dark incubation chamber under mesophilic conditions.  Destructive 
samples techniques will be utilized.  Solids material will be collected before thermal 
hydrolysis treatment, after the flash tank of the process, and from the anaerobic 
digestion tanks at DC Water’s Blue Plains facility.  Reactors will setup to achieve a 
inoculum to substrate volatile solids ratio of 1.5:1.  Experiments will be run for 22 
days and samples will be collected periodically from for analysis of TCS, TCC, and 5 
transformation products as well as DEHP, DiNP, BBP, and 4 metabolites.  Samples will 
also be analyzed for total solids, total volatile solids, chemical oxygen demand, and 
volatile fatty acids.  Finally, gas will be collected, the flow measured, and analyzed for 
methane via a gas chromatograph.  The reactors will be covered with aluminum foil to 
prevent any potential compound loss through photolysis.  This study will allow for the 
calculation or degradation rates as well as metabolite formation rates. 
1.2.5  Objective #5:  :  Analyze for 27 compounds of concern in sludge samples 
and determine the influence of wastewater treatment processes on 
concentrations of compounds. 
Hypothesis 5-1:  Degradation via aerobic and anaerobic digestion will be compound 
specific. 
 
Hypothesis 5-2:  Compounds not degraded during treatment will be concentrated 
due to the reduction in mass of solids during anaerobic digestion. 
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Experimental Approach/Tasks: 
The first task of this objective is to fine-tune a previously established 
extraction methods for wastewater solids and analyze up to 53 chemical pollutants 
(list to be narrowed down based on recovery percentages) in sludge samples 
collected throughout the TH-AD process.  The compound list, provided in Table 1-1, 
a) represents a mix of compounds that are commonly found in the WWT process, b) 
consists of an variety of use classifications, and c) is made-up of chemicals with 
varying physical and chemical properties.  A Shimadzu ultra high performance liquid 
chromatograph, triple quadrupole mass spectrometer (UPHLC MS/MS) will be 
utilized for analysis.  Common extraction methods (sonication, microwave, and 
pressurized liquid extraction), in conjunction with solid phase extraction (SPE) 
cleanup, will be compared to determine the most efficient mode of extraction.  While 
the development of a full extraction and analytical method for all 53 compounds may 
not be possible, the goal is to establish a working method for as many of the 
compounds as possible. 
 Once the final analytical/extraction method is determined, samples collected 
from Objective #3 will be analyzed for the adjusted compound list.  This allows for 
comparison of the impact that different treatment (i.e. anaerobic digestion, aerobic 
digestion) methods have on compound concentrations in sludges and biosolids.  
Sludge samples from each WWTP will be collected pre-treatment, post-treatment, 
and as final solids (biosolids).  Collecting and analyzing samples from different 
facilities will give insight into trends of compound concentrations among different 




Table 1-1:  Compounds for Method Development 
 
Chemical Use Compound Chemical Use Compound 
Angiotensin II receptor blocker Irbesartan 
Herbicide 
Atrazine 




Trimethoprim Hormone Testosterone 
Anticonvulsant Primidone Insect repellent N,N-Diethyl-3-methylbenzamide [DEET] 




Fluoxetine  Emamectin benzoate  
Venlafaxine  Flubendiamide 
Antifungal Fluconazole Nondihydropyridine (non-DHP) Diltiazem hydrochloride 
Antihistamine Diphenhydramine  
Nonsteroidal Anti-inflammatory Drug 
(NSAID) 






Bis(2-ethylhexyl) phthalate [DEHP] 
Artificial Sweetener 
Acesulfame Potassium Bisphenol A 
Aspartame Diisodecyl phthalate [DIDP] 
Saccharin Diisononyl phthalate [DINP] 







Hydrocortisone Stimulant Caffeine 
Prednisone 
Surfactant 
Perfluorohexanoic acid [PFHxA] 
Triamcinolone Perfluorononanoic acid [PFNA] 
Fire retardant 
TCPP, mixture of isomers Perfluorooctanoic acid [PFOA] 
Triphenyl phosphate Perfluorooctanesulfonic acid [PFOS] 
Tris(2-butoxyethyl) phosphate UV Absorber Oxybenzone 
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2.1  Abstract 
 Benchtop bioreactors were run aerobically with activated sludge samples 
collected from a large municipal wastewater treatment plant (WWTP) to understand 
how increased hydraulic retention time (HRT), sludge retention time (SRT), and 
varying treatment temperatures (21°C and 30°C) impact concentrations of the 
endocrine disrupting antimicrobials triclosan (TCS), triclocarban (TCC), and their 
transformation products.  Samples from the reactors were collected periodically over 
a 122 to 196 h period and the solid and liquid fraction were separately quantitated for 
TCS, TCC, and methyltriclosan (MeTCS) and scanned qualitatively for six other 
transformation products.  Results indicated that TCS, TCC and MeTCS were 
predominately associated with the solids fraction of the activated sludge with only 
nominal concentrations in the liquids fraction.  TCS was degraded in the solids 
fraction, with increased rates at 30°C (-0.0224 ± 0.007 h-1) when compared to 
reactors run at 21°C (- 0.0170 ± 0.003 h-1).  Conversely, TCC concentrations did not 
significantly change in solids samples from reactors run at 21°C, while an increase in 
reactor temperature to 30°C resulted in TCC degradation at an average rate of - 
0.0158 ± 0.012 h-1.  Additionally, MeTCS formation in the solids fraction was 
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observed in three out of four reactors run - indicating a notable transformation of 
TCS.  Qualitative appearance of 2,4-dichlorophenol and 4-chloroanaline was 
observed in the liquids fraction of all reactor samples.  The remaining four 
qualitatively scanned compounds were not detected.  These experiments 
demonstrate that increased HRT, SRT, and temperature result in enhanced removal 
of TCS and TCC from wastewater during the activated sludge process.  
Furthermore, a substantial formation of TCS into MeTCS was observed. 
2.2  Introduction 
 Triclosan [5-chloro-2-(2,4-dichlorophenoxy) phenol] (TCS) and triclocarban 
[1-(4-chlorophenyl)-3-(3,4-dichlorophenyl) urea] (TCC) are antimicrobial organic 
chemicals utilized in a variety of consumer products, including personal care 
products, plastics, paints, and textiles [38].  Heavy use of these compounds has 
resulted in their presence in both environmental [39,40] and biotic samples [41-44], 
which has drawn concern due to the toxicological properties of TCS and TCC, most 
notably endocrine disruption [26,27,45,46].  These environmental and toxicological 
concerns have lead the United States Food and Drug Administration to issue a ruling 
restricting the use of these compounds in consumer products [47].  One such source 
of these antimicrobials to the environment is the wastewater treatment (WWT) 
process, where they are typically only partially degraded and, therefore, present in 
wastewater effluent [11], untreated sludge [48], and treated sludge or biosolids 
[21,48,49].  While degradation of TCS and TCC can occur during WWT, the extent to 
which this takes place is dependent on the treatment methods utilized by the WWT 
plant [49,50].   
TCS has been demonstrated to transform biologically into several 
compounds, including methyltriclosan (MeTCS), 2,4-dichlorophenol (2,4-DCP), and 
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4-chlorocatechol [11,51-53].  TCC, meanwhile, can be biologically transformed into 
carbanilides, including 4,4’-dichlorocarbanilide (DCC), 1-(3-chlorophenyl)-3-
phenylurea (MCC), and carbanilide (NCC), or either biologically or abiotically into 4-
chloroaniline (4-CA) [54].  Like their parent compounds, TCS and TCC 
transformation products, provided in Table 2-1, have themselves demonstrated 
undesirable environmental and health characteristics.  MeTCS has been 
demonstrated to be more persistent than TCS [25] and, like TCS, possesses 
endocrine disrupting capabilities [26].  Additionally the carbanilide analogs of TCC 
have also demonstrated the ability to impact the endocrine system [45].   
TCS and TCC degradation and the formation of transformation products have 
been shown to occur in the wastewater treatment process [11,50].  This research 
aims to simulate the activated sludge process in a controlled environment by using 
benchtop bioreactors, allowing for degradation rates and formation of degradation 
products to be determined under varying operational conditions.  Changes in 
concentrations of TCC, TCS, and MeTCS were determined in two reactors run 
simultaneously over a 122 to 196 hour time period at fixed-temperatures of 21°C and 
30°C and degradation or formation rates were calculated.  Additionally, samples 
collected from the reactors were monitored qualitatively for the presence of 2,4-DCP, 
DCC, MCC, NCC, 4-chlorocatechol, and 4-CA. The study was performed using in 
situ compound concentrations and microbial populations (no spiking or 
augmentation).  This research gives insight into how an individual, and common, 
treatment process can influence concentrations of antimicrobials and their 
transformation products in the wastewater treatment process and, thus, the amount 























Table 2-1:  Compounds Analyzed and Their Structures 
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2.3  Materials and Methods 
2.3.1  Standards and Reagents 
 TCC (>97%), TCS (>97%), MeTCS (>97%) and isotopically labeled 13C13-
TCC (≥99%), 13C12-TCS (≥99%), and 13C12-MeTCS (≥99%) were obtained from 
Wellington Laboratories (Guelph, ON, Canada).  MCC (N/A), NCC (98%), 3-CA 
(99%), 2,4-DCP (≥97%), and 4-chlorocatechol (97%) were obtained by Sigma-
Aldrich (St. Louis, MO, USA).  DCC (N/A) was acquired through Oakwood 
Chemicals (West Columbia, SC, USA).  Laboratory-grade sand was obtained from 
J.T. Baker® (Avantor Performance Materials, Center Valley, PA, USA).  Compound 
structures and properties are provided in Table 2-1. 
All organic solvents used were of high performance liquid chromatography 
(HPLC) grade (Burdick and Jackson; Fisher Scientific).  Potassium phosphate 
(monobasic) (99.2%), potassium phosphate (dibasic, anhydrous) (99.6%), 
ammonium acetate (99%), sulfuric acid, and acetic acid (both certified ACS grade) 
were obtained from Fisher Scientific (Fair Lawn, NJ, USA). Organic-free, UV-treated 
water was obtained using a Picosystem UV Plus treatment system (Hydro Service 
&Supplies, Inc.; Durham, NC, USA). 
2.3.2  Wastewater Treatment Plant Background and Sample Collection 
 Samples were collected directly from an activated sludge reactor at a large 
municipal WWT plant located in the Mid-Atlantic region of the United States (US).  
The facility serves a population greater than 2 million residents and treats 
approximately 1.25 million cubic meters (m3) of raw wastewater per day.  The raw 
wastewater at this facility is treated via preliminary treatment, primary treatment, 
aerobic secondary treatment (“activated sludge”), tertiary nitrification-denitrification 
treatment, filtration, and disinfection.  At the time of sampling, final solids were 
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handled by dewatering via centrifugation and treated with lime (~15% dry weight 
basis) to form Class B biosolids.  Solids treatment at the facility has since changed 
to the Cambi Thermal Hydrolysis Process™/anaerobic digestion [49,55]. 
 Mixed liquor samples were collected near the input of an activated sludge 
reactor, in an area where sufficient mixing was occurring.  All samples were grab 
samples.  After collection, samples were transferred to the laboratory rapidly for use 
within the bioreactors. 
2.3.3  Benchtop Bioreactors 
 Two BioFlo® 115 Benchtop Bioreactors (New Brunswick Scientific, Edison, 
NJ, USA) were utilized to simulate the activated sludge process (Figure SI-A1, 
supplemental information).  Reactors were run concurrently on two occasions, once 
at a temperature of 21°C and then at 30°C to observe the influence of temperature 
on concentrations of TCS and TCC and their transformation products.  Dissolved 
oxygen (DO) in each reactor was monitored via a DO probe and maintained at an 
approximate concentration of 4 mg/L via aeration and mixing.  pH was also 
monitored by probes and maintained in a neutral range of 6.5 to 7.5 by the addition 
of 3M sodium hydroxide (NaOH) or 1.5M sulfuric acid (H2SO4), as needed.  Mixing 
rates for DO concentration maintenance and the addition of acid/base to the reactors 
was controlled automatically by the BioFlow 115® control panel according to settings 
entered into the program prior to the start of each run.  Each reactor was covered in 
aluminum foil to avoid any photolysis. 
 Each reactor run lasted for at least 122 hours to simulate an extended 
hydraulic retention time (HRT) and extended sludge retention time (SRT).  The 
typical HRT is 6 - 8 h and the typical SRT is approximately 55 h at the facility.  These 
time periods may be much longer during low flow periods and much shorter during 
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high flow events at the facility.  Temperature ranges at the study WWTP are typically 
14°C to 23°C.  At the start of each run 5 L of mixed liquor was added to each 
reactor.  No additional mixed liquor was added once the experiments had begun.  
160 mL samples were collected from the reactors via a sample port at hours 0, 2, 4, 
6, 10, 12, 24, 28, 32, 36, 48, 54, 60, 72, 84, 96, 106, and 122.  Due to an 
observation of remaining solids in reactor #1 at 30˚C, this reactor was run for an 
additional 76 hours, with added sampling points at hours 150 and 198.  After sample 
collection, a portion of each sample was frozen at -20°C for later extraction and 
analysis of TCS, TCC, and transformation products while the remainder of the 
sample was utilized for the determination of solids, soluble chemical oxygen 
demand, and microbial activity. 
 Three airtight jars were set-up as control reactors.  Each control reactor was 
filled with 0.5 L mixed liquor collected in the same activated sludge tank of the 
WWTP used for the degradation experiments.  Mercuric chloride (1 g) was added to 
each control reactor to eliminate any bacterial activity. The control bioreactors were 
agitated and maintained at 30°C for 122 h. TCC and TCS were analyzed at the 
beginning and at the end of the experiment.  Additionally, samples from the control 
reactors at hours 0 and 122 were collected and plated to verify that bacteria within 
the reactors did not survive the mercury treatment. 
2.3.4  Solids Analysis 
 Total suspended solids (TSS), volatile suspended solids (VSS), total solids 
(TS), and total volatile solids (TVS) were processed as outlined by the US 
Environmental Protection Agency’s (US EPA) standard methods [56].  
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2.3.5  Microbial Activity 
 Each sample collected from the reactors was analyzed for total microbial 
activity using a modified version of a previously published method [57].  This method 
utilizes fluorescein diacetate  (FDA), which can be hydrolyzed by microbial enzymes 
to fluorescein, to determine relative microbial activity.  FDA methods have been 
shown to be effective in determining microbial activity in activated sludge samples. 
Briefly, 1 to 4 mL of mixed liquor from each reactor was placed into 50 mL 
Erlenmeyer flasks.  Fifteen (15) milliliters of a 60 mM potassium phosphate buffer 
(pH 7.6) and 0.2 mL of a 1000 μg/mL FDA solution was added to each flask and 
shaken briefly by hand.  Samples were incubated and agitated in a water bath at 
30°C.  After incubation, 15 mL of a chloroform:methanol solution (2:1 v/v) was added 
to each flask.  The samples were shaken by hand, transferred to disposable 
centrifuge tubes and centrifuged at 3000 x g for 3 minutes.  Samples were filtered 
into ultraviolet-visible (UV-Vis) spectrophotometer cells.  Fluorescein concentrations 
in the filtrates were determined using a UV-1800 UV-Vis spectrophotometer 
(Shimadzu North America, Columbia, MD, USA) at a wavelength of 490 nm.  The 
UV-Vis was previously calibrated using fluorescein standards of 0.1, 0.5, 1, and 5 
μg/mL.  All samples were extracted and analyzed in duplicate. 
2.3.6  Chemical Oxygen Demand 
 Soluble chemical oxygen demand (sCOD) was determined by filtering mixed 
liquor samples through a Whatman GA/F 0.7 μm filter (GE Healthcare Life Sciences, 
Pittsburgh, PA, USA).  Filtrates were acidified with H2SO4 and refrigerated at 4°C 
until analysis.  Low range dichromate COD vials  (0-150 ppm) (Chemetrics, Midland, 
VA, USA), in conjunction with a digester block and photometer (Hach Company, 
Loveland, CO, USA) were employed according to US EPA standard methods [56]. 
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2.3.7  Triclosan, Triclocarban, & Transformation Product Extraction and 
Analysis 
2.3.7.1   Sample Extraction 
After collection from the benchtop bioreactors, samples for TCC, TCS, and 
byproduct analysis were frozen at -20°C until extraction and analysis.  The liquid and 
solids fraction of the samples (40 mL aliquots) were separated via centrifugation at 
3000 x g for 30 minutes.  The liquid fraction was extracted as outlined previously 
[11,58].  In brief, the samples, acidified to pH ~2, were loaded onto Oasis® HLB solid 
phase extraction (SPE) cartridges (6 mL, 200 mg) (Waters Corporation, Milford, MA, 
USA) that were previously conditioned with 10 mL of organic-free deionized water.  
Analytes were eluted from the cartridges with 10 mL of a 10 mM acetic acid in 
methanol:acetone (50:50 v/v) solution.  Eluates were then evaporated under a gentle 
stream of nitrogen and reconstituted in 1.5 mL methanol (MeOH) for instrumental 
analysis.   
Solids extraction was performed using accelerated solvent extraction (ASE) 
[59].  Briefly, solids samples were placed into ASE cells and packed with laboratory-
grade sand.  Extraction was accomplished using a Dionex ASE #300 extraction 
apparatus (Dionex Corporation, Sunnyvale, CA, USA) with a solvent mixture of 
isopropyl alcohol (IPA) and organic-free water (80:20 v/v). Oasis® HLB solid phase 
extraction (SPE) cartridges (6 mL, 200 mg) (Waters Corporation, Milford, MA, USA) 
were again utilized for sample clean-up.  Samples were loaded onto the cartridges in 
conjunction with a phosphate buffer (pH = 7) and analytes were eluted using a 
dichloromethane (DCM):diethyl ether (DEE) solution (80:20 v/v).  Samples were 
evaporated using a rotary evaporator and reconstituted in 1.5 mL MeOH for analysis.   
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2.3.7.2  Instrumental Analysis 
2.3.7.2.1  Triclosan and Triclocarban 
 TCS and TCC analysis was performed using HPLC, tandem mass 
spectrometry (HPLC-MS/MS) via a Waters 2690XE (Waters Corporation, Milford, 
MA, USA) in conjunction Quattro Ultima triple quadrupole MS (Micromass Limited, 
Manchester, UK) using an electrospray negative spray ionization (ESI-) source.  
Chromatographic separation was achieved by an Xterra C18 reverse phase column 
(5 μm, 150 x 2.1 mm) (Waters Corp., Milford, MA, USA) and 1% formic acid:MeOH 
(70:30 v/v) (solvent A) and MeOH (solvent B).  MS acquisition was achieved in 
selected ion recording (SIR) mode.  MassLynx 4.0 (Micromass Limited, Manchester, 
UK) was used for peak integration and quantitation.  Specifics regarding HPLC-
MS/MS conditions are provided in the supplemental information. 
2.3.7.2.2  Transformation Products (excluding MeTCS) 
 After analysis for TCC and TCS via HPLC, samples were analyzed for 2,4-
DCP, DCC, MCC, NCC, 4-chlorocatechol, and 4-CA by ultra high performance liquid 
chromatography, tandem mass spectrometry (UHPLC-MS/MS) using a Shimadzu 
Nexera X2 UPLC coupled with a Shimadzu 8040 triple quadrupole MS (Shimadzu 
North America, Columbia, MD, USA) equipped with an ESI source.  A Supelco 
Ascentis® Express C18 reverse phase UHPLC/HPLC column (2.7 μm, 50 x 2.1 mm) 
(Sigma-Aldrich, St. Louis, MO, USA) with an isocratically run mobile phase of 10 mM 
ammonium acetate in a solution of MeOH:acetonitrile:water (60:15:25 v/v) were used 
to achieve chromatographic separation [49].  Multiple reaction monitoring (MRM) 
mode was used for MS acquisition for all compounds except 4-CA and 4-
chlorocatechol, where selected-ion monitoring was used. Specifics regarding 
UHPLC-MS/MS conditions are provided in the supplemental information. 
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2.3.7.2.3  Methyltriclosan 
 Following HPLC-MS/MS and UHPLC-MS/MS analysis, samples were 
evaporated and reconstituted in 1 mL of hexane for measurement of MeTCS via an 
Agilent 6890 gas chromatograph (GC) in conjunction with an Agilent 5975 mass 
selective detector (MSD) run in positive electron impact ionization mode [25].  
Compound separation was accomplished by a capillary column (DB-5-MS) with a 
length of 15 m, diameter of 0.25 mm, and film thickness of 0.1 μm (J&W Scientific, 
Folsom, CA, USA).  GC-MS setting details are provided in the supplemental 
information. 
2.3.8  Quality Assurance and Quality Control 
 Method Detection Limits (MDLs) were determined using the procedure 
established by U.S EPA (EPA, 1984). The Limit of Quantification (LOQ) was set at 2 
times the MDL values. All samples were fortified with labeled 13C12-TCC, 13C12-TCS 
13C12-MeTCS internal standard for analyte quantification and to correct for possible 
matrix interactions and any losses during sample extraction. At least seven 
standards at concentrations other than zero were run for each set of analyses and 
linearity correlations were required to yield r-squared values ≥ 0.99. Standards were 
injected every ten samples in order to verify stability of the instrument during the 
analyses. A laboratory blank, duplicate and spike were included in each batch that 
always included less than 15 samples. Statistical analysis was performed using 
GraphPad Prism 7.0 Software, Inc., San Diego, CA. Table 2-2 shows the TCC, TCS 
and MeTCS MDLs, LOQs, recoveries and Relative Standard Deviation (RSDs) for 
water, sludge and filter samples. To validate the method, 7 replicates samples plus 
two procedural blanks were spiked and processed for each compound following 
USEPA protocols (EPA, 1984). Concentrations below the LOQ are not reported. 
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Table 2-2 shows the TCC, TCS, and MeTCS MDLs, LOQs, recoveries and 
Relative Standard Deviation (RSDs) for water, sludge, and filter samples. To validate 
the method, 7 replicates samples plus two procedural blanks were spiked and 
processed for each compound following USEPA protocols (EPA, 1984). 
Concentrations below the LOQ are not reported. 
Sample 
TCC 
MDL RSD Rec LOQ 
ng L-1 % % ng L-1 
Water 1.2 2.8 70.6 ± 2.0 2.4 
Filter 2.1 11.5 91.5 ± 5.4  4.2 
aSludge 7.9 5.9 92.0 ± 6.8 15.8 
  TCS 
Water 8.3 16 88.8 ± 14.3 16.6 
Filter 19.4 3 99.2 ± 3.0 38.5 
aSludge 13.9 7 88.9 ± 2.9 27.8 
  MeTCS 
Water 2.5 7.6 111.6 ± 8.4 5 
Filter 2.5 5.2 108.0 ± 5.6 5 
aSludge 13.3 9.5 94.8 ± 3.0 26.6 
aMDL and LOQ are presented on ng g-1 dry wt 
 
2.4  Results and Discussion 
 Results for secondary analyses (microbial activity, sCOD, and solids 
analyses) are provided in Figure SI-A2 through SI-A7. 
2.4.1  Triclosan, Triclocarban, and Methyltriclosan 
 For TCS, TCC, and MeTCS, degradation or formation rates (Table 2-3) were 




= −   (1) 
Table 2-2:  Method detection limit (MDL), Relative Standard Deviation (RSD), Recoveries 
(Rec) and Quantification Limits (LOQ) (n=7) 
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where C is the concentration at any given time, C0 is the initial concentration, t is 
time, and k is the pseudo-first order degradation rate. 
Compound Temperature Rate of Change in 
Solids (hour-1) 
Rate of Change in 
Liquids (hour-1) 
TCS 
21°C - 0.0170 ± 0.003 - 0.0737 ± 0.015 a 
30°C - 0.0224 ± 0.007 - 0.0191 ± 0.002 
TCC 
21°C N/A N/A 
30°C - 0.0158 ± 0.012 N/A 
MeTCS 
21°C + 0.0415 b N/A 
30°C + 0.0071 c; + 0.0191 d N/A 
a Degradation began after 60 hours of the reactor running, prior to that, TCS concentrations were 
unchanging. 
b Bioreactor #1 only, no MeTCS formation was observed in bioreactor #2 at 21°C. 
c Bioreactor #1 only. 
d Bioreactor #2 only. 
 
2.4.1.1  Triclosan 
The majority of the total TCS concentration in the reactors was associated 
with the solids fraction (Figure 2-1a).  This is unsurprising given its hydrophobic log 
Kow value of 4.8 [60].  Overall, TCS concentrations in activated sludge solids 
decreased during the course of the experiments at 0.0170 ± 0.003 hour-1 (21°) and 
0.0224 ± 0.007 hour-1 (30˚C).  TCS concentrations in the solids fraction were 
reduced to 50% of the initial concentrations between hours 48 – 60 at 21°C and 
hours 28 – 36 at 30°C, demonstrating that TCS reduction is the solids matrix of 
activated sludge treatment is more effective at a higher temperature.  The activated 
sludge HRT for the studied WWTP is 6-8 h and the SRT is ~55 hours.  After six 
hours of treatment, approximately 9.14 ± 4.89% of the initial TCS was removed at 
21ºC.  Removal in the solids fraction after the first six hours of treatment was 
increased in reactors run at 30˚C: 18.8 ± 11.1% removal.  At 21ºC, about 56.7% of  






TCS was removed after 55 hours, while approximately 70.3% was removed by 55 
hours at a temperature of 30°C.  This implies that TCS removal from activated 
sludge reactors at WWTPs will be increased during weather periods of increased 
temperature as well as with increased HRT and SRT.  In a study focusing on 
seasonal variations of 40 organic contaminants in a membrane bioreactor (MBR) 
from an Australian WWTP, Trinh et al. (2016) found that TCS removal via 
biodegradation was increased during summer sampling (24˚C) when compared to 
winter sampling (15˚C). Conversely, removal of TCS via sorption to sludge increased 
in the winter, concurrent with the decrease in biodegradation removal rates [61].  
Guerra et al. (2015) studied the concentrations of 41 organic pollutants in various 
stages of treatment in five different Canadian WWTPs.  The study, which also 
compared seasonal differences, found that TCS concentrations in waste activated 
sludge and aerobically digested biosolids were significantly higher in samples 
collected in colder temperatures when compared to those collected in warmer 
temperatures.  This difference in TCS concentrations in samples collected between 
the different sampling temperatures was attributed to an increased microbial 
degradation rate during warmer conditions. [62]   Thus, the present study agrees 
with previous studies concluding that increased temperature results in an increase in 
TCS degradation. 
 In addition to temperature influences on TCS degradation, factors like HRT 
and SRT are also important in impacting TCS concentrations during wastewater 
treatment.  As evidenced in the present study, extending the HRT beyond the 6-8 
hours and the SRT beyond the 55 hours that typically occur at the study WWTP 
leads to a greater overall TCS degradation at both 21˚C and 30˚C.  Furthermore, in a 
study focusing on the degradation of the pharmaceuticals atenolol, gemfibrozil, and 
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ciprofloxacin from laboratory bioreactor studies simulating activated sludge, a MBR, 
and submerged attached biofilter, it was determined that a reduction in HRT from 10 
hours to 5 hours resulted in reduced pharmaceutical removal efficiencies due to a 
reduction in the exposure time of the compounds to microbial populations.  In the 
same study, a decrease in the SRT for the activated sludge and MBR treatments 
also led to a decrease in atenolol, gemfibrozil, and ciprofloxacin degradation [63].  
Clara et al. (2005), found that the degradation of pharmaceuticals, musks, and 
endocrine disrupting chemicals is increased (for compounds that can be biologically 
degraded under aerobic conditions) when SRT in both laboratory MBRs and full-
scale WWTPs is increased.  An increased SRT allows for a more diverse microbial 
population with more diverse physiological capabilities to develop since the 
increased residence time allows for slow-growing microbes, that would not have time 
to establish populations during reduced time periods, to proliferate. [64] 
Concentrations of TCS in the aqueous fraction (Figure 2-1b) of all reactors 
(21°C and 30°C) were below 5 ng/mL.  These concentrations were much lower than 
those associated with solids and represent a negligible (less than 0.01%) fraction of 
the total mass of TCS in the reactors.  Trends of TCS in the aqueous fraction 
differed between the reactors run at 21°C and those run at 30°C.  The aqueous 
phase concentrations in reactors run at 21°C (Figure 2-1b) fluctuated until hour 60, 
when TCS then decreased significantly at a rate of 0.0737 ± 0.015 hour-1.  
Bioreactors run at 30°C, on the other hand (Figure 1b), demonstrated a steady 
decrease in TCS concentrations during the course of the experiments, with a 
degradation rate of 0.0191 ± 0.002 hour-1. Fifty percent (50%) reduction of TCS 
concentrations occurred between hours 84 and 96 at 21°C and 12 to 36 hours at 
30°C, indicating that the increased temperature was more effective at reducing TCS 
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concentrations in the aqueous fraction during activated sludge treatment, as was 
observed with solids samples.  No TCS was removed from the aqueous fraction after 
6 hours, which is the facility HRT, at 21°C and at 30°C 36.4 ± 7.78% removal 
occurred after 6 hours.  Again, this indicates that increases in temperature and HRT 
help to further degrade TCS in activated sludge. 
2.4.1.2  Triclocarban 
 As observed with TCS, concentrations of TCC in the activated sludge 
predominantly associated with the solids fraction.  Concentrations in the solid phase, 
however, did not decrease over the course of the experiments run at 21°C until hour 
96 (Figure 2-2a).  The decrease at these time points was likely due to the reduced 
solids impacting the amount of sample available for analysis (not enough sample 
volume for detection above analytical limits).  Conversely, reactors run at 30°C 
(Figure 2-2a) demonstrated an overall decreasing trend (0.0158 ± 0.012 hour-1) in 
the solids fraction throughout the course of the experiments.  While the increased 
temperature did improve upon TCC degradation, 50% removal did not occur until 
between hours 48 – 54, indicating reduced removal efficiency at this temperature, 
when compared to TCS, and the importance of an increase in HRT and SRT for 
improved degradation. 
 Average concentrations of TCC in the aqueous fraction was less than 2.0 
ng/mL for all bioreactors at both 21°C and 30°C (Figure 2-2b).  While some variation 
occurred, concentrations of TCC generally remained stable during experiments at or 
just above the LOQ.  Overall, meaningful reduction did not occur in aqueous 
samples.   
 Low percentages of TCC removal in WWTPs have been found within the 
literature. For instance, Heidler et al. (2006) observed that even though 97% of TCC  
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Figure:  2-2  Concentrations of TCC in a) Solids and b) Aqueous Factions of Activated 




present in the liquid fraction was removed from a WWTP with a secondary treatment 
followed by tertiary treatment of disinfection, 76% of this TCC removed from the 
water line was still present in the solids fraction. It was concluded that no more than 
21% of the influent TCC was lost to bio-, chemical, or physical transformation. [65] 
Additionally, Lozano et al. (2013) studied all treatment stages of the WWTP where 
samples were collected for this current study and no TCC removal was observed 
during activated sludge process and only 18% of total TCC removal was obtained 
along the whole WWTP [11]. A study by Blair et al. (2015) using a 190 L batch 
reactor and focusing on the fate of 57 hormones, pharmaceuticals, and personal 
care products within mixed liquor suspended solids collected from a conventional 
activated sludge tank in Wisconsin, USA found that the removal efficiency of TCC 
was 11.4%.  It was also observed that for several compounds degradation 
plateaued, where despite what is expected from first-order kinetics, degradation 
slows/stops for TCC.  The degradation plateau for TCC was determined to be ~50 
ng/L and degradation was not observed when concentrations were near this value 
but did occur for concentrations much greater than 50 ng/L, indicating the relevance 
of initial concentration in degradation efficiency. [66] While TCC degradation has 
been shown to occur under aerobic conditions in WWTPs, degradation occurs at 
slower rates than TCS.  Studies of these two compounds in soils under aerobic 
conditions also demonstrate this trend [67,68] further indicating the capacity for TCC 
to be biologically degraded with sufficient time.  This further indicates that increases 
in wastewater treatment parameters such as HRT and SRT, in an attempt to 
increase the contact time between microbes and TCC, are vital in improving 
degradation. 
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2.4.1.3  Methyltriclosan 
MeTCS, like TCS and TCC, is predominantly associated with solids fraction 
of reactor samples.  Concentrations of the compound also demonstrated the ability 
to increase during activated sludge treatment, although this was not observed 
uniformly within each reactor.  Due to the varying difference in MeTCS formation 
during experiments, MeTCS data for each individual reactor is presented separately.  
At 21°C, bioreactor #1 MeTCS concentrations were relatively stable until hour 72 
and 84, when concentrations increased at a rate of 0.0415 hour-1, after which 
concentrations were not detected above the MDL, likely due to a low amount of 
solids available for analysis at this point in the experiment (not enough sample 
volume for detection above analytical limits) rather than an actual decrease in 
concentrations (Figure 2-3a).  This MeTCS formation represents approximately 42% 
of initial TCS in the bioreactor.  Alternatively, concentrations remained stable in 
bioreactor #2 until hour 96, when, again, concentrations were below the MDL.  
Experiments run at 30°C (Figure 2-3b) resulted in formation of MeTCS in both 
bioreactors.  Concentrations increased in bioreactor #1 at a rate of 0.0071 hour-1 
beginning at hour 96 while MeTCS increased at a rate of 0.0191 hour-1 beginning at 
hour 48 in bioreactor #2.  The production of MeTCS at 30°C represents 
approximately 81% of the initial TCS concentrations in bioreactor #1 and 176% of 
the initial concentrations in bioreactor #2.  Elevated concentrations of MeTCS in 
solids are of concern as the compound has higher endocrine disrupting capabilities 
than TCS [26].  These high rates of MeTCS production may be due to not only direct 
transformation of TCS to MeTCS, but the transformation of other TCS byproducts 
not analyzed in this study as well.  Complex transformation pathways with numerous 
intermediate products have been demonstrated in the literature [52,69,70].  Further  
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Figure 2-3:  Concentrations of MeTCS in the Solids Faction of Activated Sludge Samples 
at a) 21°C and b) 30°C Over Time 
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investigations into the presence of these intermediates in activated sludge and their 
influence on MeTCS formation have not yet been conducted.  These results indicate 
that an increase in HRT and temperature may influence the production of MeTCS 
from TCS.  Additionally, because MeTCS production was reactor specific, the results 
indicated that microbial communities formed in an activated sludge reactor would 
also likely have a significant influence on the amount of MeTCS produced.  Further 
research into the identification of microbial communities in different activated sludge 
treatment systems is needed. 
Conversely, MeTCS concentrations in the aqueous fraction of activated 
sludge (Figure SI-A8) remained stable at both 21°C and 30°C.  Additionally, average 
concentrations were below 3.5 ng/mL for both temperatures, indicating that the 
aqueous fraction represented only a very small portion of the total MeTCS in the 
activated sludge. 
Studies have shown that MeTCS can be formed by the biological degradation 
of TCS under aerobic conditions [71,72]. Many of these studies are done at lab scale 
and with TCS spiked at the beginning of experiments, with concentrations that favor 
MeTCS formation and detection. Chen et al. (2011) observed that high TCS 
concentrations (1,000 and 2,000 µg/L) were necessary to observe MeTCS at 
detectable concentrations after aerobic treatment of activated sludge. These TCS 
concentrations were much higher than the initial TCS concentrations detected in this 
study.  For initial concentrations of 20 µg/l  (unspiked), Chen et al. did not observe 
MeTCS formation.  However, it is important to note that in the studies performed by 
Chen et al., only the liquid fraction of reactor samples was analyzed for MeTCS.  
Given the propensity of MeTCS to associate with solids (log Kow = 5), it can be 
expected that much of the MeTCS formed would be found within the sludge phase of 
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a wastewater sample rather than the aqueous phase, as was observed in the 
present study.  Additionally, in the same study performed by Chen et al., it was 
observed in preliminary reactor experiments that MeTCS significantly increased by 
16% during aerobic experiments after 80 hours with an initial MeTCS concentration 
of 30 µg/L [71]. Furthermore, Tohidi & Cai (2017) noted MeTCS formation from TCS 
to be as high as 25.5% during secondary biological treatment in a study focusing on 
three WWTPs with different treatment streams [73].  Overall, these results are in 
concordance with Lozano et al. (2013), who observed an increase in MeTCS in the 
activated sludge process at the typical TCS concentrations found in the wastewater 
of the current study facility. 
2.4.1.4  TCS and TCC degradation products 
The TCS and TCC byproducts 2,4-DCP, 4-chlorocatechol, DCC, MCC, NCC 
and 4-CA were monitored qualitatively to determine their presence in the 
bioreactors.  4-Chlorocatechol, DCC, MCC and NCC were not detected in any solid 
or liquid samples collected from reactors run at 21 and 30ºC. However 2,4-DCP and 
4-CA were clearly detected in the liquids samples but not in the solids. Both 
compounds were confirmed using authentic standards. While this study was not 
designed to quantify the byproducts, a preliminary qualitative scan was performed 
(no internal standards were used, QA/QC was not determined). 
2,4-DCP is known to form from aerobic biodegradation of TCS [74,75] and 
photolysis [69]. No formation of 2,4-DCP was observed during the present study at 
either of the temperatures studied.  However, decreases were observed at both 21 
and 30ºC.  All concentrations of 2,4-DCP observed in this study were below 3.5 
ng/mL and represent a very small portion of the total TCS detected. The ability of 
2,4-DCP to be biodegraded aerobically has been demonstrated in the literature.  For 
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instance, Matafonova et al. (2006) found that Bacillus sp. isolated from an aeration 
basin at a Russian pulp and paper mill were able to degrade 2,4-DCP. The Bacillus 
sp. were effective in biodegradation for concentrations of 2,4-DCP 400 µM and 
below; higher concentrations inhibited cell growth and efficient degradation did not 
occur [76].  2,4-DCP is listed as a priority pollutant by the US Environmental 
Protection Agency and has demonstrated toxicological properties including 
endocrine disruption [69,77] and its removal during treatment prior to release by 
wastewater treatment liquid effluent is important for environmental health.  Further 
studies involving quantitation with QA/QC protocols should be conducted to further 
understand the fate of 2,4-DCP in activated sludge. 
Chloroanilines, such as 4-CA, can be formed from TCC biodegradation [54]. 
In this study, 4-CA was detected in liquid samples from bioreactors run at both 21˚C 
and 30˚C.  The concentrations were found to be very variable during the reactor 
runs. Because 4-CA was analyzed qualitatively in this study, variation of the 
compound may have been due to the fact that the extraction method was not 
optimized for this compound. Also, 4-CA can be biologically degraded to 4-
chlorocatechol [54,78] but has also been found to be present in wastewaters due to 
their utilization in the production of products such as pharmaceuticals, dyes, and 
pesticides [79], further complicating concentrations in the wastewater treatment 
system.  4-CA concentrations in this study were below 40 ng/mL and represent a 
small portion of total TCC concentrations observed within the bioreactors.  Again, 
further studies regarding the fate of 4-CA conducted under QA/QC protocols should 




2.5  Conclusions 
 The antimicrobials TCS and TCC have demonstrated various environmental 
and health concerns, notably endocrine disruption.  Prolific use of these compounds 
has resulted in their presence in the wastewater treatment process, where they are 
only partially degraded and often released into the environment via wastewater 
effluent or the land application of biosolids.  Understanding how wastewater 
treatment processes influence degradation of these compounds is vital to reducing 
their discharge from the wastewater process.  While TCS was predominantly 
associated with the solids fraction of the samples, activated sludge treatment 
demonstrated the ability to degrade TCS from both the liquid and solids fraction.  
Solids fraction degradation rates were increased in reactors run at 30°C and the 
increased HRT and SRT resulted in more efficient TCS removal.  MeTCS increased 
in concentration in the solids fraction of three of the four reactors run, indicating a 
noteworthy formation of the compound from degraded TCS or other TCS byproducts 
not analyzed in the present study.  Further research would need to be conducted to 
further understand compound sources for MeTCS formation during activated sludge 
treatment.  TCC concentrations were only observed to decrease in the solids fraction 
in reactors run at 30°C, emphasizing the importance of increased temperature during 
anaerobic digestion for efficient TCC removal.  Additionally, as with TCS, the 
increased HRT and SRT resulted in improved TCC removal from the system.  
Finally, 2,4-DCP and 4-CA were observed in the liquids fraction of the bioreactors 
while 4-chlorocatechol, DCC, MCC and NCC were not detected.  Further studies 
involving quantitation with QA/QC protocols should be conducted to further 
understand the fate of these additional TCS/TCC transformation products in 
activated sludge.   
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Chapter 3:  Fate of Triclosan, Triclocarban, and Their 
Transformation Products in Wastewater Under Nitrifying 
Conditions 
Dana L. Armstrong, Nuria Lozano, Clifford P. Rice, Mark Ramirez, and Alba Torrents 
This chapter has been submitted for publication in Journal of Water Process 
Engineering and is under review. 
3.1  Abstract 
 The nitrification process was simulated using benchtop bioreactors to gain 
insight into the fate of the antimicrobials triclosan (TCS) and triclocarban (TCC), as 
well their transformation products, during wastewater treatment.  Currently, little 
information exists on the impact of nitrification treatment on concentrations of TCC, 
TCC degradation products, and TCS degradation products.  Reactors were run 
using samples collected from a large municipal wastewater treatment plant at two pH 
ranges (6.5 – 7.5 and 8.5 – 9.5) for 171 hours to simulate an extended hydraulic 
retention time (HRT).  TCS was degraded under both pH conditions, with a 28.5% 
overall reduction in solids samples when the pH range was 6.5 – 7.5 and an overall 
reduction of 83.2% in solids samples when the pH ranged 8.5 – 9.5.  Methyltriclosan 
(MeTCS) was formed in solids samples during both treatment conditions.  MeTCS 
formed the most rapidly during the first 25 hours of treatment at pH 8.5 – 9.5.  Levels 
of 2,4-dichlorophenol, a TCS photolysis product, and TCC did not change over the 
171 h treatment period, indicating that nitrification is not an effective treatment for 
reduction of these compounds.  Three TCC dechlorination products and triclosan-O-




3.2  Introduction 
 The land application of treated sludge (biosolids) and discharge of liquid 
effluent to local water bodies from wastewater treatment plants (WWTPs) can act as 
environmental sources of emerging contaminants (ECs) not fully removed within 
treatment systems.  With worldwide chemical production projected to increase 
beyond population growth [1], the inevitable reliance on chemicals by industry, 
medicine, agriculture, households, etc. can result in the presence of a variety of ECs 
within wastewater treatment processes.  Such chemicals can include 
pharmaceuticals and personal care products (PPCPs), flame retardants, surfactants, 
and food additives, among others [80]. 
 One group of PPCPs that have garnered interest from regulatory agencies 
due to health and environmental concerns are antimicrobials – specifically, triclosan 
(TCS) and triclocarban (TCC).  In 2016, the United States Food and Drug 
Administration issued a phase-out of TCS and TCC from consumer antiseptic 
washes [7], while in the same year TCS was not approved for use in product-type 1 
items (human hygiene biocidal products for skin or scalps) by the European 
Commission [81].  In the United States these antimicrobials can still remain in 
products used in healthcare situations [7].  Concerns regarding TCS and TCC in the 
environment primarily center around their endocrine disrupting capabilities [27,45,46] 
as well as microbial resistance issues [82,83].  Furthermore, TCS and TCC 
transformation products, such as methyltriclosan (MeTCS) and carbanilides, can 
also induce endocrine disruption [45]. 
TCS and TCC have been shown to be prolific in the wastewater treatment 
system [73,84,85] and, as such, present in the environment due to wastewater 
effluent discharge and biosolids application.  Field studies have estimated the half-
 44
lives of TCS and TCC in soils after biosolids applications to be 104 days and 288 
days, respectively, while MeTCS is more persistent, with a half-life of approximately 
443 days after biosolids application [25,86].  Additionally, it has been demonstrated 
that the long-term application of biosoids to agricultural soils can result in the 
migration of both TCS and TCC through a terrestrial food web, from primary 
consumers to secondary and tertiary consumers [87] as well as the 
phytoaccumulation of the compounds in different vegetative species, including 
switch grass and squash [88].  In surface waters, concentrations of the 
antimicrobials have been detected in aqueous, suspended particulate, and sediment 
samples, with the highest concentrations occurring near WWTP discharge points 
[89].  TCS, TCC, and MeTCS can bioaccumulate in freshwater snails and algae [90] 
and, furthermore, TCS and TCC can also inhibit the growth of freshwater algae [91]. 
 One way to reduce the presence of TCS and TCC in the environment via 
wastewater treatment discharge is by altering common wastewater treatment 
processes to improve compound degradation.  Nitrification treatment biologically 
converts ammonia/ammonium in waste streams to nitrate and the process has 
demonstrated the ability to degrade TCS [92,93].  Little information exists on the 
impact of nitrification treatment on concentrations of TCC, TCC degradation 
products, and TCS degradation products.  This study focuses on the fate of TCS, 
TCC, and their transformation products during nitrification treatment in a laboratory 
setting.  Benchtop bioreactors were used to simulate the nitrification process and 
allowed for conditions such as hydraulic retention time (HRT) and pH to be altered in 
order to understand how these changes impact compound concentration over time.  
Research has demonstrated that increasing the HRT during activated sludge 
treatment improves TCS and TCC degradation [94] and that the optimum pH for 
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nitrification in waste streams can vary [95,96].  The US EPA reports that while the 
ideal pH range for Nitrosomonas and Nitrobacter is between 7.0 and 8.0, nitrification 
can occur at pH concentrations ranging from 6.6 to 9.7 due to additional 
environmental factors that can impact nitrifying bacterial populations [97].  Two 
reactors were run simultaneously at 21°C for 171 hours at a pH range of 6.5 – 7.5 
and then again at a range of 8.5 – 9.5 with sample collected from a nitrification 
reactor from a large WWTP located in the Mid-Atlantic region of the United States.  
No spiking of the target compounds into the bioreactors took place.  Samples were 
collected periodically from each reactor so that TCS and TCC degradation rates and 
transformation product formation rates could be calculated over the 171-hour period.  
Results from this study demonstrate how altering a somewhat common treatment 
process can impact concentrations of antimicrobials and their transformation 
products in wastewater, which, in turn, can influence the amount of each compound 
emitted to the environment. 
3.3  Materials and Methods 
3.3.1  Target Analytes 
 All samples were analyzed for concentrations of TCS and its transformation 
products: MeTCS, 2,4-dichlorophenol (2,4-DCP), and triclosan-O-sulfate (TCS-O-
sulf).  Additionally, samples were analyzed for TCC and its dechlorination products: 
4,4’-dichlorocarbanilide (DCC), 1-(3-chlorophenyl)-3-phenylurea (MCC), and 
carbanilide (NCC).  Further information regarding the suppliers of analytical 
standards for the target analytes and the compound purities is located in Table SI-B1 




3.3.2  Wastewater Treatment Plant Background 
 The study facility is located in the Mid-Atlantic region of the United States and 
serves a population of over 2 million, with a daily treatment load of approximately 
1.14 million m3 of raw sewage per day.  The facility treats incoming wastewater by 
preliminary treatment, primary treatment, aerobic secondary treatment (“activated 
sludge”), tertiary nitrification-denitrification treatment, filtration, and disinfection.  
Sludge is treated by the Cambi Thermal Hydrolysis Process™ in conjunction with 
mesophilic anaerobic digestion.  A process flow diagram of treatment stages at the 
facility is provided in Figure SI-1 in the Supplemental Information. 
 The average HRT for the nitrification-denitrification reactors combined is 8 
hours while the average sludge retention time for the two reactors is 20 days.  These 
time periods, however, can vary with flow.  The target dissolved oxygen (DO) 
concentration for the nitrification reactors is 2.0 mg/L but can range from 1.2 to 4.8 
mg/L.  The target pH of the nitrification process is 6.5.  The on-site reactors are 
outdoors, exposed to the elements, and without heating elements.  As such, typical 
temperatures within the reactors can range from 14 to 23°C, depending on seasonal 
ambient temperatures. 
3.3.3  Benchtop Bioreactor Experimental Setup 
 The nitrification treatment process was simulated at a laboratory-scale using 
two BioFlo® 115 Benchtop Bioreactors (New Brunswick Scientific, Edison, NJ, USA).  
Samples were collected from the study WWTP near the input of a nitrification 
reactor, in an area of sufficient mixing, and immediately transported to the laboratory 
for use within the bioreactors.  Five (5) liters of nitrification sample was placed in 
each bioreactor.  No spiking of target compounds into the bioreactors took place.  No 
additional wastewater was added to the reactors after the start of the experiments.  
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The two reactors were operated simultaneously, as duplicates, for two separate 
runs.  Experimental conditions for each run are provided in Table 1.  The BioFlow 
115® control panel allowed, as needed, for the automatic addition of 3M sodium 
hydroxide or 1.5M sulfuric acid to constantly maintain the pH within the allowable 
range provided in Table 1 as well as the automatic adjustment of mixing rates to 
maintain a target dissolved oxygen (DO) concentration of 2 mg/L. 
 The bioreactors were operated for 171 hours during each run – well beyond 
the 8-hour HRT for the nitrification reactors at the study WWTP.  In order to gauge 
trends of TCS, TCC, and transformation product concentrations, 200 mL samples 
were collected at hours 0, 2, 4, 6, 8, 12, 25, 29, 33, 37, 49 (Run #1 only), 55, 59, 73, 
85, 98, 122, 146, and 171 from the sample port of each bioreactor.  Samples were 
analyzed immediately for solids, soluble chemical oxygen demand, and microbial 
activity.  The remainder was frozen at -20°C for eventual analysis of TCS, TCC, and 
transformation products.  Additionally, 1L airtight jars were filled with 0.5 L of 
nitrification sample and 1g of mercuric chloride to act as control reactors.  The 
control reactors were placed in a water bath, maintained at 30°C, and agitated 
continuously for 171 hours.  Initial samples (hour 0) and final samples (hour 171) 
were analyzed for all target compounds.  Furthermore, final samples were plated to 
confirm that microbial populations within the control reactors did not survive 






  Run #1 Run #2 
Temperature (°C) 21 21 
pH (target) 7.0 9.0 
pH (range allowed) 6.5 - 7.5 8.5 - 9.5 
DO (mg/L) 2.0 2.0 
Total run time (hours) 171 171 
 
3.3.4  Extraction and Analysis of Target Analytes 
3.3.4.1  Sample Extraction 
 The aqueous and solid fractions of each sample collected from the bioreactor 
were analyzed separately.  To achieve this, each sample was filtered through a 
Whatman GA/F 0.7 μm filter (GE Healthcare Life Sciences, Pittsburgh, PA, USA) 
prior to extraction.  All samples were extracted in duplicate. 
 The aqueous matrix was extracted according to a previously established 
method [11,58].  In short, Oasis® HLB solid phase extraction (SPE) cartridges (6 
mL, 200 mg) (Waters Corporation, Milford, MA, USA) were utilized to separate the 
target compounds from acidified (pH ~2) liquid samples.  A solution of 10 mM acetic 
acid in methanol:acetone (50:50 v/v) was used for compound elution from the 
cartridges prior to eluate evaporation and reconstitution for instrumental analysis in 
1.5mL methanol. 
 The filters containing the solids fraction of the bioreactor samples were baked 
at 100°C for at least 24 hours so that the samples could be extracted on a dry weight 
basis using a method published previously [59].  Briefly, dried filters and solids 
samples were packed in accelerated solvent extraction (ASE) cells along with 
laboratory-grade sand.  A Dionex ASE #300 instrument (Dionex Corporation, 
Table 3-1:  Experimental Conditions for Bioreactor Runs 
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Sunnyvale, CA, USA) was run with an isopropyl alcohol and organic-free water 
(80:20 v/v) mixture to extract the target analytes from the sludge matrix.  Extract 
clean-up was achieved with Oasis® HLB solid phase extraction (SPE) cartridges (6 
mL, 200 mg) (Waters Corporation, Milford, MA, USA).  SPE eluates were evaporated 
and reconstituted in 1.5 mL methanol. 
3.3.4.2  Instrumental Analysis 
 Analysis of all compounds except MeTCS took place using a Shimadzu 
Nexera X2 Ultra High Performance Liquid Chromatograph (UHPLC) coupled with a 
Shimadzu 8040 triple quadrupole mass spectrometer (MS/MS) (Shimadzu North 
America, Columbia, MD, USA) with an electrospray ionization source run in negative 
mode.  To achieve chromatographic separation of TCS, TCC, 2,4-DCP, DCC, MCC 
and NCC, a solution of 10 mM ammonium acetate in methanol:acetonitrile:water 
(60:15:25 v/v) was run isocratically through a Supelco Ascentis® Express C18 
reverse phase column (2.7 μm, 50 x 2.1 mm) (Sigma-Aldrich, St. Louis, MO, USA) at 
a rate of 0.5 mL/min [49].  For TCS-O-sulf, an isocratically run mobile phase of 0.2 % 
formic acid in methanol along with a Supelco Ascentis® Express C18 reverse phase 
column (2.7 μm, 50 x 2.1 mm) (Sigma-Aldrich, St. Louis, MO, USA) was run at a rate 
of 0.55 mL/min [49].  For all compounds, multiple reaction monitoring was used for 
MS acquisition.  Further details regarding UHPLC-MS/MS conditions are provided in 
elsewhere [49]. 
 After all UHPLC-MS/MS analyses were completed, samples were evaporated 
and reconstituted in 1 mL hexane for MeTCS analysis via an Agilent 7890B gas 
chromatograph (GC) in conjunction with an Agilent 5977A mass selective detector 
(MSD) run in positive electron impact ionization mode [25].  For this method, 
chromatographic separation was achieved using a 15 m capillary column (DB-5-MS) 
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with diameter of 0.25 mm, and film thickness of 0.1 μm (J&W Scientific, Folsom, CA, 
USA).  Further details regarding the GC-MS analytical methodology are provided in 
a previous publication [49]. 
3.3.5  Secondary Analyses 
3.3.5.1  Solids Analysis 
 All samples collected from the bioreactors were analyzed for total suspended 
solids (TSS), volatile suspended solids (VSS), total solids (TS), and total volatile 
solids (TVS) via the standard methods established by the American Public Health 
Association [56] 
3.3.5.2  Soluble Chemical Oxygen Demand (sCOD) 
 Soluble chemical oxygen demand (sCOD) was determined according to 
standard methods [56].  Nitrification samples collected at each time point were 
filtered through a Whatman GA/F 0.7 μm filter (GE Healthcare Life Sciences, 
Pittsburgh, PA, USA), acidified with H2SO4, and refrigerated at 4°C until analysis.  
Dichromate COD vials  (low range, 0-150 ppm) (Chemetrics, Midland, VA, USA), a 
digester block, and a photometer (Hach Company, Loveland, CO, USA) were used 
for the measurement sCOD in each sample. 
3.3.5.3  Microbial Activity 
 A previously established fluorescein diacetate  (FDA) method was utilized for 
total microbial activity [94].  In short, for each time point, 1 to 2 mL of sample from 
each reactor was shaken with 15 mL of a potassium phosphate buffer and 0.2 mL of 
a FDA solution.  The mixtures were then incubated at 30°C after which 15 mL of a 
chloroform/MeOH solution was added to each flask.  Finally, samples were shaken, 
centrifuged, and filtered for analysis of fluorescein concentrations in the filtrates via a 
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UV-1800 UV-Vis spectrophotometer (Shimadzu North America, Columbia, MD, USA) 
at a wavelength of 490 nm. 
3.3.6  Quality Assurance/Quality Control 
 The method detection limits (MDLs) for all target analytes were calculated 
using a United States Environmental Protection Agency established method [98] and 
the limits of quantitation (LOQs) for each compound were defined as two times the 
MDL.  MDLs and LOQs for all compounds are provided in Table SI-B2 in the 
Supplemental Information.  
 Prior to the extraction process, all samples were spiked with 13C13-TCC, 13C12-
TCS 13C12-MeTCS, and d3-2,4-DCP to account for extraction efficiency.  All 
extractions were carried out in batches of 12 or less and all samples were extracted 
in duplicate.  Each extraction batch consisted of a blank (either organic-free water or 
laboratory-grade sand) and a spiked sample for the determination of compound 
recoveries.  Average compound recovery for target analytes in each sample matrix 
are provided in Table SI-B2 in the Supplemental Information.  
 For UHPLC-MS/MS and GC-MS analysis, calibration curve consisting of a 
minimum of seven standards for each compound at concentrations other than zero 
was run.  Linear calibrations curves yield r-squared values ≥ 0.99.  Additionally, two 
standards and two solvent blanks were injected every 10 samples to verify 
instrument stability. 
 GraphPad 7 was used for statistical analyses and figure creation (GraphPad 
Software Inc., San Diego, CA, USA). 
3.4  Results and Discussion 
Microbial activity, sCOD, and solids analyses results are provided in Figures 
SI-B2 through SI-B4 in the Supplemental Information.  Microbial activity generally 
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decreased during the experiments with the most rapid decrease occurring between 
hours 0 and 36 (Figure SI-B2).  sCOD (Figure SI-B3), on the other hand, steadily 
increased in all reactors during the course of nitrification experiments.  Finally, solids 
concentrations (in all forms) decreased overall (Figure SI-B4). 
Pseudo-first-order kinetics were used to determine compound degradation or 




= −   (1) 
where C is the target compound concentration at a given time point, Co is the initial 
concentrations of the target compound, t is time, and k is the degradation rate. 
3.4.1  Triclosan and Its Transformation Products 
3.4.1.1  Triclosan 
 The majority of the TCS mass in the nitrification reactors was sorbed to the 
solids matrix at both experimental pH ranges (Figure 1a).  At a pH range of 6.5 – 7.5, 
TCS concentrations decreased under nitrifying conditions at an average rate of 
0.0195 ± 0.006 h-1 until approximately 37 – 49 hours, after which concentrations 
leveled out and did not change significantly.  Conversely, when the reactors were 
run at a pH range of 8.5 – 9.5, TCS was consistently degraded over the 171-hour 
period at a rate of 0.0101 ± 0.005 h-1.  After 171 hours, concentrations of TCS were 
reduced by 28.5 ± 0.09 % at a pH range of 6.5 – 7.5 and 83.2 ± 0.05 % at a pH 
range of 8.5 – 9.5, demonstrating an increased efficiency over the course of the 
experiments of compound degradation during nitrification at a higher pH range.  
Additionally, TCS degradation continued to occur beyond the 8-hour mark under 
both treatment conditions, demonstrating that extending treatment beyond facility 
HRT led to increased degradation of TCS. 
 53
  
Figure 3-1:  Concentrations of TCS in a) Solids and b) Aqueous Factions of Nitrification 
Samples Over Time 
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Concentrations of TCS in the aqueous fraction (Figure 1b) of nitrification samples did 
not significantly change over the 171-hour period when the bioreactors were run at a 
pH range of 6.5 – 7.5 (Linear regression slope test, P = 0.2034) and 8.5 – 9.5 (Linear 
regression slope test, P = 0.8329).  Average concentrations in aqueous samples 
were below 2.5 ng/mL under reactor conditions. 
 Observations within this study that demonstrate that TCS can be degraded 
under nitrifying conditions are consistent with those within the literature.  Roh et al. 
(2009) found that a pure culture of the ammonia oxidizing bacteria (AOB) 
Nitrosomonas europaea has the ability to biodegrade the antimicrobial via 
cometabolic reactions.  In experiments carried out in 1-L flasks, the bacterial strain 
reduced TCS concentrations by over 60%.  Additionally, the authors demonstrated 
the TCS could be significantly removed by nitrifying activated sludge samples over a 
5-day period, concluding that both AOB and heterotrophic microbes possess the 
ability to biodegrade the compound [92].  Laboratory-scale simultaneous nitrification 
and denitrification (SND) reactors operated with synthetic wastewater resulted in 
high TCS removal rates.  Seventy seven percent (77%) of TCS removal from the 
SNDs was attributed to various processes which included biodegradation but not 
sorption or removal via effluent [99].  However, while these experiments demonstrate 
the ability of microbial populations associated with nitrification-denitrification can 
degrade TCS, they do not specifically focus on actual treatment of wastewater by 
either nitrification, as in the present study, or nitrification-denitrification.   
In a mass balance performed at the same WWTP utilized for the present 
study, Lozano et al. (2013) found that the combined nitrification-denitrification 
process at the facility was able to remove 2.29 kg TCS per day.  It was also 
observed that this removal was higher than that observed during secondary 
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activated sludge treatment at the facility [11].  Conversely, in a similar study 
conducted using benchtop bioreactors and activated sludge from the same facility, 
TCS degradation rates in the solids fraction for reactors run at 21°C and 30°C (- 
0.0170 ± 0.003 and - 0.0224 ± 0.007 h-1, respectively) were fairly similar to those 
observed in the course of this study (Table 2) [94], indicating that a variety of aerobic 
microbial populations can degrade TCS in wastewater.  Results from these studies, 
in conjunction with the present study, demonstrate the complexity of the treatment 
process and, based on these results, future work should focus on the impact of the 




Present Study Armstrong et al. (2018) 
 
Nitrification Activated Sludge 
 
pH: 6.5 - 7.5 pH: 8.5 - 9.5 Temp: 21°C Temp: 30°C 
TCS - 0.0195 ± 0.006 - 0.0101 ± 0.005 - 0.0170 ± 0.003 - 0.0224 ± 0.007 
TCC N/A N/A N/A - 0.0158 ± 0.012 
MeTCS + 0.00985 ± 0.007 + 0.0023 ± 0.004 + 0.0415 a + 0.0071 b; + 0.0191 c 
 a Bioreactor #1 only, no MeTCS formation was observed in bioreactor #2 at 
21°C. 
b Bioreactor #1 only. 
c Bioreactor #2 only. 
 
3.4.1.2  Methyltriclosan 
 As was observed for TCS, the MeTCS present within the systems was 
overwhelmingly associated with the solids fraction (Figure 2), while concentrations 
within the aqueous fraction were not detected above the LOQ.  MeTCS formation 
began right from the start of the experiments under both pH conditions.  In reactors 
run at the pH range of 6.5 – 7.5, concentrations increased slowly, at a rate of 
Table 3-2:  TCS. TCC, MeTCS Rates of Change in Nitrification and Activated Sludge 
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0.00985 ± 0.007 h-1 until hour 98.  MeTCS concentrations then leveled out for the 
remainder of the experiments.  However, when run at a pH range of 8.5 – 9.5, 
MeTCS solids concentrations within the bioreactors increased more rapidly, at a rate 
of 0.0174 ± 0.005 h-1 until hour 25 and then continued to increase more slowly, at a 
rate of 0.00190 ± 0.002 h-1.  The overall rate of MeTCS formation for reactors run 
with a pH range of 8.5 – 9.5 was 0.0023 ± 0.004 h-1.  While MeTCS is considered 
one of the main TCS transformation products, its formation in solids samples was 
associated with 19.5% and 22.2% of observed TCS loss in solids for pH ranges of 
6.5 – 7.5 and 8.5 – 9.5, respectively, indicating that more mechanistic studies 
focusing on both TCS degradation and MeTCS formation are needed. 
 
 
Figure 3-2:  Concentrations of MeTCS in the Solids Fraction of Nitrification Samples 
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Little information exists regarding the formation of MeTCS during the 
nitrification treatment process.  Lozano et al. (2013) observed that significant MeTCS 
formation occurred during nitrification-denitrification treatment at the same WWTP 
used for the present study.  A mass balance of the facility revealed that 0.03 kg 
MeTCS per day was produced and was associated with TCS degradation [11].  
Formation rates of MeTCS in the present study differed from those observed by 
Armstrong et al. (2018) in bioreactors run using activated sludge from the same 
WWTP (Table 2).  In the previous study, formation rates of MeTCS appeared to be 
more variable – different reactors run under the same treatment conditions were 
shown to result in dissimilar final concentrations of MeTCS during the course of 
experiments.  This demonstrates the complexity of the degradation/formation 
process during aerobic wastewater treatment. 
3.4.1.3  2,4-Dichlorophenol 
 2,4-DCP was only detected in solids samples from all bioreactors (Figure 3).  
Over the course of the experiments, concentrations did not significantly change in 
bioreactors run at a pH range of 6.5 – 7.5 (Linear regression slope test, P = 0.8632) 
or 8.5 – 9.5 (Linear regression slope test, P = 0.3472).  The presence of 2,4-DCP in 
the reactors could be due to a combination of TCS photolysis [69] upstream and the 
degradation of other organic compounds that result in 2,4-DCP formation.  Given 
that 2,4-DCP can be both formed by the degradation of other compounds, such as 
dichlorprop (2,4-DP) and 2,4-dichlorophenoxyacetic acid (2,4-D) [100-102] and 
degraded aerobically [103], it may be that concentrations remain relatively steady 





3.4.1.4  Triclosan-O-Sulfate 
TCS-O-sulf was not detected at or above the LOQ in any samples, aqueous 
or solids fraction, collected from the bioreactors. 
3.4.2  Triclocarban and Its Transformation Products 
3.4.2.1  Triclocarban 
TCC was predominantly affiliated with the solids fraction of nitrification 
samples (Figure 4a).  Concentrations within the solids matrix were unchanged under 
both experimental pH ranges [Linear regression slope test, P = 0.1209 (pH: 6.5 – 
7.5); P = 0.1151 (pH: 8.5 – 9.5)].  Furthermore, TCC was not detected above 2.5 
ng/mL in any aqueous samples (Figure 4b).  Results show that the nitrification 
process was unable to degrade TCC significantly.  Conversely, Lozano et al. (2013) 
Figure 3-3:  Concentrations of 2,4-DCP in the Solids Fraction of Nitrification Samples 
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observed that at the same study facility, significant amounts of TCC was degraded 
during nitrification-denitrification treatment.  However, removal of TCC during 
nitrification-denitrification, as observed by Lozano et al., may have been due 
predominantly to the denitrification process.  The bacterial strain Ochrobactrum sp. 
TCC-1 has been demonstrated to degrade TCC under anoxic conditions and could 
do such during wastewater denitrification [104].  Under aerobic conditions, activated 
sludge was demonstrated to degrade TCC at a rate of - 0.0158 ± 0.012 h-1 at a 
temperature of 30°C but was not removed at all at 21°C (Table 2) [94].  Further 
research into the separate impacts of wastewater nitrification and denitrification on 
concentrations of TCC, as well as the microbial populations involved in the 
processes needs to be conducted to gain further insight into the degradability of the 
antimicrobial during treatment. 
3.4.2.2  Triclocarban Dechlorination Products 
Concentrations of DCC, MCC, and NCC were not detected at or above the 
LOQ during the course of the experiments. 
3.5  Conclusions 
 TCS and TCC are commonly detected in the wastewater treatment process.  
Concerns exist regarding their environmental impacts due to release via wastewater 
effluent discharge and the land application of biosolids.  Simulation of nitrification 
process allows for a better understanding of how the treatment can influence 
concentrations of TCS, TCC, and their antimicrobials.  The majority of TCS was 
associated with the solids fraction of nitrification samples and concentrations 




Figure 3-4:  Concentrations of TCC in a) Solids and b) Aqueous Factions of Nitrification 
Samples Over Time 
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and 8.5 – 9.5.  A greater reduction of TCS levels in solids samples occurred at the 
higher pH range.  MeTCS was formed in solids samples under both pH conditions, 
with formation rates being the most rapid under pH conditions ranging 8.5 – 9.5 
(0.0174 ± 0.005 h-1, first 25 hours).  TCC and 2,4-DCP concentrations, however, did 
not change during either nitrification treatment.  Overall, the impact of nitrification 
treatment on the antimicrobials and their transformation products was varied. 
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4.1  Abstract 
 
 The growing concern worldwide regarding the presence of emerging 
contaminants in biosolids calls for a better understanding of how different treatment 
technologies at water resource recovery facilities (WRRFs) can influence 
concentrations prior to biosolids land application.  This study focuses on the 
influence of solids treatment via the Cambi Thermal Hydrolysis Process™ in 
conjunction with anaerobic digestion (TH-AD) on concentrations of triclosan (TCS), 
triclocarban (TCC), and their transformation products in biosolids and sludge.  
Concentrations of the target analytes in biosolids from the TH-AD process (Class A), 
sludge from the individual TH-AD treatment steps, and limed biosolids (Class B) 
from the same WRRF were compared.  TCC concentrations were significantly lower 
in Class A biosolids than those in the Class B product - a removal that occurred 
during thermal hydrolysis.  Concentrations of TCS, methyl triclosan, and 2,4-
dichlorophenol, conversely, increased during anaerobic digestion, leading to 
significantly higher concentrations of these compounds in Class A biosolids when 
compared to Class B biosolids.  Implementation of the TH-AD process had mixed 
effect on contaminant concentrations. 
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4.2  Introduction 
 Extensive use of pharmaceutical and personal care products (PPCPs) by 
society has led to their presence in the wastewater treatment (WWT) process, 
including wastewater effluent and biosolids [11,105].  Two such compounds are the 
antimicrobials triclosan [5-chloro-2-(2,4-dichlorophenoxy)-phenol] (TCS) and 
triclocarban [N-(4-chlorophenyl)-N-(3,4-dichlorophenyl) urea] (TCC), both of which 
have been demonstrated to show endocrine disrupting capabilities [26,27,45,46] 
and, due to concerns regarding their ecological impact, are currently under phase-
out regulations in consumer antiseptic wash products in the United States (U.S.) 
[47].  TCC and TCS have been detected in all stages of the WWT process and most 
notably concentrate in the solids fraction [11,65,106]. 
In the US, treated wastewater solids (biosolids) are commonly land-applied 
as a means of nutrient recovery/soil reclamation [107] allowing for this material to 
become a potential source of organic pollutants to the environment.  TCC and TCS 
have been detected in biosolids from wastewater treatment facilities throughout the 
U.S. [21,50] and studies have shown the ability of TCC and TCS to persist in 
agricultural soils after the land-application of biosolids, with estimated half-lives of 
191 and 107 - 258 d, respectively [59,108].  Furthermore, these antimicrobials can 
accumulate in the roots of plants grown in biosolids-amended soils [109,110] and 
earthworms living in treated soils [41,42], indicating the potential for ecological risk. 
 TCC and TCS can also be partially transformed both biotically and abiotically 
during the WWT process.  For instance, methyl triclosan (MeTCS) can form during 
aerobic treatment [11], has higher endocrine disrupting capabilities [26] than its 
parent compound TCS, and is more persistent in biosolids amended soils than TCS 
[25].  Furthermore, the carbanilide analogs of TCC associate primarily with solids 
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within the WWT process [50] and have also been linked to endocrine system 
disruption [45].  The amount of TCC and TCS degradation and the compounds 
formed is highly dependent on the treatment processes employed by the WWT plant 
[50]. 
Currently, WWT facilities within the United States (US) are focusing efforts 
into the beneficial recovery of resources throughout the treatment process and many 
have begun changing their designation from WWT plant to water resource 
reclamation facility (WRRF) (WEF, 2014).  This emphasis on resource recovery not 
only includes the land-application of biosolids for beneficial uses, but changes in 
treatment processes as well.  One such process is the innovative Cambi Thermal 
Hydrolysis Process™ (CambiTHP™), a pretreatment for anaerobic digestion of 
wastewater sludge.  Amongst other benefits, the CambiTHP™ allows for a reduction 
in the volume of final solids as well as increases the biodegrability of sludge – 
leading to an increase in biogas production during anaerobic digestion, which can be 
captured and beneficially used as an energy source.  Limited studies have dealt with 
the fate of organic microconstituents in the CambiTHP™ process.  Previous 
experiments on the fate of TCS, bisphenol-A, and nonylphenol ethoxylates in spiked 
water samples and nonlyphenol in spiked sludge treated via high temperature and 
pressure by a lab-scale chemical digestion bomb found that these compounds were 
not degraded during the treatment.  Furthermore, the study found that laboratory-
scale anaerobic digesters treating sludge with conventional mesophilic anaerobic 
digestion (MAD) more readily transformed nonylphenol ethoxylates to nonylphenol 
than sludge that had been pretreated with thermal hydrolysis prior to MAD.  [111]  
The present study examines concentrations of TCC and TCS as well as three TCS 
and five TCC transformation products in biosolids from a single WRRF in the Mid 
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Atlantic region of the US that has recently changed its solids handling process.  In 
October 2014, the facility began transitioning from lime-stabilizing final solids (Class 
B biosolids) to treating solids via the CambiTHP™, in conjunction with anaerobic 
digestion (TH-AD) (Class A biosolids), the first of its kind in the US and currently the 
largest in the world.  Class A biosolids have severely reduced pathogen levels as 
well as increased vector attraction reduction when compared to Class B biosolids, 
allowing for increased options for land application.  The study goal was to expand 
upon a previous study of historical trends of TCC and TCS in limed biosolids from 
this WRRF [21] by examining how advances in solids handling processes within this 
same facility can influence the concentrations of these antimicrobials as well as their 
degradation products (not examined in the previous study) in biosolids prior to their 
application onto agricultural soils.  Additionally, the study examines the influence of 
individual stages of the TH-AD process itself on the concentrations of these 
antimicrobials and their transformation products. 
4.3  Materials and Methods 
4.3.1  Target Analytes 
 Class A and Class B biosolids, as well as sludge samples collected 
throughout the TH-AD process, were analyzed for the antimicrobials TCS and TCC.  
Additionally, all samples were analyzed for three TCS transformation products: 
MeTCS, 2,4-dichlorophenol (2,4-DCP), and triclosan-o-sulfate (TCS-O-Sulf); and five 
TCC degradation products: 4,4’-dichlorocarbanilide (DCC), 1-(3-chlorophenyl)-3-
phenylurea (MCC), carbanilide (NCC), 4-chloroaniline (4-CA), and 3,4-dichloraniline 
(3,4-DCA).  These compounds have been identified previously in the literature as 

























Figure 4-1:  Structures of Triclosan, Triclocarban, and their Transformation Products 
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4.3.2  Wastewater Treatment Plant 
 The current study focuses on sludge and biosolids samples collected from an 
east coast U.S. municipal WRRF serving a highly populated region.  Approximately 
1.25 million cubic meters (m3) of raw sewage is treated daily by the facility via open-
air primary sedimentation, activated sludge, and tertiary treatment (including 
nitrification-denitrification, filtration, and disinfection).  Prior to full phase-out in 
February 2015, treated sludge from the facility was classified as Class B biosolids 
and the final product achieved by thickening, centrifugation, and addition of lime (15 
– 20% on a dry weight basis) to solids from primary, secondary, and nitrification-
denitrification treatment.  Solids treated with lime did not go through an anaerobic 
digestion treatment.  Class B biosolids from the WRRF were typically land-applied to 
agricultural fields for resource recovery.  This solids treatment process may be 
utilized in in the future during situations requiring the processing of short-term peak 
loads due to lack of TH-AD treatment capacity. 
Implementation of the TH-AD processes began in October 2014, with solids 
meeting US Environmental Protection Agency (US EPA) Exceptional Quality Class A 
requirements by February 2015.  Solids from primary, secondary, nitrification-
denitrification, and filtration are currently treated by TH-AD.  Primary solids are 
thickened by gravity and secondary solids by dissolved air floatation thickening 
process, blended, and dewatered by one of four centrifuges yielding approximately 
15 – 19 % dry solids.  The separated water is returned back into the wastewater 
treatment process.  The dewatered sludge is then sent to a storage hopper prior for 
processing via the CambiTHP™.  The WWTP employs four (4) TH process streams.  
Each stream consists of:  
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a) One pulper, which preheats the sludge to approximately 60 – 99 °C via 
recycled steam from the TH process.  
b) Six digesters, where hydrolysis occurs via heat (150 – 180 °C) and 
pressure (0.37 - 0.95 MPa).  Retention time is 30+ minutes. 
c) One flash tank, where heat and pressure are rapidly decreased by flashing 
steam back into the pulper.  The sludge is released at a temperature of 
approximately 70 – 115 °C and consists of 8 – 12 % total solids. 
Prior to anaerobic digestion (AD), the sludge is diluted via service water to decrease 
the sludge temperature and the percentage of dry solids to approximately 9.5 %.  
The TH streams feed into four AD tanks that can each accommodate approximately 
14,500 m2 of sludge.  After a retention time of approximately 22 d at 37 °C, the 
digested solids are dewatered via belt presses.  The final solids are classified by the 
US EPA as Exceptional Quality Class A biosolids and predominantly land-applied for 
agricultural purposes.  A diagram of the TH-AD process is provided in Figure 4-2. 
4.3.3  Sample Collection and Handling 
4.3.3.1  Biosolids Collection  
 Class B biosolids were collected routinely (approximately every 2 – 3 months) 
from the WRRF treatment line (post liming) between 2005 and 2015 for previous 
studies on trends of persistent organic pollutants (POPs), including TCC and TCC, in 
biosolids [21,113].  Liquid streams from the dewatering of solids were not sampled.  
Samples were archived and stored at -20 °C until analysis.  For this study, a subset 
of the samples collected between 2011 and 2015 were analyzed.  More information 
regarding long-term temporal trends of TCS and TCC between 2005 and 2011 in 
Class B biosolids from this facility can be found elsewhere [21].
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Figure 4-2:  Diagram of the CambiTHP™ - Anaerobic Digestion Solids Treatment Process and Sampling Locations 
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 Grab samples of Class A biosolids produced from the TH-AD process were 
collected beginning in November 2014.  Samples were collected on a weekly basis 
while the TH-AH process was still in the beginning stages of full-scale 
implementation (between the end of November 2014 and the beginning of March 
2015).  Samples were collected on a monthly basis thereafter.  Samples were stored 
at -20 °C until analysis.  Again, a subset of the samples was analyzed for this study. 
4.3.3.2  TH-AD Process Sample Collection 
In June 2015, grab samples were collected from various stages within the 
TH-AD process: a) after centrifugation; b) along one of the four CambTHP™ streams 
(input and post-flash tank); c) from one AD tank (via the digestion solids recycle 
line); and d) from the belt press dewatering process (final solids).  All sampling 
locations are provided in Figure 4-2.  After collection, samples were placed on ice 
until laboratory arrival, where they were stored at -20 °C until analysis.   
4.3.4  Standards and Reagents 
TCC (>97 %), TCS (>97 %), and MeTCS (>97 %) were obtained from 
Wellington Laboratories (Guelph, ON, Canada).  MCC (N/A), NCC (98 %), 2,4-DCP 
(≥97 %), and 4-CA (98 %) were acquired by Sigma-Aldrich (St. Louis, MO, USA).  
DCC (>97 %) was acquired through Oakwood Chemicals (West Columbia, SC, 
USA).  TCS-O-Sulf (N/A) was obtained from Toronto Research Chemicals (Toronto, 
Canada).  Isotopically-labeled 13C13-TCC (≥99 %), 13C12-TCS (≥99 %), and 13C12-
MeTCS (≥99 %) were obtained from Wellington Laboratories (Guelph, ON, Canada), 
d2-3,4-DCA (98 %) from Santa Cruz Biotechnology (Dallas, TX, USA), and d3-2,4-
DCP (98 %) through Cambridge Isotope Laboratories (Andover, MA, USA).   
All organic solvents used were high performance liquid chromatography 
(HPLC) or ultra high performance liquid chromatography (UHPLC) grade (Burdick 
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and Jackson; Fisher Scientific).  Laboratory-grade sand was obtained from J.T. 
Baker® (Avantor Performance Materials, Center Valley, PA, USA).  Potassium 
phosphate (monobasic and dibasic), ammonium acetate, sulfuric acid, and acetic 
acid were acquired through Fisher Scientific (Fair Lawn, NJ, USA).  A Picosystem 
UV Plus treatment system (Hydro Service & Supplies, Inc.; Durham, NC, USA) 
provided organic-free, UV-treated water. 
4.3.5  Triclosan, Triclocarban, & Transformation Product Extraction and 
Analysis 
4.3.5.1  Sample Extraction 
Biosolids samples were extracted on a wet weight basis.  However, due to 
the high liquid content and high amount of solubilized organics in the liquid faction of 
the sludges collected from the TH-AD process (specifically post-flash tank and 
anaerobic digestion samples), sludge collected from this process were lyophilized 
prior to extraction.   
Samples for analysis of all compounds except 4-CA and 3,4-DCA were 
processed using a previously published method [25].  Briefly, samples were 
extracted using a Dionex Accelerated Solvent Extraction (ASE) #300 system (Dionex 
Corporation, Sunnyvale, CA, USA) with a 20:80 (v/v) blend of water:isopropyl alcohol 
(IPA). Oasis® HLB solid phase extraction (SPE) cartridges (6 mL, 200 mg) (Waters 
Corporation, Milford, MA, USA) were employed for extract clean-up and analytes 
were eluted from the cartridges with a dichloromethane (DCM):diethyl ether (DEE) 
solution (80:20 v/v).  Eluates were evaporated using a rotary evaporator and 
reconstituted in 1.5 mL methanol (MeOH) for instrumental analysis.  Further details 
regarding the extraction method are provided in the supplemental information. 
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For 4-CA and 3,4-DCA extraction, samples were placed in a 15 mL centrifuge 
tube and vortexed for 5 minutes in a solution of acetonitrile (ACN):MeOH (50:50 v/v).  
Samples were then centrifuged for 3 minutes and the supernatant decanted.  The 
extraction process was repeated two additional times and the supernatants for each 
sample combined.  The samples were then evaporated under nitrogen at 35 ˚C and 
reconstituted in 1 mL ACN for instrumental analysis. 
4.3.5.2  Instrumental Analysis 
 A Shimadzu Nexera X2 Ultra High Performance Liquid Chromatograph 
(UHPLC) coupled with a Shimadzu 8040 triple quadrupole mass spectrometer 
(MS/MS) (Shimadzu North America, Columbia, MD, USA) equipped with an ESI- 
source was utilized for the analysis of TCC, TCS, as well as the transformation 
products 2,4-DCP, DCC, MCC, and NCC.  The UHPLC was run isocratically using a 
mobile phase of 10 mM ammonium acetate in a solution of MeOH:ACN:water 
(60:15:25 v/v) at a flow of 0.5 mL/min and equipped with a Supelco Ascentis® 
Express C18 reverse phase column (2.7 μm, 50 x 2.1 mm) (Sigma-Aldrich, St. Louis, 
MO, USA). The total run time per sample was 1.45 minutes.  MS acquisition 
occurred in multiple reaction monitoring (MRM).  TCS-O-Sulf was also analyzed via 
UHPLC-MS/MS with chromatographic separation occurring via 0.2 % formic acid in 
MeOH run isocratically through a Supelco Ascentis® Express C18 reverse phase 
column (2.7 μm, 50 x 2.1 mm) at a rate of 0.55 mL/min for 0.9 min.  MS acquisition 
was achieved in MRM.  Additional details regarding all UHPLC-MS/MS conditions 
are provided in the supplemental information. 
 Following UHPLC-MS/MS analysis, samples from the ASE extraction process 
were evaporated and reconstituted in 1 mL of hexane for measurement of MeTCS.  
Samples were analyzed by an Agilent 7890B gas chromatograph (GC) in 
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conjunction with an Agilent 5977A mass selective detector (MSD) run in positive 
electron impact ionization mode [25].  A capillary column (DB-5-MS) with a length of 
15 m, diameter of 0.25 mm, and film thickness of 0.1 μm (J&W Scientific, Folsom, 
CA, USA) was used for compound separation.  4-CA and 3,4-DCA were also 
analyzed via the same GC-MS set-up and details for both analytical methods are 
provided in the supplemental information. 
  TCS TCC MeTCS DCC MCC 
MDL (ng L-1) 16.2 8.5 15.8 75.2 88.1 
Recovery (%) 85.4 ± 3.9 91.1 ± 7.0 83.1 ± 4.2 87.5 ± 8.0 90.9 ± 6.5 
 
NCC TCS-O-Sulf 2,4-DCP 4-CA 3,4-DCA 
MDL (ng L-1) 81.7 55.3 90.4 100.3 112.9 
Recovery (%) 90.3 ± 3.7 71.8 ± 22.3 75.2 ± 13.9 62.3 ± 26.1 67.0 ± 19.4 
 
4.3.5.3  Quality Assurance/Quality Control 
 All samples were spiked with 150 ng of 13C13-TCC, 13C12-TCS, 13C12-MeTCS 
and d2-3,4-DCA as surrogate standards prior to extraction.  Samples were extracted 
in duplicate and extractions were performed in batches containing less than 20 
samples, including a blank of laboratory-grade sand a sample spiked with all 
compounds analyzed for recovery determination.  A standard curve of eight 
standards at concentrations other than zero was run for each compound, with 
linearity correlations yielding r2 ≥0.99.  Instrument stability was verified via injection 
of standards and solvent blanks every 10 samples.  Method detection limits (MDLs) 
were determined using United States Environmental Protection Agency guidelines 
[98].  Average compound recoveries and MDLs are provided in Table 4-1.  Statistical 
Table 4-1:  MDLs and Recoveries of Target Analytes 
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analysis was performed using GraphPad Prism 7 (GraphPad Software, Inc., San 
Diego, CA, USA). 
4.4  Results and Discussion 
4.4.1  Concentrations in the TH-AD Process 
Concentrations of TCC, TCS, MeTCS, and 2,4-DCP throughout the TH-AD 
process are presented in Figure 4-3.  4-CA, 3,4-DCA, DCC, MCC, NCC, and TCS-
O-sulfate were not detected in samples collected within the TH-AD process. 
 
 
Levels of TCC significantly decreased during the thermal hydrolysis step of 
the TH-AD process (Tukey’s multiple comparisons test, P<0.01).  Average 
concentrations of TCC prior to TH ranged from 6,816 – 7,368 ng g-1 dry weight (dw) 
Figure 4-3:  Concentrations of TCC, TCS, MeTCS, and 2,4-DCP in Individual Stages of the TH-
AD Treatment Process (error bars represent the standard error of the mean) 
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while concentrations collected after TH treatment ranged from 67.5 – 89.9 ng g-1 
dw.  While degradation pathways were not determined in this study, research has 
shown that TCC can be hydrolyzed to 4-CA and 3,4-DCA [54,112]. 4-CA and 3,4-
DCA were also not detected in this study, but this may be due to their ability to be 
degraded by reactive oxygen species [114].  Free radicals have been shown to form 
during heat treatment of biomass [115].  Pyrolysis of biosolids has been 
demonstrated to degrade TCC to 1-(3,4-dichlorophenyl)-3-phenylurea and 1-(4-
chlorophenyl)-3-phenylurea [116], two TCC dechlorination compounds not analyzed 
in this study.  
Conversely, concentrations of TCS increased during the anaerobic digestion 
stage of the TH-AD process.  Average concentrations of TCS before and after AD 
treatment ranged from 6,884 – 7,489 ng g-1 dw and 10,872 – 12,345 ng g-1 dw, 
respectively.  The increase in average TCS concentration between TH and AD was 
statistically significant (Tukey’s multiple comparisons test, P<0.05).  Like TCS, 
MeTCS concentrations also increased significantly during the AD phase of treatment 
(Tukey’s multiple comparisons test, P<0.05) with average concentrations prior to AD  
ranging from 248 – 280 ng g-1 dw and after ranging from 326 – 340 ng g-1 dw.  
Finally, concentrations of 2,4-DCP increased significantly (Tukey’s multiple 
comparisons test, P<0.05) during AD as well.  Average 2,4-DCP concentrations 
before and after AD ranged from 204 – 283 ng g-1 dw and 396 – 661 ng g-1 dw, 
respectively.  Concentrations of 2,4-DCP also increased significantly between the 
AD stage and final cake samples (Tukey’s multiple comparisons test, P<0.01), likely 
due to the dewatering process.  These results indicate that the increase of TCS, 
MeTCS, and 2,4-DCP can be explained by the biological activity of the AD treatment 
step.  If the compounds cannot be degraded by either TH or AD, they will instead 
 76
become concentrated during AD as 60 – 70 % of the sludge volumes are reduced 
during microbial anaerobic respiration.  The addition of a thermal hydrolysis 
pretreatment step allows for more efficient sludge reduction during AD, causing an 
even further reduction in sludge volumes over conventional AD. [117]  Therefor, the 
combination of efficient sludge removal during AD and the lack of target compound 
degradation causes TCS, MeTCS, and 2,4-DCP to become concentrated in the 
remaining sludge, thus increasing concentrations associated with sludge and 
biosolids.  Additionally, concentrations of 2,4-DCP appeared to increase 
(approximately 95 %) more than TCS and MeTCS (~58 % and ~30 %, respectively) 
during anaerobic digestion (when compared to concentrations during TH).  This may 
be due to the degradation of other organic compounds that can form 2,4-DCP as a 
degradation product.  For instance, compounds such as the herbicides 2,4-
dichlorophenoxyacetic acid and 2-(2,4-dichloro-phenoxy)propionic acid have been 
demonstrated to form 2,4-DCP during degradation [100,101], amongst others.  
4.4.2  Concentrations in Biosolids 
4.4.2.1  TCC & TCC Degradation Products 
 Concentrations of TCC in biosolids after both treatment processes are 
provided in Figure 4-4a.  Average concentrations of TCC in Class A biosolids 
samples ranged from 102 – 3,006 ng g-1 dw with an average concentration over the 
November 2014 – August 2015 sampling period of 630 [standard deviation (SD) = 
974] ng g-1 dw.  Average concentrations in Class B biosolids ranged from 2,627 – 
9,483 ng g-1 dw and the overall average between August 2011 – January 2015 was 
5,734 (SD = 2,182) ng g-1 dw.  Statistical analysis (Kolmogorov-Smirnov test) 
showed that the overall mean concentration of TCC in Class A solids was 
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significantly lower than that of Class B biosolids (P<0.01), indicating that the TH-AD 
process was effective in decreasing TCC levels in final solids.  It is important to note  
 
 
that during the start-up period of the TH-AD process TCC concentrations in Class A 
biosolids continuously decreased until the TH-AD process was stabilized and 
implemented full time in February 2015, after which concentrations remained 
relatively steady with a range of 102 – 294 ng g-1 dw.  The implementation of the 
TH-AD process at the study facility allowed for a significant decrease in TCC 
concentrations in Class A biosolids, stabilizing after full-scale system operation at 
levels over 95 % lower (when comparing overall mean concentrations) than those 
Figure 4-4:  Concentrations of a) TCC, b) TCS, c) MeTCS, and d) 2,4-DCP in Class A and 
Class B Biosolids (error bars represent the standard error of the mean) 
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present in Class B biosolids from the same facility.  Temporal trends of TCC at the 
same facility (prior to the employment of the TH-AD process) demonstrated that 
while TCC concentrations in Class B biosolids (n = 31) were decreasing between 
2005 and 2011, the concentrations were still generally greater than 10,000 ng g-1 
dw [21].  Additionally, a study of TCS, TCC, and their transformation products in 
biosolids in WRRFs throughout the United States showed that TCC concentrations 
did not decrease in samples collected monthly between March 2009 and April 2010 
[50].  Therefore, this study demonstrates that treating solids via TH-AD can 
significantly reduce concentrations of TCC in biosolids and, thus, the amount of TCC 
being introduced to the environment via the beneficial reuse of biosolids. 
Although 4-CA and 3,4-DCA can be formed via hydrolysis of TCC [54,112],  
they were not detected in the biosolids samples from this study.  This lack of 
detection may be due to their propensity to associate in the liquid phase over the 
solids phase (log Kow = 1.72 and 2.37, respectively) and the ability of these 
chloroanilines to be degraded biologically [112,118] and in the presence of reactive 
oxygen species [114].   
The formation of the TCC dechlorination products DCC, MCC, and NCC has 
been demonstrated in anaerobic sediment communities [119,120] and some 
dechlorination products have been detected in biosolids samples throughout the 
United States [50].  These compounds, however, were not detected in biosolids 
samples from this study. 
4.4.2.2  TCS & TCS Degradation Products 
 Levels of TCS in Class A & B biosolids are provided in Figure 4-4b.  Average 
TCS concentrations in Class A biosolids ranged from 13,008 – 16,839 ng g-1 dw 
with an overall average of 15,119 (SD = 1,334) ng g-1 dw over the sampling period.  
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Concentrations ranged from 6,514 – 10,180 ng g-1 dw in Class B biosolids and the 
overall average was 8,955 (SD = 1,594) ng g-1 dw between August 2011 and 
January 2015.  Comparisons of overall average concentrations in Class A and Class 
B biosolids indicate that TCS is significantly higher in Class A biosolids (Kolmogorov-
Smirnov test; P<0.01).  This signifies that the TH-AD process is concentrating TCS 
in final solids.  Temporal studies of TCS have shown that TCS concentrations are 
remaining relatively steady in biosolids collected from WRRFs the United States 
[21,50].  Implementation of the TH-AD process significantly concentrates levels in 
biosolids (due, specifically to anaerobic digestion), demonstrating that without an 
increase in input of TCS into the wastewater treatment system, the use of this new 
process could increase the discharge of TCS into the environment via land-
application of biosolids assuming equivalent application rates. 
 While less pronounced, MeTCS concentrations (provided in Figure 4-4c) 
exhibited similar trends to its parent compound TCS.  Concentrations ranged from 
77.9 – 309 ng g-1 dw in Class A biosolids and 87.6 – 276 ng g-1 dw in Class B 
biosolids.  Overall average MeTCS concentrations over the sampling periods [216.9 
(SD = 74.1) ng g-1 dw for Class A solids; 153.2 (SD = 55.6) ng g-1 dw for Class B 
solids] were significantly different (Kolmogorov-Smirnov test; P<0.05), demonstrating 
that the TH-AD process increased concentrations over lime treatment of solids and, 
as with TCS, the new treatment process, specifically the AD step, will increase the 
amount of MeTCS being introduced to the environment via the beneficial reuse of 
biosolids.  
 Increases in 2,4-DCP concentrations, shown in Figure 4-4d, also 
demonstrated a notable increase after the change from lime treatment to the TH-AD 
process.  Average concentrations in Class A biosolids between November 2014 and 
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August 2015 ranged from 566 – 1,220 ng g-1 dw while average concentrations of 
samples of Class B biosolids collected between August 2011 and January 2015 
ranged from 196 – 356 ng g-1 dw.  Overall average concentrations of 2,4-DCP were 
768 (SD = 184) ng g-1 dw in Class A solids and 281 (SD = 55.5) ng g-1 dw in Class 
B solids.  The overall average for 2,4-DCP in Class A biosolids were significantly 
higher than that of Class B biosolids (Kolmogorov-Smirnov test; P<0.01).  This again 
demonstrates that the implementation of the anaerobic digestion can increase the 
concentration of organic pollutants in final biosolids. 
 Liming of biosolids at the facility for production of Class B biosolids was 
executed at a target rate of 15 – 20 % on a dry weight basis, which could, at times, 
vary between 10 – 25 %, depending on processing loads.  However, given that 
average TCS, MeTCS, and 2,4-DCP concentrations increased by approximately 68 
%, 41 %, and 173 %, respectively, dilution of concentrations in biosolids via liming 
cannot be the only reason for the increase in compound levels in the Class A 
product.  Another explanation is reduction of total solids by the AD process.  Solids 
reduction at the facility during AD treatment ranges from 60 – 70 % indicating that if 
compound degradation is not occurring, TCS, MeTCS, and 2,4-DCP could effectively 
be concentrated during this process.  Figure 4-5 presents average concentrations of 
the detected target analytes in Class A biosolids (n = 9) compared with 
concentrations in Class B biosolids (n = 9) corrected for an 80 % change in solids 
amount (assuming a 15% dilution from liming and 65% reduction of solids from AD 
treatment).  t-tests were performed to determine whether the average concentrations 
in Class A biosolids and corrected Class B biosolids were significantly different (via 
the Holm-Sidak method).  Results indicated that the averages for TCS and MeTCS 
were not significantly different (P>0.05), further supporting the notion that increases 
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in concentrations of these two compounds in biosolids due to TH-AD treatment was 
due solids reduction.  Conversely, the averages for 2,4-DCP were significantly  
 
 
different (P<0.05) with concentrations in the Class A product remaining higher than 
those in Class B, even after factoring in the change in solids, showing that increases 
in concentrations of this compound were not due solely to solids reduction.  2,4-DCP 
has been shown to be a degradation product of other chlorinated organic 
compounds not analyzed in this study [100,101] and its increase may be due to the 
breakdown of such compounds during TH-AH treatment.  Biosolids from this facility 
are typically land-applied at a rate that meets each individual farm’s nutrient 
management needs.  Typical concentrations of total nitrogen (TN), ammonium as N 
Figure 4-5:  Concentrations of TCS, MeTCS, and 2,4-DCP in Class A Biosolids and Class B 
Biosolids (Corrected for Solids Concentration Losses) (error bars represent the standard 
error of the mean; n = 9) 
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(NH4-N), and total phosphorus (TP) are provided in Table 4-2.  Given that 
concentrations of TN, NH4-N, and TP are all higher in Class A biosolids, the 
application rates may be lower at farms when compared to rates used for the Class 
B product, indicating that input of TCS, MeTCS, and 2,4-DCP into the environment 
via land-application of Class A biosolids may not be as high as the concentrations in 
the final product indicate. 
 TCS-O-sulfate was not detected in any biosolids samples at or above the 
MDL. 
 
  Total Nitrogen Ammonium as N  Total Phosphorus 
  (mg kg-1, dw) (mg kg-1, dw) (mg kg-1, dw) 
Class A Biosolids 48000 7500 33000 
Class B Biosolids 37000 1400 13000 
 
4.5  Conclusions 
 The implementation of the TH-AD solids treatment process allows for the 
WRRF to utilize a more environmentally friendly technology – namely, via the 
creation of Class A biosolids (more opportunities for land application over Class B 
biosolids due to reduced pathogen concentrations and increased vector attraction 
reduction), reduction in volume of final solids created, and efficient methane 
production for the WRRF’s energy needs.  The growing awareness and concern 
regarding emerging contaminants in biosolids brings forth the need to assess how 
new treatment technologies influence contaminant concentrations.  This study 
demonstrated a significant decrease in TCC concentrations in US EPA Exceptional 
Quality Class A biosolids, when compared to Class B biosolids from the same 
WRRF; the removal occurred during the thermal hydrolysis stage of treatment.  
Table 4-2:  Typical Nutrient Concentrations in Class A and Class B Biosolids 
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Conversely, TCS, MeTCS, and 2,4-DCP concentrations increased during TH-AD 
treatment, with concentrations in Class A biosolids significantly higher than those in 
Class B biosolids.  The concentration of these compounds occurred during the 
anaerobic digestion stage of treatment.  The degradation compounds TCS-o-sulf, 
DCC, MCC, NCC, 4-CA, and 3,4-DCA were not detected in sludge or biosolids 
samples.  This research shows that implementation of TH-AD treatment can have 
mixed results on emerging contaminant concentrations and further research 
exploring the influence of the treatment on other compounds should be performed.  
Additionally, further research should be conducted to compare the TH-AD process 
on concentrations of emerging contaminants with AD processes without TH 
treatment as well as other AD treatments. 
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Chapter 5:  Effect of Cambi Thermal Hydrolysis Process-
Anaerobic Digestion Treatment on Concentrations of Phthalate 
Plasticizers in Wastewater Sludge 
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5.1  Abstract 
The impact of the recently implemented Cambi Thermal Hydrolysis 
Process™-Anaerobic Digestion (TH-AD) solids treatment method on concentrations 
of 4 phthalate plasticizers in wastewater sludge samples was explored in this study.  
Samples were analyzed for diisononyl phthalate (DiNP), diisodecyl phthalate (DiDP), 
di(2-ethylhexyl) phthalate (DEHP), and benzyl butyl phthalate (BBP) concentrations 
during individual stages of the TH-AD treatment process, in biosolids produced by 
the TH-AD process (Class A biosolids), and Class B biosolids from the same facility 
produced via the liming of sludges.  Results showed significantly higher 
concentrations of all 4 compounds in Class A biosolids when compared to 
concentrations in Class B biosolids.  For DEHP, DiNP, and DiDP, this increase 
occurred during the anaerobic stage of treatment.  Calculations indicate that 
increases of the four study compounds in Class A biosolids, when compared to 
Class B biosolids, was not solely due to solids reduction during anaerobic digestion 
and dilution during liming.  Overall, implementation of the TH-AD process increased 
concentrations of phthalate plasticizers in biosolids. 
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5.2  Introduction 
The presence of phthalate plasticizers in biota and the environment is of 
concern due to their toxicological properties, chiefly their endocrine disrupting 
capabilities [121,122].  Phthalate plasticizers are commonly used to increase the 
flexibility of products such as polyvinyl chloride (PVC), rubber, cellulose, and styrene 
and are also frequently used as additives in paints/varnishes, lubricants, propellants, 
adhesives, and cosmetics [15,17,123,124].  Production of these compounds is 
estimated to be over 4 million metric tons per year, with the compounds diisononyl 
phthalate (DiNP), diisodecyl phthalate (DiDP), and di(2-ethylhexyl) phthalate (DEHP) 
being the most highly produced [13,15].  Phthalates are not chemically bonded to the 
plastics and polymers in which they are used, allowing the compounds to leach from 
consumer and commercial products [13,14].  For instance, DEHP is frequently used 
in food packaging and, thus, has been detected in various food samples, such as 
dairy products, meats, fish, and breads, among others. [14,125,126].  Tubing and 
storage bags containing DEHP and other plasticizers are frequently used in medical 
settings and extensive leaching of the compound from this equipment has been 
observed as well [125,127].  Leaching of these compounds from consumer and 
industrial products has led to the detection of these compounds and their 
metabolites in human [32,128] and environmental samples [129,130].  
 Phthalate plasticizers make up over 90% of worldwide plasticizer production 
[16] and their content in plastics is typically 20 – 40% [35].  The extensive use of 
these compounds in piping and consumer products has led to the detection of these 
compounds in the wastewater treatment (WWT) process, including wastewater 
effluent and final solids [13,16,35].  High molecular weight phthalate plasticizers 
have been demonstrated to predominantly adsorb to wastewater solids [17,131,132], 
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with approximately 80% of DEHP [log Kow = 8.39 [18]] in the WWT process 
accumulating in sludges [17].  In the United States an estimated 60% of biosolids 
produced are land-applied for beneficial reuse [133], leading to concern over the 
introduction of toxic organic pollutants to the environment via the application of 
biosolids.  A study concerning plasticizers in agricultural fields in France found the 
sum of nine phthalate plasticizers to be 407 ng/g in the surface soil horizon (0 – 20 
cm) of an agricultural soil, with DEHP accounting for over 50% of the total [131].  In 
China, samples collected from agricultural soils in 123 different regions were 
analyzed for 15 phthalate plasticizer compounds.  The mean sum of the plasticizers 
was determined to be 1,088 ng/g, again with DEHP demonstrating the highest 
concentrations of the compounds analyzed [134].  Phthalate plasticizers in soils 
have been shown to transfer into vegetation [29,135], leach into deeper soil horizons 
[131,136], accumulate in earthworms [30], and to migrate via water run-off from solid 
waste dumps  [137]. 
 Due to toxicity concerns and the ability of phthalate plasticizers to travel in the 
environment and into biota, it is important to understand how different wastewater 
treatment technologies influence concentrations of these compounds in biosolids 
prior to their land-application.  Given the desire of WWTPs within the United States 
to increase resource recovery throughout treatment [138], studying how different 
technologies that improve resource recovery, such as Cambi THP™, impact 
concentrations of organic pollutants is vital.  When used as a pretreatment for 
anaerobic digestion, the Cambi THP™ results in both increased solids reduction as 
well as an increase in biogas production, a renewable resource, when compared to 
anaerobic digestion treatment alone.  However, despite its use since 1995, few 
studies have explored the influence of the Cambi THP™ in conjunction with 
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anaerobic digestion (TH-AD) on concentrations of organic pollutants.  In the only 
research conducted to date on the influence of a full-scale TH-AD treatment facility, 
Armstrong et al. (2017) observed that the ability of the process to degrade organic 
pollutants was very compound specific [49], indicating the need to further understand 
the impact that TH-AD treatment has on a variety of compounds.  This study focuses 
on the influence of the Cambi Thermal Hydrolysis Process™ (Cambi THP™) in 
conjunction with anaerobic digestion (TH-AD) on concentrations of four common 
phthalate plasticizers in wastewater sludges and biosolids.  The objectives of the 
present study are two-fold: 1) to understand the influence that individual stages in 
the TH-AD process have on concentrations of phthalate plasticizers and 2) compare 
concentrations of phthalate plasticizers in biosolids produced by the TH-AD process 
(Class A biosolids) to those in limed biosolids (Class B biosolids) produced at the 
same facility since the liming of biosolids is a treatment still frequently used in 
WWTPs located within the USA [139]. 
5.3  Materials and Methods 
5.3.1  Target Analytes 
 Sludge and biosolids samples were analyzed for the phthalate plasticizers: 
benzyl butyl phthalate (BBP), DEHP, DiNP, and DiDP.  Compound structures and 
log Kow values are provided in Table SI-D1 of the Supplemental Information. 
5.3.2  Sample Collection and Handling 
 Biosolids and sludge samples were collected from a municipal wastewater 
treatment plant (WWTP) located in the Mid-Atlantic, USA.  The facility, which serves 
a population of over 2 million residents, treats an average of 1.14 million m3 of raw 
sewage daily (300 million gallons per day).  The facility employs primary 
sedimentation, activated sludge, nitrification-denitrification, filtration, and disinfection 
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for waste treatment.  Sludge at the facility is currently treated via TH-AD (Figure 5-1) 
to produce Exceptional Quality Class A biosolids, as designated by the United States 
Environmental Protection Agency (US EPA).  Briefly, the TH-AH process consists of: 
1. Centrifugation of primary and secondary solids, resulting in a sludge 
consisting of 15 – 19% dry solids. 
2. Preheating of sludge at 60 – 99 °C in pulper. 
3. Hydrolysis of sludge under high heat (150 – 180 °C) and high pressure (0.37 - 
0.95 MPa) conditions. 
4. Rapid reduction of heat and pressure in flash tank to 70 – 115 °C.  Here the 
sludge consists of 8 – 12 % total solids. 
5. Anaerobic digestion of sludge at 37 °C for 22 days. 
6. Dewatering of sludge by belt presses. 
Wastewater sludge was previously treated via liming (approximately 15% by weight) 
to produce Class B biosolids prior to the phase-out of the process in February 2015.  
Liming is still commonly used in most US facilities [139].  Further details regarding 
past and present solids treatment at the study facility can be found elsewhere [49].  
Biosolids from this WWTP are land-applied on local agricultural fields as a soil 
amendment.   
5.3.2.1  TH-AD In-line Sampling 
 In October 2016, sludge samples were collected in-line at various locations 
throughout the TH-AD process, including: post centrifuge, Cambi THP™ input and 
effluent (post flashtank), anaerobic digestion, and final solids (Class A biosolids).  
Sampling locations are provided in Figure 5-1.  Samples were immediately 






Figure 5-1:  Diagram of the Cambi THP™-Anaerobic Treatment Process 
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5.3.2.2  Biosolids Sampling 
 Routine sampling of Class B biosolids from the WWTP occurred on a 
bimonthly basis beginning in 2005 and continuing until phase-out of this treatment 
process (liming of sludge) in 2015.  The samples were collected from the treatment 
line, immediately after the liming process and stored at -20°C until analysis.  Routine 
sampling of Class A biosolids from the facility began in 2014 during start-up of the 
TH-AD treatment process and continues through present day.  Samples were 
collected after TH-AD treatment and dewatering and stored at -20°C until analysis.  
A subset of the Class A and Class B biosolids samples collected during these 
sampling campaigns was used for this study. 
5.3.3  Standards and Reagents 
 DEHP (99.7%), DiNP (≥ 99%), DiDP (≥ 99%), BBP (98%), d4-DEHP (99.7%), 
and d4-BBP (98%) were acquired from Sigma Aldrich (St. Louis, MO, USA).  
Solvents were purchased from Burdick and Jackson® (Morris Plains, NJ, USA) and 
Fisher Scientific (Hampton, NJ, USA) and were of ultra high performance liquid 
chromatography (UHPLC) grade.  Laboratory-grade sand was procured from Fisher 
Scientific (Hampton, NJ, USA).   
5.3.4  Extraction Method 
 Sludge and biosolids produced by TH-AD treatment contain a high volume of 
solubilized organics in the liquid faction.  Because of this, samples were lyophilized 
and the solid and liquid faction of all samples were extracted and analyzed together.  
Compound extraction from lyophilized samples was achieved using a Dionex 
Accelerated Solvent Extraction (ASE) #300 system (Dionex Corporation, Sunnyvale, 
CA, USA) according to a previously published method [140].  Briefly, a solvent 
mixture of dichloromethane (DCM):acetone (50:50 v/v) was used for compound 
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extraction at a temperature of 110°C and pressure of 1500 psi.  Three extraction 
sequences in total were performed.  Extracts were cleaned-up via the modification of 
an established method [131].  ASE extracts were evaporated gently under nitrogen 
at a temperature of 55°C and reconstituted in 2 mL of DCM.  Extracts were then 
loaded onto HyperSep™ Florisil (1 g, 6 mL) solid phase extraction (SPE) cartridges 
(Thermo Fisher Scientific, Waltham, MA, USA) and the eluates collected.  The vials 
previously housing the ASE extracts were rinsed with 2 mL of DCM and the solvent 
was, again, loaded onto the SPE cartridges and the eluates collected.  Compounds 
were eluted from the cartridges via 2 x 5 mL of hexane:diethyl ether (80:20 v/v).  The 
combined eluates were evaporated under nitrogen at 55°C and reconstituted in 2 mL 
methanol (MeOH) for instrumental analysis. 
5.3.5  Instrument Analysis 
 Samples were analyzed for BBP, DEHP, DiNP, and DiDP, via a Shimadzu 
Nexera X2 UHPLC system paired with a Shimadzu 8040 triple quadrupole mass 
spectrometer (MS/MS) (Shimadzu North America, Columbia, MD, USA).  A mobile 
phase of 5 mM of ammonium formate in MeOH and a Waters Acquity UPLC® HSS 
T3 column (1.8 µm, 2.1 x 100 mm) were utilized for compound separation.  The 
mobile phase was run isocratically at a rate of 0.55 mL/min for 1.7 min.  The MS was 
equipped with an electrospray ionization source in negative mode and acquisition 
was achieved by multiple reaction monitoring.  Further details regarding UHPLC-
MS/MS settings are available in the Supplemental Information. 
5.3.6  Quality Assurance and Quality Control 
 Materials containing plastics were avoided during all sampling campaigns and 
glass jars were used for sample storage.  d4-DEHP and d4-BBP were used as 
surrogate standards and, prior to extraction, all biosolids and sludge samples were 
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spiked with 150 ng of each.  All samples were extracted in duplicate.   Extractions 
were performed in batches containing 12 samples or less and each extraction batch 
included a blank consisting of laboratory-grade sand a sample spiked with all 4 
plasticizer compounds for the determination of recovery percentages.  In instances 
where target analytes were detected in extraction blanks above the method 
detection limit (MDL), this value was subtracted from all samples within that 
extraction batch. 
During instrumental analysis, a standard curve of six standards at 
concentrations of 50, 100, 250, 500, 1000, 2500 ng/mL was run for each compound.  
Linearity correlations of the standard curve yielded r2 ≥0.99.  Instrument stability was 
verified via injection of standards and MeOH blanks every 10 samples.  MDLs were 
determined using US EPA guidelines [98].  Average compound MDLs and 
recoveries ranged from 14.6 – 27.2 ng/L and 87.1 – 100.8%, respectively.  Individual 
values are provided in Table SI-2.  GraphPad Prism 7 (GraphPad Software, Inc., 
San Diego, CA, USA) was used for figure creation and statistical analysis of data. 
5.4  Results and Discussion 
5.4.1  Influence of TH-AD Treatment 
 Analyses of plasticizer concentrations throughout the TH-AD process show 
concentrations of DEHP, DiNP, and DiDP increasing during anaerobic digestion 
(Figure 5-2).   Average DEHP concentrations were 29.2 ± 0.886 [standard error of 
the mean (SEM)] mg/kg post flashtank and 51.8 ± 2.17 mg/kg during anaerobic 
digestion.  Similarly, DiNP concentrations post flashtank were 20.3 ± 0.114 mg/kg 
and 39.2 ± 4.30 mg/kg in anaerobic digestion.  DiDP was detected post flashtank at 
11.5 ± 0.405 mg/kg and 19.7 ± 1.93 mg/kg during anaerobic digestion.  The increase 
in DEHP, DiNP, and DiDP between the post flashtank samples and anaerobic 
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digestion samples was statistically significant for all three compounds [Tukey’s 
multiple comparisons test; P < 0.0001 (DEHP), P < 0.0001 (DiNP), P = 0.0355 
(DiDP)].   
 
 
Results from this study indicate that concentrations of DEHP, DiNP, and 
DiDP were not reduced during treatment.  This observation is consistent with studies 
focusing on the impact of anaerobic digestion on phthalate plasticizers.  For 
instance, DEHP in landfill waste incubated under anaerobic conditions was shown to 
degrade only 15% after a 278 day period [141].  Additionally, microcosms run under 
anaerobic methanogenic conditions with BBP-degrading enrichment culture 
Figure 5-2:  Concentrations of DEHP, DiNP, and DiDP and BBP (x10) in Individual Stages of 
TH-AD Treatment.  BBP concentrations were multiplied by 10 for ease of viewing. (* 
designates concentrations are statistically different than those in the previous treatment step; 
error bars are standard error of the mean, n=2) 
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demonstrated only an 8% decrease in DEHP concentrations after approximately 90 
days.  The authors concluded that phthalate plasticizers with low solubility were 
more recalcitrant and that it may be due to the three-dimensional structure of the 
hydrophobic moieties.  [142]  Given that the retention time of the anaerobic digesters 
at the study facility is approximately 22 days, it is likely that there was not a sufficient 
amount of time for DEHP degradation to occur.  This is consistent with the 
observation in a previous study that DEHP is not removed during anaerobic 
digestion of wastewater sludge [132].  While little information exists on the 
degradation of DiNP and DiDP under anaerobic conditions, Lertsirisopon et al. 
(2006) observed that in natural sediment microcosms run under anaerobic condition, 
approximately only 10% of DiNP was degraded after 90 days – less than was 
observed for DEHP [143].  DiDP has a lower solubility and higher log Kow than DEHP 
and DiNP, indicating that substantial degradation during anaerobic digestion is 
unlikely due to decreased bioavailability, based on observations regarding the fate of 
DEHP and DiNP [144].  In a previous study of antimicrobials in the TH-AD process, 
Armstrong et al. (2017) noted that triclosan and two of its transformation compounds 
were not degraded but rather, as observed here, concentrations increased during 
the AD stage of treatment.  This was attributed to the solids reduction of the 
anaerobic digestion process, which essentially concentrated the compounds on the 
remaining solids [49].  
 Conversely, concentrations of BBP appeared to increase during the thermal 
hydrolysis treatment stage and decrease again during anaerobic digestion (Figure 
2).  While the increase of BBP during TH and decrease during AD was not 
statistically significant [Tukey’s multiple comparisons test; P = 0.995 (TH increase), P 
= 0.999 (AD decrease)], it is still important to note.  The increase in BBP during TH 
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treatment could not be explained but BBP has been shown to be degradable under 
anaerobic conditions, which may explain the decrease in concentrations during AD.  
Ejlertsson et al. (1997) found in that BBP was fully degraded in anaerobic 
methanogenic microcosms after approximately 30 days [142].  BBP in landfill waste 
was degraded by 70% over a 278 day period when incubated under anaerobic 
conditions [141]. 
5.4.2  Comparison of plasticizers in Class A and Class B biosolids 
 Overall, concentrations of DEHP, DiNP, DiDP, and BBP in Class A biosolids 
were higher than those in Class B biosolids.  Concentrations of DEHP in Class A 
biosolids produced by the TH-AD ranged from 54.3 to 87.5 mg/kg with an overall 
average of 66.7 mg/kg (SEM = 2.47 mg/kg).  Concentrations in the limed Class B 
biosolids ranged from 3.28 to 50.0 mg/kg with an overall average of 25.0 (SEM = 
3.78) mg/kg.  Differences in average concentrations of DEHP between the two 
biosolids classifications were statistically different (Kolmogorov-Smirnov test, P < 
0.0001).  DEHP values in Class A and Class B biosolids are provided in Figure 5-3a.  
Concentrations of DEHP in Class A and Class B biosolids are within range of those 
from other studies focusing on sewage sludge [16,130,132].  While the US EPA has 
not issued maximum concentrations for organic pollutants in biosolids, 
concentrations in Class A and Class B biosolids from this study were below the 100 
mg/kg proposed, and later withdrawn, by the European Commission.  However, 
those associated with Class A biosolids were higher than the 50 mg/kg instituted by 
Denmark. [145]  
 The overall average DiNP concentration in Class A biosolids was 48.2 (SEM 
= 1.56) mg/kg (range of 38.6 to 57.7 mg/kg) while the overall average in Class B 
biosolids was 18.6 (SEM = 1.60) mg/kg (range of 11.5 to 28.1 mg/kg) (Figure 5-3b).  
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Concentrations of DiNP in Class A biosolids were statistically higher than those in 
Class B biosolids (Kolmogorov-Smirnov test, P < 0.0001).  A previous study of DiNP 
in sludge from a WWTP with secondary treatment and a WWTP with tertiary 
treatment found concentrations to range from 2.60 – 31.3 mg/kg and below detection 
limit to 37.1 mg/kg, respectively [140].  DiNP in sludge samples collected from seven 
Swedish WWTPs ranged from 21 – 78 mg/kg [20].  Concentrations of DiNP biosolids 




Figure 5-3:  Concentrations of a) DEHP, b) DiNP, c) DiDP, and d) BBP in Class A and Class 
B Biosolids (error bars represent the standard error of the mean) 
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 DiDP concentrations (Figure 5-3c) ranged from 19.7 to 32.5 mg/kg in Class A 
biosolids and 3.64 to 11.7 mg/kg in Class B biosolids.  Overall averages in Class A 
and Class B biosolids were 22.5 (SEM = 1.07) mg/kg and 6.98 (SEM = 0.717) 
mg/kg, respectively.  Again, concentrations were significantly higher in Class A 
biosolids when compared to Class B biosolids (Kolmogorov-Smirnov test, P < 
0.0001).  However, as demonstrated with DEHP and DiNP, these concentrations are 
in accordance with those from other WWTPs [20].  
 Concentrations of BBP in Class A biosolids ranged from 0.969 to 8.28 mg/kg 
with an overall average of 3.05 mg/kg (SEM = 0.570 mg/kg).  Concentrations in the 
limed Class B biosolids ranged from 0.229 to 1.37 mg/kg with an overall average of 
0.601 (SEM = 0.111) mg/kg.  Differences in average concentrations of BBP between 
the two biosolids classifications were statistically different (Kolmogorov-Smirnov test, 
P = 0.0005).  BBP values in Class A and Class B biosolids are provided in Figure 5-
3d.  Concentrations from Turkish WWTPs had sludges with BBP concentrations 
ranging from 2.8 to 6.2 mg/kg [132].  Class B biosolids from the present study 
possessed BBP concentrations that were lower than this range while BBP in Class A 
biosolids were within or above this range. 
These results indicate that utilization of the TH-AD resulted in higher 
concentrations of the four phthalate plasticizers in biosolids when compared to the 
liming process.  As indicated in Figure 5-2, an increase occurs during the anaerobic 
digestion process for DEHP, DiNP, and DiDP.  On the other hand, despite the 
difference in BBP concentrations within Class A and Class B biosolids, levels of BBP 
did not change significantly throughout the TH-AD process.  Overall, this implies that 
the 4 phthalate plasticizers studied did not degrade during TH-AD treatment.  One 
explanation for this difference between the two biosolids types is the combination of 
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solids reduction that occurs during anaerobic digestion of the TH-AD process and 
addition of lime to produce the Class B biosolids.  To produce Class B biosolids, lime 
was applied to sludge at a rate of 15 – 20% on a dry weight basis.  Based on 
processing loads, this percentage could vary between 10 – 25%.  During the 
anaerobic digestion stage of TH-AD treatment, solids are reduced by 60 – 70%, a 
higher reduction than conventional AD due to the TH pretreatment [117].  The 
average concentrations of each target phthalate plasticizer in Class A biosolids were 
compared to concentrations in Class B biosolids adjusted for an 80% change in 
solids (15% for liming and 65% for loss of solids during AD treatment) and are 
provided in Figure 5-4.  For all compounds, concentrations in Class A biosolids were 
significantly higher than the adjusted Class B concentrations (multiple t-tests; Holm-
Sidak method; P < 0.01).  This demonstrates that differences in concentrations of 
DEHP, DiNP, DiDP, and BBP between Class A and Class B biosolids were not 
solely due to liming dilutions and/or solids reduction.  As discussed in Section 3.1, 
compounds such as DEHP and DiNP degrade very little during anaerobic digestion.  
However, unlike what was noted in this study, significant increases in concentrations 
of these compounds during anaerobic treatment were not observed in previous 
studies.  BBP was shown to be degradable under anaerobic conditions but, again, 
no explanation or observations of increases in BBP were seen in the literature.  One 
possible explanation for the difference in compound concentrations between 
treatment technologies is deconjugation of phthalate plasticizer metabolites.  
Research has indicated that when phthalate plasticizers are consumed and 
metabolized by the human body they can form conjugates, which can be excreted 
into the WWT system [146-149].  The transformation of conjugated pharmaceuticals 
back to the original compound (deconjugation) has been demonstrated to occur 
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during WWT [36,150].  Further research would have to be conducted to confirm 




Another reason for the difference in phthalate plasticizer concentrations 
between Class A and Class B biosolids may be due to the hydrolysis of these 
compounds due to the liming of sludge.  Previous research has indicated that 
phthalate plasticizers may be hydrolyzed to monoester and diacid products in 
aqueous samples under alkaline conditions, with hydrolysis rates decreasing with an 
increase in chain length [151,152].  Given that after the liming process sludge pH in 
Class B biosolids is ~12, this may be an explanation for the variation in 
Figure 5-4:  Concentrations of Phthalate Plasticizers in Class A Biosolids and Class B 
Biosolids (Corrected for Solids Concentration Losses) (error bars represent the standard error 
of the mean) 
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concentrations between the two biosolids types studied.  However, estimated 
hydrolysis half lives for phthalate plasticizers can be quite high [152], indicating that 
this process may only be a partial explanation for concentrations differences – 
further research exploring hydrolysis in sludge via liming would need to be 
conducted. 
5.4.3  Predicted Concentrations of Phthalate Plasticizers in Soil 
 Given that the land-application of biosolids to agricultural fields would 
constitute a major source of phthalate plasticizers to the soils, the predicted 
environmental concentration (PEC) was calculated for DEHP, DiNP, DiDP, and BBP 
for the application of the two different types of biosolids.  The PEC for each 
compound and biosolids type was calculated using: 
PEC = Csoil +
Cbiosolids  ×  AR
D × SD × CF
 
The initial soil concentrations (Csoil) was assumed to be zero, the concentration of 
the phthalate plasticizer in the biosolids (Cbiosolids) was assumed to be the average 
concentration outlined in Section 3.2 and provided in Table 5-1, the density (D) was 
assumed as 1.35 kg/cm3 [25,34], the soil depth (SD) was assumed as 7.6 cm to 
represent no till biosolids application [34], and CF is a units conversion factor.  The 
application rate (AR) was based on the average rate employed for application of 
biosolids from the study WWTP onto agricultural fields.  The ARs used are provided 
in Table 5-1 and differ between Class A and Class B biosolids due to higher nutrient 
concentrations in Class A biosolids [49].  
 Most toxicity studies regarding phthalate plasticizers in soil ecosystems 
revolve around DEHP (of those analyzed in the present study).  Hulzebos et al. 
(1993) determined the DEHP EC50 for the lettuce Lactuca sativa to be > 1000 µg/g 
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[153].  A study conducted on juvenile and adult collembolans (Folsomia fimetarra) 
found that juvenile mortality, growth, and development of the organisms were 
unaffected at DEHP concentrations up to 5000 mg/kg [154].  Additionally, Cartwright 
et al. (2000) observed that soil microbial populations were unaffected by DEHP at 
concentrations of 0.1 mg/g (representative on nonindustrial environmental) and 100  
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PEC in Soils 
(mg/kg) 
Avg Conc in 
Biosolids 
(mg/kg) 
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 Class A 
Biosolids 
6.95 x 103 66.7 0.452 48.2 0.327 
 Class B 
Biosolids 
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(mg/kg) 
PEC in Soils 
(mg/kg) 
Avg Conc in 
Biosolids 
(mg/kg) 
PEC in Soils 
(mg/kg) 
 Class A 
Biosolids 
6.95 x 103 22.5 0.152 3.05 0.0207 
 Class B 
Biosolids 
9.42 x 103 6.98 0.0641 0.601 0.00552 
 
mg/g (representative of a spill environment) [155]. However, Hu et al. (2005) noted 
that uptake of the compound by earthworms was rapid during the initial 10 day 
contact period and estimated the biota-to-soil accumulation factor to be 0.17 ± 0.03 
in soils with a DEHP concentration of 5 mg/kg [156].  Furthermore, an environmental 
risk limit emphasizing endocrine disrupting properties for DEHP was determined to 
be 1 mg/kg for fresh soil and sediments [157].  These determined toxicity values, 
and the environmental risk limit of 1 mg/kg are all above the PEC for DEHP in soils 
applied with Class A or Class B biosolids.  Further studies regarding the impact of 




DEHP on ecological risks as well as the impact of other phthalate plasticizers are 
needed. 
5.5  Conclusions 
 Concentrations of DEHP, DiNP, and DiDP in wastewater sludge increased 
significantly during the anaerobic digestion stage of the TH-AD process.  No change 
in concentration was observed during the thermal hydrolysis stage of treatment for 
these three compounds.  An increase in BBP was observed during thermal 
hydrolysis with a decrease in concentrations occurring during anaerobic digestion.  
These changes in BBP concentrations during TH-AD, however, were not statistically 
significant. Implementation of the TH-AD process led to higher concentrations of 
DEHP, DiNP, DiDP, and BBP in biosolids, when comparing Class A and Class B 
biosolids from the same facility.  Adjusting concentrations for solids reduction during 
anaerobic digestion and dilution via liming did not fully account for the differences in 
concentrations of phthalate plasticizers in Class A and Class B biosolids.  Further 
research should be conducted to determine the reason for differences in plasticizer 
concentrations between Class A and Class B biosolids.  Calculation of PECs for all 4 
compounds indicate that concentrations in soils land-applied with biosolids may not 
be above toxic levels, but more information regarding the ecological impact of these 
compounds needs to be explored. 
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6.1  Abstract 
The fate of four phthalate plasticizers during wastewater treatment processes 
at six different wastewater treatment plants (WWTPs) was investigated. 
Concentrations of benzyl butyl phthalate (BBP), di(2-ethylhexyl) phthalate (DEHP), 
diisononyl phthalate (DiNP), and diisodecyl phthalate (DiDP) were determined prior 
to either aerobic or anaerobic (conventional and advanced) treatment, after 
treatment, and in final, dewatered solids. Despite their elevated use worldwide, the 
fate of DiNP and DiDP during wastewater treatment have not been well 
characterized. DEHP was readily degraded during aerobic treatments while 
anaerobic digestion resulted in either no significant change in concentrations or an 
increase in concentration, in the case of more advanced anaerobic processes 
(thermal hydrolysis pretreatment and a two-phase acid/gas process). Impacts of the 
various treatment systems on DiNP, DiDP, and BBP concentrations were more 
varied – anaerobic digestion led to significant decreases, increases, or no significant 
change for these compounds, depending on the treatment facility, while aerobic 
treatment was generally effective at degrading the compounds. Additionally, thermal 
hydrolysis pretreatment of sludge prior to anaerobic digestion resulted in increases 
in DiNP, DiDP, and BBP concentrations. The predicted environmental 
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concentrations for all four compounds in soils after a single biosolids application 
were calculated and the risk quotients for DEHP in soils were determined. The 
estimated toxicity risk for DEHP in soils treated with a single application of sludge 
from any of the six studied WWTPs is lower than the level of concern for acute and 
chronic risk, as defined by the US EPA. 
6.2  Introduction 
 Phthalate plasticizers, also known as phthalic acid esters (PAEs), are 
typically used to improve upon the flexibility of plastics [[124]], among other uses, and 
have been detected extensively in the environment, such as in air [129,130,158], 
dust [159], sea water [130,160], fresh water [129,130], sediments [129,130,160,161], 
and soil samples [129,130]. These compounds are not chemically bound to the 
polymer they are associated with, allowing for leaching of these compounds to occur 
[13,14,162]. This leaching, in conjunction with their high production volumes - over 4 
million tons worldwide [13], has led to concerns regarding environmental and human 
exposure. PAEs have been demonstrated to induce various negative health effects, 
including reproductive toxicity [162-164], changes in hormone levels [165], birth 
defects [165], tumor formation [162], disturbance of thyroid function [122], and 
metabolic disorders [162]. Several PAEs, including benzyl butyl phthalate (BBP), 
di(2-ethylhexyl) phthalate (DEHP), diisodecyl phthalate (DiDP), and diisononyl 
phthalate (DiNP), have been listed in Proposition 65 by the State of California as 
chemicals known to cause cancer or reproductive toxicity [166]. 
 Various PAE compounds have been detected throughout the wastewater 
treatment (WWT) process, including wastewater effluent and biosolids, indicating 
that WWT can act as a source of these compounds to the environment. Armstrong et 
al. (2018) determined concentrations of DEHP, DiNP, DiDP, and BBP to be as high 
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as 87.5, 57.7, 32.5, and 8.28 mg/kg dry weight (dw), respectively, in Class A 
biosolids produced by thermal hydrolysis/anaerobic digestion. These concentrations 
were higher than those in limed Class B biosolids from the same facility [55], 
indicating the importance of treatment processes on PAE concentrations. A study of 
plasticizers in sludges from Canadian WWT plants demonstrated concentrations of 
DEHP in dewatered final sludge ranging from non detect to 119 mg/kg [16]. In a 
2017 study performed in Saudi Arabia, concentrations of 6 PAEs and bisphenol A 
were measured from the effluent of 5 WWT facilities. PAEs such as dibutyl phthalate 
(DBP), BBP, and DEHP were analyzed and concentrations ranged from 0.408 – 
1.037, 0.108 – 0.660, and 0.340 – 0.935 µg/L, respectively [167]. Relatively high 
concentrations of PAEs in biosolids lead to concern over the environmental 
contamination of soils due to biosolids land application. It is estimated that in the 
United States approximately 60% of biosolids are land applied for soil reclamation 
[133]. In a cultivation study conducted with lettuce, strawberry, and carrot, Sun et al. 
(2015) observed the ability of all three hydroponically grown plant types to uptake 
DBP, DEHP, and two principal metabolites [29]. Similarly, Zhao et al. (2015) 
demonstrated the ability of a variety of cabbage cultivars to accumulate DBP and 
DEHP from soils contaminated with the PAE compounds [135]. In both studies, the 
DBP and DEHP accumulation occurred predominantly in the roots faction of the 
vegetation studied. Regarding biota, a study of both live and deceased ants showed 
the ability of DBP, diisobutyl phthalate, DEHP, and BBP to be absorbed by cuticles 
of living ants [168]. Additionally, earthworm DEHP bioaccumulation factors from soils 
were determined to be 0.1 – 0.3 [30].  
Indications of the potential of PAEs to transfer to vegetation and biota 
demonstrates the need to better understand how to reduce concentrations of these 
 106 
compounds in biosolids prior to their land application. The present study focuses on 
the impact of various wastewater treatment processes on concentrations of four high 
molecular weight PAEs from six municipal WWT plants in the Mid Atlantic region of 
the US. Treatments within the six facilities vary between aerobic and anaerobic (both 
conventional and advanced) and the facilities themselves are located in both rural 
and developed areas. Samples were collected prior to treatment, post-treatment, 
and after final solids dewatering and were analyzed for DEHP, DiNP, DiDP, and 
BBP. While DEHP and BBP have been well studied due to extensive use, few 
investigations have focused on the fate of DiNP and DiDP during wastewater 
treatment and in biosolids, despite the fact that they among the most highly 
produced PAEs [15]. Results from this study allow for increased insight into how 
anaerobic digestion, including two infrequently characterized advanced processes 
(thermal hydrolysis pretreatment and a two-phase acid/gas process), or aerobic 
digestion impact concentrations of commonly utilized PAEs in wastewater and final 
solids. Finally, the predicted environmental concentrations of the four compounds in 
soils after a single biosolids application and the risk quotients for DEHP in these 
soils were determined as a means of gauging the risk that these PAEs pose to the 
environment due to the beneficial reuse of biosolids. 
6.3  Materials and Methods 
6.3.1  Sample Collection and Handling 
The focus of this study is on concentrations of BBP, DEHP, DiNP, and DiDP 
in final solids and the influence that varying treatment processes can have on the 
fate of these compounds in final solids. Because of this objective, the solids 
treatment processes at each facility were the primary sampling focus. In the case of 
WWTPs #5 and 6, which are very small facilities that employ a single treatment 
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process, the system utilized was the sampling focus since a separate solids 
treatment process does not exist at these facilities. All wastewater and sludge 
samples were lyophilized prior to extraction and analyzed for the four target PAEs. 
For wastewater samples, the solids and liquids factions were not separated prior to 
analysis but, rather, analyzed together. 
6.3.2  Study treatment facilities 
 Six different WWTPs located in the Mid-Atlantic region of the United States  
(Maryland and Washington, D.C.) were sampled for PAE analysis. Four (4) facilities 
(WWTPs #1 – 4) utilized anaerobic digestion for sludge treatment while two 
employed aerobic processes (WWTPs #5 and 6). Further details regarding specific 
treatment processes, average and maximum flows, and solids disposal practices are 
provided in Table 6-1. 
6.3.3  Standards and Reagents 
 PAE analytical standards were purchased from Sigma Aldrich (St. Louis, MO, 
USA): DEHP (99.7%), d4-DEHP (99.7%), DiNP (≥99.0%), DiDP (≥99.0%), BBP 
(98.0%), and d4-BBP (98.0%). All organic solvents were of at least high performance 
liquid chromatography grade and were obtained from Fisher Scientific (Hampton, NJ, 
USA). Laboratory-grade sand for sample extraction was also obtained from Fisher 
Scientific. 
6.3.4  Extraction Method 
 All samples were extracted in duplicate. Prior to extraction, samples were 
spiked with 300 ng of d4-DEHP and d4-BBP as surrogate standards. PAE 
compounds were extracted from lyophilized sludge samples using a Dionex 
Accelerated Solvent Extraction (ASE) #300 System (Dionex Corporation, Sunnyvale, 
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six in-ground digesters run at 37°C.  RT is for mesophilic processes.   
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and temperature of 110°C [[140]]. A solvent mixture of acetone:2-isopropanol (50:50 
v/v) was utilized for the three extraction sequences. Clean up of extracts was 
achieved via HyperSep™ Florisil (1 g, 6 mL) solid phase extraction cartridges 
(Thermo Scientific, Waltham, MA, USA) using a previously published method [55]. 
All samples were extracted in batches of 12 or less. Each extraction batch consisted 
of a blank and a spiked sample for recovery calculations. 
6.3.5  Instrumental Analysis 
 A Shimadzu Nexera X2 Ultra High Performance Liquid Chromatograph 
(UHPLC) coupled with a Shimadzu 8040 triple quadrupole mass spectrometer 
(MS/MS) was used for DEHP, DiNP, DiDP, and BBP analysis. Chromatographic 
separation was achieved via 5 mM ammonium formate in methanol run isocratically 
through a Waters Acquity UPLC® HSS T3 column (1.8 µm, 2.1 x 100 mm). The MS 
source was an electrospray ionization source run in negative mode. Acquisition 
occurred in multiple reaction monitoring. Further details regarding the UHPLC-
MS/MS method, as well as the compound method detection limits (MDLs), can be 
found in a previous publication [55].  
6.4  Results and Discussion 
6.4.1  Di(2-ethylhexyl) Phthalate (DEHP) 
 Concentrations of DEHP throughout the treatment processes of the six 
WWTPs sampled are provided in Figure 6-1a and Table 6-2. DEHP concentrations 
demonstrated three distinct trends. In WWTPs #1 and #2, DEHP was observed to 
decrease during anaerobic digestion treatment and then increase in final solids. For 
WWTP #1, the decrease during anaerobic digestion was not significant while the 


















Figure 6-1:  Concentrations of a) DEHP, b) DiNP, c) DiDP, and d) BBP during each stage of treatment in 
WWTPs #1 – 6.  * denotes concentrations are significantly different than those in the preceding stage of 
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Anaerobic Digestion Influent 6.74 ± 1.24 --- 5.38 ± 0.0377 --- 4.76 ± 0.109 --- 0.202 ± 0.0157 --- 
Anaerobic Digestion Effluent 3.91 ± 0.967 NS 2.76 ± 0.447 - 48.7% 3.25 ± 0.380 - 31.7% 0.0520 ± 0.00128 - 74.3% 








 Anaerobic Digestion Influent 12.4 ± 1.47 --- 6.80 ± 0.592 --- 7.34 ± 0.857 --- 0.135 ± 0.00892 --- 
Anaerobic Digestion Effluent 8.39 ± 0.227 NS 6.23 ± 0.0498 NS 6.90 ± 0.242 NS 0.334 ± 0.0180 + 147% 









Thermal Hydrolysis Influent 28.3 ± 0.207 --- 17.2 ± 1.03 --- 10.9 ± 0.408 --- 0.373 ± 0.0881 --- 
Thermal Hydrolysis Effluent 30.0 ± 2.35 NS 21.7 ± 0.572 + 26.2% 15.6 ± 0.637 + 43.1 % 1.22 ± 0.0316 + 227% 
Anaerobic Digestion 54.2 ± 4.78 + 80.7% 33.0 ± 0.842 + 52.1% 23.5 ± 1.29 + 50.6% 0.970 ± 0.177 NS 









Anaerobic Digestion Influent 14.7 ± 0.539 --- 9.90 ± 0.197 --- 5.24 ± 0.0221 --- 0.491 ± 0.00108 --- 
Anaerobic Digestion Effluent 30.5 ± 0.830 + 107% 21.1 ± 1.01 + 113% 14.9 ± 0.0933 + 184% 0.116 ± 0.0458 - 76.4% 









Aerobic Digestion Influent 18.0 ± 1.09 --- 10.3 ± 0.515 --- 7.42 ± 0.761 --- 0.790 ± 0.0146 --- 
Aerobic Digestion Effluent 11.7 ± 0.171 - 35.0% 6.07 ± 0.0590 - 41.1% 8.62 ± 0.443 NS 0.251 ± 0.00506 - 68.2% 









Aerobic Digestion Influent 20.1 ± 2.57 --- 26.7 ± 0.604 --- 11.6 ± 0.295 --- 0.398 ± 0.0271 --- 
Aerobic Digestion Effluent 4.50 ± 0.105 - 77.6% 3.76 ± 0.219 - 85.9% 3.97 ± 0.0746 - 65.8% 0.177 ± 0.0398 - 55.5% 
Final Solids 4.87 ± 0.141 NS 4.28 ± 0.308 NS 4.30 ± 0.253 NS 0.273 ± 0.0504 NS 
NS = change in concentration not significant and, thus, not calculated 
      
SD = standard deviation 
        
* calculated change from previous treatment step 
       
Table 6-2:  Concentrations and calculated percent changes of PAEs during each stage of treatment in WWTPs #1 – 6. 
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in the anaerobic effluent (Tukey’s multiple comparisons test, P = 0.027), which may 
be due to sampling from biosolids stockpiles on-site rather than directly after the 
dewatering process. Likewise, the decrease in DEHP concentrations during 
anaerobic digestion was not significant during treatment at WWTP #2. 
Concentrations again increased in final solids, but the increase was not significant. 
Conversely, an increase in DEHP concentrations during anaerobic digestion was 
observed in WWTPs #3 and #4. In WWTP #3, concentrations of the compound 
remained steady during thermal hydrolysis treatment while anaerobic digestion 
resulted in a significant increase of 80.7% (Tukey’s multiple comparisons test, P = 
0.0059). There was no significant change in DEHP concentrations between 
anaerobic digestion and final solids. Similarly, a significant (107%) increase in DEHP 
(Tukey’s multiple comparisons test, P = 0.0007) was observed during anaerobic 
digestion at WWTP #4. Additionally, concentrations of DEHP were, again, not 
significantly different between samples collected from anaerobic digestion and final 
solids post dewatering. 
 Previous studies have demonstrated that DEHP is not well degraded under 
anaerobic conditions. For instance, in a study of a Turkish WWTP, Çifci et al. (2013) 
observed that during anaerobic digestion treatment, only 17% of DEHP was 
degraded while the remaining amount was either recirculated through the treatment 
process or sorbed to dewatered sludge [132]. Additionally, anaerobic methanogenic 
microcosms enriched with a BBP-degrading culture showed that PAEs with low 
solubilities were not readily degraded, resulting in a reduction of DEHP 
concentrations by just 8% after 90 days [142]. During previous research conducted 
on the influence of the TH-AD treatment process at WWTP #3 on concentrations of 
PAEs in sludge, DEHP concentrations did not significantly change during thermal 
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hydrolysis treatment but were significantly higher during anaerobic digestion [55]. 
Furthermore, laboratory experiments comparing the influence of sludge thermally 
pretreated at 70°C prior to anaerobic digestion and sludge digested without 
pretreatment demonstrated that pretreatment had negative impacts on PAEs, 
including DEHP [169]. Overall, the current research supports prior studies that 
DEHP is not readily degraded anaerobically, an occurrence that can be exasperated 
by pretreatment prior to digestion. 
 Conversely, aerobic processes at the study WWTPs demonstrated the ability 
to greatly reduce DEHP concentrations. The aerobic SBR of WWTP #5 significantly 
reduced DEHP concentrations by 35% (Tukey’s multiple comparisons test, P = 
0.0081) while WWTP #6’s MBR caused an even larger (77.6%), and still significant, 
reduction of DEHP during treatment (Tukey’s multiple comparisons test, P < 0.0038). 
Concentrations in samples collected after aerobic treatment and from final solids 
were not significantly different for either WWTP #5 or WWTP #6. 
 Observations of DEHP degradation during aerobic treatment are consistent 
with those from previous studies. For instance, microbial degradation of DEHP in 
activated sludge from a Danish WWTP was estimated to be 81% [170]. A study 
concentrating on Indian WWTPs found that treatment via either a SBR or 
conventional activated sludge was effective at degrading DEHP by 61 – 70% [171]. 
Thus indicating that aerobic treatments appear to be more effective in degrading 
DEHP than anaerobic. 
6.4.2  Diisononyl Phthalate (DiNP) 
 Treatment effects of the various WWTPs on concentrations of DiNP (Figure 
6-1b, Table 6-2) were similar to those observed for DEHP. Concentrations of DiNP in 
WWTP #1 significantly decreased by 48.7% (Tukey’s multiple comparisons test, P = 
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0.0047) during anaerobic digestion and then significantly increased by 98.9% 
(Tukey’s multiple comparisons test, P = 0.0042) in final solids samples. This 
increase, again, is likely due to sampling from biosolids stockpiles on-site rather than 
directly after the dewatering process. Conversely, DiNP concentrations did not 
significantly change across all treatments in WWTP #2. WWTPs #3 and #4 
demonstrated an increase in DiNP concentrations during treatment. Thermal 
hydrolysis pretreatment in WWTP #3 resulted in a small, but significant increase 
(26.2%) in concentrations (Tukey’s multiple comparisons test, P < 0.018) as well as 
significant increases of DiNP during anaerobic digestion (52.1%) (Tukey’s multiple 
comparisons test, P < 0.0005). Additionally, concentrations of DiNP in the final solids 
of WWTP #3 were significantly higher than those in samples collected from the 
anaerobic digestion reactor by 10.0% (Tukey’s multiple comparisons test, P < 
0.049). Treatment at WWTP #4 also resulted a significant increase in concentrations 
by 113% during anaerobic digestion (Tukey’s multiple comparisons test, P < 0.0010) 
and in final solids by 20.4% (Tukey’s multiple comparisons test, P < 0.015). 
 Few studies exist regarding the fate of DiNP under anaerobic processes 
during wastewater treatment. Armstrong et al. (2018) observed that, similar to the 
present study, concentrations of DiNP greatly increased during the anaerobic stage 
of treatment at WWTP #3, increasing from approximately 30 mg/kg to over 50 mg/kg 
[55]. While not conducted with wastewater, a microcosm study performed with 
natural sediments under anaerobic conditions resulted in a DiNP degradation of only 
~10% after a 90 day period [143], demonstrating that DiNP is not readily degraded 
under anaerobic conditions. The increase in DiNP concentrations in WWTPs #3 and 
#4 are similar to what was observed for DEHP and may indicate that more advanced 
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anaerobic treatment processes, such as the thermal hydrolysis pretreatment or the 
two-phase acid/gas process, may have inhibitory effect on DiNP degradation. 
 As with DEHP, aerobic processes resulted in decreased concentrations of 
DiNP. Treatment of wastewater via SBR at WWTP #5 resulted in significantly 
decreased (41.1%) concentrations of DiNP in aerobic effluent samples (Tukey’s 
multiple comparisons test, P = 0.0016) and final cake samples (26.7%) (Tukey’s 
multiple comparisons test, P = 0.025). Concentrations of DiNP also decreased 
significantly (85.9%) during aerobic wastewater treatment (Tukey’s multiple 
comparisons test, P < 0.0001) at WWTP #6. Little research regarding the 
degradability of DiNP under aerobic conditions at WWTPs is available. Nevertheless, 
it has been demonstrated that bacteria such as Sphingobium chungbukense can 
effectively degrade the compound aerobically under various starting concentrations. 
Full degradation of DiNP by this bacterium strain, however, can take from 54 to 228 
hours for initial concentrations ranging from 50 to 500 mg/L and a lag phase was 
required for higher initial concentrations [172]. This, along with the present study, 
indicates that aerobic treatment can be an effective means for removing DiNP from 
wastewater, but factors such as duration of treatment and initial concentration, along 
with microbial populations present, will influence degradation of the compound. 
6.4.3  Diisodecyl Phthalate (DiDP) 
 DiDP concentrations during treatment at the six studied treatment plants are 
provided in Figure 6-1c and Table 6-2. The treatment system employed by WWTP 
#1 resulted in a significant decrease of DiDP concentrations by 31.7% during 
anaerobic digestion (Tukey’s multiple comparisons test, P = 0.035). However, DiDP 
was significantly higher (121%) in final solids samples (Tukey’s multiple comparisons 
test, P = 0.0023), when compared to anaerobic digestion effluent samples – an 
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occurrence likely due to final solids sampling locations and timing. The anaerobic 
treatment system at WWTP #2 had no significant impact on DiDP; concentrations 
remained stable in all samples. Conversely, the TH-AD treatment process utilized by 
WWTP #3 resulted in significant increases of DiDP during both the thermal 
hydrolysis (43.1%) and anaerobic digestion (50.6%) stages of treatment [Tukey’s 
multiple comparisons test, P = 0.012 (thermal hydrolysis), P = 0.0016 (anaerobic 
digestion)], as was observed for DEHP and DiNP. Similarly, WWTP #4 treatment 
systems resulted in a significant increase of 184% in DiDP during anaerobic 
treatment (Tukey’s multiple comparisons test, P = 0.0234). While higher than those 
in anaerobic digestion effluent samples, concentrations of DiDP were not 
significantly higher in final solids collected from WWTP #4. 
 As with DiNP, there is little information regarding the impact that anaerobic 
treatment has on concentrations of DiDP in the wastewater treatment process. While 
little information exists on the fate of this compound during anaerobic digestion, the 
fact that DiDP has a very low solubility (< 0.001 g/L) and its log Kow values are higher 
than those of DEHP and DiNP [173] support the observation that DiDP would not be 
readily degraded during anaerobic treatment. Furthermore, increases in DiDP 
concentrations were observed during anaerobic digestion during a previous study 
conducted at WWTP #3 [55], indicating that, along with the results in the present 
study, advanced anaerobic treatment processes may have a negative impact on 
DiDP degradation, as was observed for DEHP and DiNP.  
 While the SBR at WWTP #5 was able to decrease DEHP and DiNP 
concentrations, levels of DiDP did not change significantly throughout the treatment. 
The MBR employed by WWTP #6, however, was able to significantly decrease DiDP 
concentrations by 65.8% (Tukey’s multiple comparisons test, P < 0.0001). Again, 
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there is little information available regarding the fate of DiDP during aerobic 
wastewater treatment. A study focusing on Bacillus sp. SB-007 found that this 
bacteria species was able to efficiently degrade DiDP under aerobic conditions, with 
degradation rates decreasing with increased starting concentrations. Furthermore, 
degradation of initial DiDP concentrations between 100 and 500 mg/L did not begin 
until after a lag time of 12 to 60 hours and complete removal could take up to 234 
hours for starting concentrations of 500 mg/L [174]. The mixed effectiveness of 
aerobic treatment for degrading DiDP observed in the present study, along with the 
results presented by Park et al. (2009), indicate that aerobic processes may be a 
useful tool in reducing concentrations, but factors such as treatment time, microbial 
populations, and initial concentrations would likely have a large impact on treatment 
efficiency. 
6.4.4  Benzyl Butyl Phthalate (BBP) 
 BBP concentrations throughout the treatment processes of the six study 
WWTPs are provided in Figure 6-1d and Table 6-2. The anaerobic digestion process 
at WWTP #1 resulted in a significant decrease of BBP concentrations by 74.3% 
(Tukey’s multiple comparisons test, P = 0.046), similar to what was observed for 
DiNP and DiDP. Additionally, as was observed with the other study PAEs, the final 
solids samples demonstrated a significant increase (506%) in BPP concentrations 
(Tukey’s multiple comparisons test, P = 0.0098), which may be due to sampling of 
final solids from stockpiles on-site. Conversely, BBP exhibited different trends in 
WWTP #2 than was previously observed for DEHP, DiNP, and DiDP. Concentrations 
were significantly increased by 147% during anaerobic digestion (Tukey’s multiple 
comparisons test, P = 0.028) while levels observed in final solids were significantly 
lower by 54.5% than those in anaerobic digestion effluent (Tukey’s multiple 
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comparisons test, P = 0.036). Thermal hydrolysis pretreatment at WWTP #3 resulted 
in significantly increased concentrations of BBP (227%) (Tukey’s multiple 
comparisons test, P = 0.0082). Concentrations at the facility did not significantly 
change during anaerobic digestion or in final solids. Anaerobic digestion treatment at 
WWTP #4, however, resulted in significantly decreased BBP concentrations (76.4%) 
(Tukey’s multiple comparisons test, P = 0.0048) while concentrations in the final 
solids were not significantly different than those observed in the anaerobic digestion 
effluent. 
 Anaerobic conditions have been demonstrated to degrade BBP in previous 
studies. For instance, anaerobic microcosms run under methanogenic conditions 
resulted in full BBP degradation after 30 days of treatment [142]. Furthermore, 
landfill waste containing BBP incubated under anaerobic conditions resulted in 70% 
degradation after 278 days [141]. The large increase in BBP concentrations at 
WWTP #2 during anaerobic treatment, however, could not be explained by a 
literature search. An increase in BBP during thermal hydrolysis was observed in a 
previous study conducted at WWTP #3 by Armstrong et al. (2018). While the 
detected increase during TH treatment in the previous study was not significant, it is 
still important to note, as it is consistent with observations from this current study. 
 Aerobic treatment at the study treatment facilities decreased BBP 
concentrations, with both the SBR at WWTP #5 and the MBR at WWTP #6 
significantly reducing concentrations of the compound by 68.2% and 55.5%, 
respectively, during treatment [Tukey’s multiple comparisons test, P < 0.0001 
(WWTP #5), P = 0.024 (WWTP #6)]. Additionally, concentrations of BBP in final 
solids from WWTP #5 were significantly lower (57.8%) than those from aerobic 
digestion effluent concentrations (Tukey’s multiple comparisons test, P = 0.0013) 
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whereas BBP concentrations in final solids collected from WWTP #6 were not 
significantly different than those in aerobic treatment effluent from the facility. 
 BBP has been well documented to be degradable under aerobic conditions. 
Roslev et al. (2007) found that 90% of BBP was degraded microbially during 
activated sludge treatment in a Danish WWTP [170]. A study of Indian WWTPs 
showed that the compound was biologically removed by 88% and 38% in a SBR and 
during activated sludge treatment, respectively [171]. Results from this study indicate 
that both SBRs and MBRs can be an effective tool for degrading BBP during 
wastewater treatment. 
6.4.5  Predicted Environmental Concentrations of PAEs in Soil and DEHP Risk 
 A majority of the WWTPs sampled in this study land apply their biosolids as 
at least one of their means of disposal. Given the high concentrations in final solids, 
this land application can act as a source of PAEs into the environment. Predicted 
environmental concentrations (PECs) of the 4 PAEs analyzed were calculated as a 
means of estimating soil concentrations after a single biosolids land application. The 
PEC for each compound from each WWTP was determined according to Equation 1: 
PEC = Csoil +
Cbiosolids × AR
D × SD
  (1) 
where Csoil is the initial concentration in soils, prior to biosolids application, assumed 
to be zero; Cbiosolids is the concentration in final solids, provided in Table 6-2; D is the 
soil density, assumed to be 1.35 g/cm3 [55]; and SD is the soil depth, assumed to be 
7.6 cm to represent no till application [34]. The application rate (AR) was assumed to 
be 9.42 x 103 dry kg/ha for Class B biosolids and landfilled solids (WWTPs #1, #2, & 
#4 - #6) and 6.95 x 103 dry kg/ha for Class A biosolids (WWTP #3) due to 
differences in nutrient content of the products [49,55].  
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 The PECs of the analyzed PAEs in soil after land application of final solids 
from WWTPs #1 - #6, provided in Table 6-3, ranged from 0.0447 – 0.373 mg/kg for  
 
  PEC in Soils (mg/kg) 
  DEHP DiNP DiDP BBP 
WWTP #1 0.0828 0.0504 0.0660 0.00289 
WWTP #2 0.107 0.0631 0.0720 0.00140 
WWTP #3 0.373 0.246 0.169 0.00738 
WWTP #4 0.308 0.233 0.174 0.00151 
WWTP #5 0.0927 0.0409 0.0737 0.000973 
WWTP #6 0.0447 0.0393 0.0395 0.00251 
 
DEHP, 0.0393 – 0.246 mg/kg for DiNP, 0.0395 – 0.174 mg/kg for DiDP, and 
0.000973 – 0.00738 mg/kg for BBP. These predicted concentrations are consistent 
with those observed in various studies of PAEs in soils [129]. A majority of toxicity 
studies concerning PAE compounds in soils focus on DEHP [55]. van Wezel et al. 
(2000) calculated the environmental risk limit (ERL) for DEHP in soils and 
sediments, in regards to endocrine or reproductive endpoints, to be 1.0 mg/kg [157]. 
This ERL is appreciably higher than the PECs calculated for DEHP from all six study 
WWTPs. Furthermore, the lethal concentration 50 (LC50), the effective 
concentration 50 (EC50), and the inhibitory concentration 50 (IC50) of DEHP for a 
variety of species have been determined [130,153,154,175]. The risk quotient (RQ) 




  (2) 
where the toxicity value is the determined LC50, EC50, or IC50. The RQs for the DEHP 
PEC from all six WWTPs, presented in Table 6-4, were several orders of magnitude 
Table 6-3:  Predicted environmental concentrations of PAEs in soils for each WWTP after a 
single biosolids application. 
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lower than 0.5, the level of concern for acute risk, and 1.0, the level of concern for 
chronic risk [176]. The ERL determined by van Wezel et al. and the calculated RQs 
presented in Table 6-4 all show that the PECs for DEHP in soil are lower than these 
indicators of concern, signifying that the estimated concentrations in soils are lower 
than the amount needed to induce toxicological concern after a single biosolids 
application. Further research regarding PAE concentrations in soil and toxicity to 
terrestrial species needs to be conducted to further understand the environmental 
and health risk of these compounds – specifically, further research into the various 
PAE compounds in biosolids (including metabolites), impacts on different terrestrial 
species, the concentrations in soils and their toxicological effects after several 
biosolids applications, varying application rates and frequencies, etc. – as RQs are 
simply conservative screening-level estimates.   
6.5  Conclusions 
 Impacts of treatment processes on concentrations of DEHP, DiNP, DiDP, and 
BBP varied between treatment facilities. Overall, aerobic treatment resulted in 
significantly reduced concentrations of all compounds except for the inability of the 
sequencing batch reactor to influence DiDP concentrations. Conversely, standard 
anaerobic digestion of wastewater sludge could result in an increase, decrease, or 
no significant change, dependent on the facility and PAE compound. The more 
advanced anaerobic digestion processes generally resulted in concentration 
increases. Anaerobically digested sludge pretreated via thermal hydrolysis resulted 
in significant increases of DEHP, DiNP, and DiDP while the thermal hydrolysis 
pretreatment process itself increased DiNP, DiDP, and BBP concentrations in 
sludge. Additionally, sludge treated anaerobically via a two-phase acid/gas system 
also significantly increased DEHP, DiNP, and DiDP concentrations. Further research 
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  Risk Quotients 
Organism: Rodents Collembolan Collembolan Lettuce Rape Seed Rape Seed Rape Seed 









Toxicity Value: 40 g/kga >5,000 mg/kgb >1,000 mg/kgb 1000 ug/gc 2,014 mg/kgd 1,426 mg/kgd 3,767 mg/kgd 
WWTP #1 2.07E-06 1.66E-05 8.28E-05 8.28E-05 4.11E-05 5.81E-05 2.20E-05 
WWTP #2 2.69E-06 2.15E-05 1.07E-04 1.07E-04 5.33E-05 7.53E-05 2.85E-05 
WWTP #3 9.31E-06 7.45E-05 3.73E-04 3.73E-04 1.85E-04 2.61E-04 9.89E-05 
WWTP #4 7.71E-06 6.17E-05 3.08E-04 3.08E-04 1.53E-04 2.16E-04 8.19E-05 
WWTP #5 2.32E-06 1.85E-05 9.27E-05 9.27E-05 4.60E-05 6.50E-05 2.46E-05 
WWTP #6 1.12E-06 8.94E-06 4.47E-05 4.47E-05 2.22E-05 3.14E-05 1.19E-05 
a Net et al. (2015); b Jensen et al. (2001); c Hulzebos et al. (1993); d Ma et al. (2013) 
 
 
Table 6-4:  DEHP risk quotients for terrestrial organisms for each WWTP after a single biosolids application. 
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as to why these more advanced processes result in compound increases during 
treatment should be investigated, as factors such as an increase in solids reduction 
over conventional activated sludge and transformation of PAE metabolites may play 
a role in this phenomenon.  
 Risk quotients for estimated DEHP concentrations in soils after a single 
biosolids application were determined and indicated that the acute and chronic risk 
of this compound is low – well below the levels of concern indicated by the US EPA. 
However, further research into the impacts of multiple application rates, additional 
PAE compounds, etc. on toxicity to various terrestrial species should be conducted. 
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Chapter 7:  Influence of Anaerobic Digestion With and Without 
Thermal Hydrolysis Pretreatment on Concentrations of 
Endocrine Disrupting Compounds and Their Transformation 
Products in Wastewater Sludge 
Dana L. Armstrong, Sarah J. Fischer, Robert Lupitskyy, Birthe V. Kjellerup, Clifford 
P. Rice, Mark Ramirez, Alba Torrents 
Research presented in this chapter is one part of a collaborative effort with S.J. 
Fischer of UMD (focus on microbial aspects of anaerobic digestion) and R. Lupitskyy 
of the USDA (focus on biogas production during digestion).  Only the research 
performed by D.L. Armstrong (focus on fate of chemicals) is included in this chapter.  
All three research aspects will be combined for eventual publication in a peer 
reviewed journal. 
7.1  Abstract 
 Mesophilic anaerobic digestion of wastewater sludge with and without 
pretreatment by the Cambi Thermal Hydrolysis Process™ (CambiTHP™) was 
simulated using 250 mL serum bottles.  The fate of two antimicrobials, triclosan 
(TCS) and triclocarban, three phthalic acid esters (PAEs), and their transformation 
products during treatment was explored over a 22-day period.  Results show that 
TCS and its metabolite methyl triclosan increased during anaerobic digestion with no 
significant impact when pretreated via CambiTHP™.  However, concentrations of 
TCC increased more rapidly when sludge was not pretreated while 2,4-
dichlorophenol levels increased at a faster rate with CambiTHP™ pretreatment.  
Anaerobic digestion and CambiTHP™ pretreatment had a more varying effect on 
PAEs with di(2-ethylhexyl) phthalate decreasing, diisononyl phthalate levels 
remaining steady, and benzyl butyl phthalate concentrations increasing with 
CambiTHP™ pretreatment and decreasing with out pretreatment.  PAE metabolites 




7.2  Introduction 
 The land application of treated wastewater sludge, or biosolids, as a means 
to improve soil quality [133,177] has become common practice in various regions 
worldwide.  For instance, over 50% of treated sludge produced within the United 
States, Europe, and Canada is land applied [178,179].  While this practice can help 
to increase soil nutrient concentrations, organic matter composition and water 
holding capacity [133,177], the land application of biosolids can also act as an 
environmental source of organic pollutants, including endocrine disrupting 
compounds (EDCs).  Such compounds are not always fully removed during the 
wastewater treatment process and normally accumulate in wastewater sludge 
[11,55,180].   
 Compounds such as phthalate plasticizers (PAEs) and the antimicrobials 
triclosan (TCS) and triclocarban (TCC) are considered to be EDCs [26,45,122] and 
have been detected in biosolids at relatively high concentrations [16,35,49,55].  
Concerns regarding the health and environmental impacts of these compounds have 
garnered the attention of regulatory agencies.  In 2016, TCS was rejected for use in 
the European Union in human hygiene biocidal products for skin and scalps [81].  
Also in 2016, the United States Food and Drug Administration instituted a phase-out 
of both TCS and TCC from over the counter antiseptic washes, such as hand soaps, 
bar soaps, and body washes [7].  Additionally, both the United States and European 
Union regulate the amount of several PAE compounds allowed for use in toys and 
children’s products [181].  Moreover, some transformation products of these EDCs 
can also display toxicological properties [26,31,45,182], further emphasizing the 
negative impacts these compounds may have when released into the environment. 
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 The individual solids treatment processes utilized by wastewater treatment 
plants (WWTPs) can have a varying effect on TCS, TCC, and PAE concentrations in 
biosolids [49,183](Chapter 6 - results).  As more WWTPs move to employ treatment 
methods that enhance resource recovery [138], it is important to understand how 
these newer systems influence these antimicrobial and PAE concentrations in 
biosolids.  The Cambi Thermal Hydrolysis Process™ (CambiTHP™) is an anaerobic 
digestion pretreatment that can both improve sludge biodegrability and reduce the 
volume of final sludge solids.  A major benefit to the enhanced biodegradation 
provided by the CambiTHP™ is the increase in the production of biogas – a 
renewable energy source [49].  However, when Cambi THP™ is coupled with 
anaerobic digestion, the overall process can have a varying effect on EDCs 
concentrations.  The treatment of wastewater sludge with CambiTHP™ has been 
demonstrated to significantly reduce TCC concentrations while TCS and its 
transformation products were unaffected.  Furthermore, concentrations of TCS and 
its transformation products increased during the anaerobic digestion of sludge 
pretreated with CambiTHP™ [49].  A similar study concentrating on four PAEs 
throughout CambiTHP™/anaerobic digestion treatment demonstrated that the 
treatment system resulted in significantly higher concentrations of all four 
compounds during anaerobic digestion while the CambiTHP™ itself did not have any 
impact on compound concentrations [55]. 
 The objective of this study was to simulate the anaerobic digestion of 
wastewater sludge with and without CambiTHP™ pretreatment at a laboratory scale 
in an effort to gain further insight into how the innovative pretreatment process 
influences concentrations of TCS, TCC, PAEs, and their metabolites during the 
digestion process.  Furthermore, microbial populations between the two treatments 
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were assessed as a means to 1) understand how CambiTHP™ can influence 
populations during anaerobic digestion and 2) correlate populations to changes in 
target compound concentrations. 
7.3  Materials and Methods 
7.3.1  Wastewater Treatment Plant Background  
 The present study centered on sludge samples collected from a large 
municipal WWTP.  The facility, located in the Mid-Atlantic region of the United 
States, provides sewage treatment to over 2 million customers – approximately 1.14 
million m3 of raw sewage per day.  Treatment at the facility is achieved via primary 
sedimentation, activated sludge treatment, nitrification-denitrification treatment, 
filtration, and disinfection.  Sludge is pretreated by CambiTHP™ as follows: 
centrifugation of solids, preheating of sludge to 60 - 99°C using recycled stream, 
hydrolysis of sludge using heat (150 - 180°C) and pressure (0.37 – 0.95 MPa), and a 
rapid decrease of heat and pressure in a flash tank.  After CambiTHP™, sludge is 
anaerobically digested at 37°C for approximately 22 days prior to dewatering by belt 
presses.  Treated solids from the WWTP are classified as Exceptional Quality Class 
A biosolids by the United States Environmental Protection Agency (US EPA) and are 
typically land-applied to agricultural fields.  Further details regarding the 
CambiTHP™/anaerobic digestion process at the facility can be found elsewhere 
[49,55]. 
7.3.2  Sample Collection and Experimental Setup 
 Sludge from the study WWTP was collected 1) after centrifugation but prior to 
CambiTHP™ treatment [henceforth classified as “without thermal hydrolysis (TH) 
pretreatment”] and 2) after CambiTHP™ treatment, post flash tank (considered “with 
TH pretreatment”).  Anaerobic digestion sample used as inoculant for the 
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experiments was collected from an anaerobic digestion solids recycle line.  Use of 
plastic was avoided during the sampling campaign to avoid contamination of 
samples with phthalates. 
 Anaerobic digestion experiments were carried out using 250 mL serum 
bottles.  Each bottle was filled with 20 mL of sludge without TH pretreatment and 130 
mL of anaerobic digestion inoculum or 22 mL of sludge with TH pretreatment and 
128 mL of anaerobic digestion inoculum to maintain an inoculum to substrate volatile 
solids ratio of 1.5:1 [184,185].  Treatment controls were setup in the same manner 
as the experimental bottles, but were treated with 1 g of mercuric chloride while 
inoculum control bottles consisted of 150 mL of anaerobic digestion inoculum only.  
Prior to sealing with rubber stoppers, each bottle was purged with N2 gas.  
Additionally, each bottle was covered with aluminum foil to prevent light exposure of 
the samples.  Bottles were then placed on tabletop shakers for consistent agitation 
and maintained at 37°C in a dark incubation room for 22 days.   
 A sufficient number of serum bottles were prepared so the destructive 
sampling at predetermined time points could take place, allowing for the fate of TCS, 
TCC, PAEs, and their transformation products over the course of experiments to be 
determined.  Destructive sampling dates occurred on days 0, 1, 3, 5, 7, 10, 13, 17, 
20, and 22.  Two duplicate bottles were sampled on each specified date.  In addition 
to organic compound analysis, these samples were also analyzed for total solids 
(TS), volatile solids (VS), soluble chemical oxygen demand (sCOD), volatile fatty 
acids (VFAs), and biogas composition.  Additionally, microbial analyses were 




7.3.3  Target Analytes 
 Experimental target analytes consisted of the antimicrobials TCS and TCC, 
several PAEs, and at least one commonly detected transformation product for each 
compound.  Compounds analyzed are provided in Table 7-1.  Details regarding 
suppliers of analytical standards and standard purities are provided in Table SI-E1 of 







Triclosan (TCS) Antimicrobial 79.3 ± 4.4 18.9 
Methyl triclosan (MeTCS) TCS metabolite 71.8 ± 6.1 22.7 
2,4-Dichlorophenol (2,4-DCP) TCS photolysis product 77.0 ± 9.6 85.1 
Triclocarban (TCC) Antimicrobial 88.3 ± 5.9 11.0 
4,4'-Dichlorocarbanilide (DCC) TCC dechlorination product 82.2 ± 9.2 79.2 
1-(3-Chlorophenyl)-3-phenylurea (MCC) TCC dechlorination product 89.7 ± 5.0 94.3 
Carbanilide (NCC) TCC dechlorination product 84.1 ± 4.8 73.9 
Bis(2-ethylhexyl) phthalate (DEHP) Phthalate plasticizer 88.5 ± 4.3 50.8 
Mono-(2-ethylhexyl) phthalate (MEHP) DEHP metabolite 68.4 ± 12.5 88.8 
Diisononyl phthalate (DiNP) Phthalate plasticizer 97.6 ± 11.1 53.2 
Monoisononyl phthalate (MNP) DiNP metabolite 62.9 ± 10.7 84.4 
Benzyl butyl phthalate (BBP) Phthalate plasticizer 93.8 ± 6.4 35.3 
Monobutyl phthalate (MBuP) BBP metabolite 60.3 ± 6.6 49.0 
Monobenzyl phthalate (MBeP) BBP metabolite 70.1 ± 9.4 42.5 
 
7.3.3.1  Extraction Methods and Instrumental Analyses 
 Prior to extraction and analysis for the compounds outlined in Table 7-1, all 
samples were lyophilized, the liquids and solids fraction of each sample were not 
separated prior to lyophilization.  Samples were extracted for TCS, TCC, and their 
transformation products using a Dionex Accelerated Solvent Extraction (ASE) 
system in conjunction with Oasis® HLB solid phase extraction (SPE) cartridges, as 
previously published [25], with the exception of one slight modification: a solution of 
Table 7-1:  Compounds Analyzed and Their Descriptions, Recoveries, and LOQs 
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ethyl acetate:diethyl ether (65:35 v/v) was used for SPE conditioning and elution 
rather than the previously published dichloromethane:diethyl ether (80:20 v/v) 
solution.  After extraction, samples were analyzed for TCS, TCC, and all 
transformation products except MeTCS using a Shimadzu Nexera X2 Ultra High 
Performance Liquid Chromatograph coupled to a Shimadzu 8040 triple quadrupole 
mass spectrometer (UHPLC-MS/MS) using an electrospray negative source and a 
mobile phase of 10 mM ammonium acetate in methanol:acetonitrile:water (60:15:25 
v/v).  Afterwards, all samples were evaporated and reconstituted in hexane for 
MeTCS analysis by an Agilent 7890B gas chromatograph (GC) with an Agilent 
5977A mass selective detector (MSD) run in positive electron impact ionization 
mode.  Further details regarding UHPLC-MS/MS and GC-MS analytical conditions 
are provided in a previous publication [49]. 
For extraction of PAEs and their metabolites, the Dionex ASE system was 
also used, along with HyperSep™ Florisil SPE cartridges.  Further details regarding 
this extraction method can be found elsewhere (Chapter 6).  PAE compound 
analysis occurred using the previously mentioned Shimadzu UHPLC-MS/MS 
instrument with a mobile phase of 5 mM ammonium formate in methanol and the MS 
electrospray ionization source also run in negative mode, as previously published 
[55]. 
7.3.4  Substrate Characterization 
 Samples were analyzed for total solids (TS) and volatile solids (VS) using the 
standard methods established by the American Public Health Association [56].  
Soluble chemical oxygen demand (sCOD) was determined using Chemetrics 
dichromate COD vials and a Hach Company digester block with filtered samples 
[94]. 
 131 
7.3.5  Volatile Fatty Acid Analysis 
Anaerobic digestion samples were analyzed for four volatile fatty acids 
(VFAs): acetic acid, propionic acid, n-butyric acid, and n-valeric acid.  VFA analysis 
was conducted via acidification to a pH of 2 using sulfuric acid and filtering of 
samples with 0.45 µm and 0.22 µm filters.  An HP 7890A gas chromatograph was 
used for VFA analysis [186]. 
7.3.6  Methane Biogas Characterization 
 The compositions of the methane produced via sludge anaerobic digestion 
was assessed on the same day that antimicrobial and PAE samples were analyzed.  
A 50 mL gas-tight glass syringe was used to collect a gas sample from the serum 
bottles.  Gas samples were injected into an Agilent 6890 gas chromatograph joined 
with a thermal conductivity detector.  Due to some leaks in bottle caps, total biogas 
production could not be accurately assessed. 
7.3.7  Quality Assurance/Quality Control 
 Each destructive time point consisted of two serum bottles, run as duplicates.  
Additionally, sampling from each serum bottle for target analyte analysis was done in 
duplicate.  Prior to extraction, samples were spiked with the surrogate standards 
13C13-TCC, 13C12-TCS, 13C12-MeTCS, d3-2,4-DCP, d4-DEHP, d4-MNP, d4-BBP, and 
d4-MBuP.  All extraction batches included a blank (laboratory-grade sand) and a 
sample spiked with unlabeled target analytes for determination of recovery 
percentages (provided in Table 7-1).  Extraction batches consisted of no more than 
12 samples.  Method detection limits for each compound were determined as 
outlined by the US EPA [98] and the limits of quantitation (LOQs), provided in Table 
7-1, were set as two times the MDL.  Calibration curves for instrumental analysis 
consisted of at least six non-zero standards and run before and after sample 
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analysis, yielding r2 values ≥ 0.99.  Two standards and two solvent blanks were also 
analyzed every 10 samples as a verification of instrument stability. 
7.4  Results and Discussion 
 Results for secondary analyses, including solids, methane production, VFAs, 
and sCOD, are provided in Figures SI-E1 through SI-E4 of the supplemental 
information. 
7.4.1  Antimicrobial Compounds 
7.4.1.1  TCS and TCS Transformation Products 
 Concentrations of TCS, MeTCS, and 2,4-DCP increased over the course of 
the experiments both with and without TH pretreatment (Figures 7-1a – 1c).  Linear 
regression analysis was applied to the datasets for all three compounds.  
Concentrations of TCS significantly increased during the course of the experiment, 
both with (R2 = 0.8862, P < 0.0001) and without (R2 = 0.7881, P = 0.0006) TH 
pretreatment (Figure 7-1a).  Furthermore, an extra-sum-of-squares F test indicated 
that the slopes of each regression model fit to TCS concentrations with and without 
TH pretreatment (m = 221.9 ± 28.11 ng/g/day and 242.6 ± 44.47 ng/g/day, 
respectively) were not significantly different (P = 0.7107).  Similarly, linear regression 
analysis also indicated concentrations of MeTCS increased in pretreated (R2 = 
0.8069, P = 0.0004) and non-pretreated (R2 = 0.9153, P < 0.0001) anaerobically 
digested sludge (Figure 7-1b).  As was observed with TCS, the slopes of the MeTCS 
linear models were not significantly different (P = 0.2250) for anaerobic reactors run 
with TH pretreatment (m = 6.673 ± 1.154 ng/g/day) and without TH pretreatment (m 
= 8.225 ± 0.8847 ng/g/day), as determined with an extra-sum-of-squares F test.  
These results demonstrate that the CambiTHP™ does not appear to influence the 
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fate of TCS and MeTCS during the anaerobic digestion process, when compared to 
sludge digested without pretreatment.   
 
 
A previous study focusing on the fate of antimicrobials throughout the 
CambiTHP™/anaerobic digestion process also found that concentrations of TCS 
and MeTCS increased during anaerobic digestion treatment, as was observed in the 
present study, but concluded that the increase was due to a reduction in total solids 
due to the anaerobic digestion process rather than a direct result of CambiTHP™ 
[49].  However, given that TCS concentrations during the present experiment 
increased by approximately 166% and 238% for anaerobically digested sludge with 
and without TH pretreatment, respectively, and MeTCS concentrations by 
Figure 7-1:  Concentrations and Trends of a) TCS, b) MeTCS, c) 2,4-DCP, and d) TCC in 
Anaerobic Digestion Samples With and Without TH Pretreatment 
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approximately 189% and 519%, respectively, the reduction of total solids observed 
over the 22-day treatment (a reduction of less than 1.5 %; Figure SI-E1, 
supplemental information) is likely not the only reason for compound increase.  One 
such explanation is that despite total solids not decreasing sufficiently over the 22 
day experimental time period, the amount of suspended solids have still have 
decreased enough to effectively concentrate TCS and MeTCS (assuming that the 
compounds partition predominantly to the suspended particles) while slightly 
increasing the amount of dissolved solids during the degradation process, thus 
resulting in a total solids degradation pattern that does not sufficiently explain 
increases in compound concentrations.  Unfortunately, due to the nature of the 
solids in the system, the quantity of suspended solids versus dissolved solids within 
samples could not be determined due to filter clogging.  Presenting results on a wet 
weight basis did not change the overall trends of these compounds during the 
experiments, indicating there is more at play here than just the influence of solids 
concentrations.  Other such explanations for the notable increase in TCS and 
MeTCS concentrations during the anaerobic digestion experiments could be the 
formation of these compounds from other metabolites and compound derivatives.  
TCS degradation has been demonstrated to be complex, with numerous 
intermediates forming during the process [69,70,75].  Furthermore, higher 
chlorinated derivatives of TCS may be formed during the transport of waste to a 
WWTP and within the treatment system itself [187].  Deconjugation of metabolites or 
the dechlorination of compounds such as tetra(II)closan [4,5-dichloro-2-(2,4-dichloro-
phenoxy)-phenol], tetra(III)closan [5,6-dichloro-2-(2,4-dichloro-phenoxy)-phenol], and 
pentaclosan [4,5,6-trichloro-2-(2,4-dichloro-phenoxy)-phenol] may be responsible, in 
part, for the formation of TCS during digestion.  Further research into the presence 
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of additional TCS intermediates and derivatives, as well as a more complex study 
into solids concentrations during treatment need to be explored. 
 Unlike TCS and MeTCS, concentrations of 2,4-DCP were appreciably 
impacted by TH pretreatment (Figure 7-1c), as observed in a previous on-site study 
[49].  Linear regression models demonstrated significant increases of 2,4-DCP both 
with [R2 = 0.9909, P < 0.001 (excluding days 20 and 22)] and without (R2 = 0.8431, P 
= 0.002) TH pretreatment.  However, when excluding days 20 and 22, which 
demonstrated a break from the trend, concentrations of the compound during 
anaerobic digestion increased at a much higher rate when pretreated with 
CambiTHP™ (m = 48.44 ± 1.898 ng/g/day) compared to no pretreatment (m = 24.35 
± 3.715 ng/g/day).  The difference in rate of compound formation between the two 
treatments was significant (extra-sum-of-squares F test, P = 0.0001).  Since TCS 
degradation was not observed and precautions were taken to prevent photolysis, 
increases in 2,4-DCP are likely due to, in part, the previously discussed changes in 
total solids during the digestion process.  However, the difference in formation rates 
between the two treatments may be due to the fact that 2,4-DCP is a degradation 
product of other compounds besides TCS such as the herbicides 2,4-
dichlorophenoxyacetic acid (2,4-D) [101] and dichlorprop [100].  Pretreatment of 
wastewater sludge by CambiTHP™ may allow for more efficient degradation of other 
organic compounds, thus causing a greater increase in 2,4-DCP formation during 
anaerobic digestion. 
7.4.1.2  TCC and TCC Transformation Products 
 Despite the fact that TCC has been observed to be dechlorinated into DCC, 
MCC, and NCC [120,183,188], this phenomenon was not observed during the 
experiments as the dechlorination products of TCC were not detected at or above 
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the LOQ and TCC concentrations rose rather than fell (Figure 7-1d).  When linear 
regression analysis was applied, it was revealed that the increases in TCC levels 
during anaerobic digestion were significant both with (R2 = 0.4527, P = 0.0330) and 
without (R2 = 0.9043, P < 0.0001) CambiTHP™ pretreatment.  Concentrations of the 
antimicrobial increased at a rate of 83.24 ± 9.577 ng/g/day without TH pretreatment, 
with an overall increase of approximately 261%.  When pretreated with 
CambiTHP™, TCC levels increased by approximately 150% at a rate of 2.665 ± 
1.036 ng/g/day, which was significantly slower than that of sludge digested without 
pretreatment (extra-sum-of-squares F test, P < 0.0001).  Additionally, initial 
concentrations of TCC were approximately 10 times higher in sludge that had not 
undergone CambiTHP™.  A previous on-site study demonstrated that this is due to 
the TH process itself significantly reducing TCC concentrations [49].  Reasons for 
the increase of TCC are likely similar to those for TCS – mainly, reduction of solids, 
as described above, and transformation of intermediates.  Souchier et al. (2016) 
outlined several proposed dechlorination pathways of TCC that involved a number of 
intermediates [189].  Furthermore, as with TCS, higher chlorinated congeners of 
TCC exist and have been observed in environmental samples [190].  The 
transformation of these compounds into TCC may be taking place during the 
anaerobic digestion process.  Further research into the fate of specific intermediates 
and the higher chlorinated TCC derivatives needs to be explored in the future. 
7.4.2  Phthalic Acid Esters 
 For all PAE compounds and treatments, rates of change were calculated 






= −    (1) 
 
Compound 
 Rate of Change (day-1) 




DEHP Parent compound -0.0126 ± 0.0039 -0.00360 ± 0.0021 
MEHP DEHP TP +0.0625 ± 0.0098 +0.0445 ± 0.0047 
DiNP Parent Compound -0.00220 ± 0.0079 +0.00195 ± 0.0033 
MNP DiNP TP +0.0889 ± 0.032 +0.0830 ± 0.0061 
BBP Parent Compound -0.0648 ± 0.030 +0.0171 ± 0.010 
MBuP BBP TP +0.142 ± 0.015 +0.131 ± 0.013 
MBeP BBP TP +0.00590 ± 0.0030 +0.0350 ± 0.010 
 
TP = Transformation product 
 
7.4.2.1  DEHP and MEHP 
 Overall, DEHP concentrations in wastewater sludge decreased during 
anaerobic digestion while its metabolite MEHP increased during treatment (Figures 
7-2a & b). Two separate studies have concluded that concentrations DEHP increase 
during anaerobic digestion with CambiTHP™ pretreatment [55](Chapter 6 - results), 
while results from this study appear to slightly deviate from that narrative.  In 
general, DEHP concentrations changed very little between day 0 and day 22 of 
digestion with pretreatment but did, indeed, decrease slightly (-0.00360 ± 0.0021 
day-1) while DEHP in sludge that did not undergo pretreatment degraded more 
rapidly (-0.0126 ± 0.0039 day-1).  MEHP concentrations increased under both 
treatment types, and the rate of increase was not notably different for either.  
However, during sludge digestion with and without TH pretreatment, MEHP 
increased at a more rapid rate than DEHP decreased.  One explanation for this may 
be the formation of MEHP through other DEHP metabolites, such as mono-(2-ethyl-
Table 7-2:  Phthalic Acid Ester Rates of Change During Anaerobic Digestion 
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5-carboxypentyl)phthalate, mono-[2-(carboxymethyl)-hexyl]phthalate, mono-(2-ethyl-
5-hydroxyhexyl)phthalate, and mono-(2-ethyl-5-oxy-hexyl)phthalate [128]. 
7.4.2.2  DiNP and MNP 
 Concentrations of DiNP changed very little over the course of the 
experiments (Figures 7-2c & d), with rates of change varying very little from zero 
both with (+0.00195 ± 0.0033 day-1) and without (0.00220 ± 0.0079 day-1) TH 
pretreatment.  Similar to what was observed with DEHP, concentrations of DiNP 
were previously observed to increase in sludge anaerobically digested after 
CambiTHP™ pretreatment [55](Chapter 6 - results), a trend that was not followed 
during the present study.  MNP, on the other hand, increased at similar rates both 
with and without pretreatment.  Concentrations of the metabolite, however, were 
over an order of magnitude lower than DiNP concentrations.  While MNP formation 
could not be directly correlated to DiNP degradation, given the much lower levels of 
the metabolite, a relationship to trends with the parent compound could be hidden 
within the standard error of analysis. 
7.4.2.3  BBP, MBuP, and MBeP 
 Concentrations of BBP decreased steadily in anaerobically digested sludge 
not treated by CambiTHP™ (-0.0648 ± 0.030 day-1) while concentrations increased 
when sludge underwent TH pretreatment (+0.0171 ± 0.010 day-1) (Figures 7-2e & f).  
In a previous study on the fate of BBP at six different WWTPs, it was observed that 
anaerobic digestion could have a varying impact on concentrations of BBP.  
Standard anaerobic digestion treatment and more advanced systems were shown 
possess the capacity to increase or degrade BBP during treatment.  Pretreatment 
with CambiTHP™ in the study was shown to increase BBP levels (Chapter 6 - 
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results).  The BBP metabolite MBeP increased in sludge what had undergone TH 
pretreatment (+0.0350 ± 0.010 day-1) but showed very little change in sludge that 
 
had not been exposed to the CambiTHP™ (+0.00590 ± 0.0030 day-1).  MBuP, 
however, demonstrated rapid increases during the course of the experiment; with 
final concentrations approximately an order of magnitude higher than starting BBP 
levels.  Since MBuP levels cannot be correlated to BBP degradation, its formation is 
Figure 7-2:  Concentrations and Trends of a) DEHP/MEHP Without TH Pretreatment, b) 
DEHP/MEHP With TH Pretreatment, c) DiNP/MNP Without TH Pretreatment, d) DiNP/MNP With 
TH Pretreatment, e) BBP/MBuP/MBeP Without TH Pretreatment, and f) BBP/MBuP/MBeP With 
TH Pretreatment in Anaerobic Digestion Samples  
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likely due to degradation of other PAE compounds.  For instance, dibutyl phthalate 
has been shown to degrade into MBuP under anaerobic conditions [141]. 
7.5  Conclusions 
 Results from this study demonstrate the variable impacts an individual 
treatment system can have on EDCs in sludge.  Concentrations of the antimicrobials 
TCS and TCC and their detected transformation products increased during 
anaerobic digestion both with and without CambiTHP™.  While there was no 
significant difference in rate of increase of TCS and MeTCS through the two 
treatment conditions, sludge that underwent pretreatment with CambiTHP™ resulted 
in a more rapid increase of 2,4-DCP while TCC concentrations increased at a slower 
rate when compared to sludge digested without pretreatment.  The influence of 
anaerobic digestion and CambiTHP™ on concentrations of PAEs and their 
metabolites was much more extensive.  DEHP revealed decreasing trends during 
the course of the experiments while DiNP concentrations did not generally change.  
BBP, on the other hand, was more widely impacted by CambiTHP™ pretreatment, 
with concentrations increasing with pretreatment and decreasing in sludge digested 
without pretreatment.  Overall, PAE metabolites increased during anaerobic 
digestion treatment, sometimes despite no degradation of the parent compound, 
implying a very complex compound transformation process. 
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Chapter 8:  Impact of Various Wastewater Treatment Conditions 
on Concentrations of 27 Emerging Contaminants and Their 
Estimated Concentrations in Soils 
Dana L. Armstrong, Clifford P. Rice, Mark Ramirez, and Alba Torrents 
This chapter will be submitted for publication in Chemosphere. 
8.1  Abstract 
The influence of solids treatment processes at six different wastewater 
treatment plants (WWTPs) on concentrations of 27 emerging contaminants (ECs) 
was explored.   Of the WWTPs sampled, two employed conventional anaerobic 
digestion for solids treatment, two utilized advanced anaerobic digestion processes, 
and two employed aerobic processes.  Of the 27 compounds analyzed, 16 were 
detected in at least one WWTP sample: 10 pharmaceutical and personal care 
products, 2 pesticides, 2 flame retardants, 1 food additive, and 1 perfluorinated 
compound.  For many ECs, the impact of treatments on compound concentrations 
was wide-ranging, emphasizing just how varied the impact that different WWTPs can 
have on EC concentrations, even in cases where the same treatment method is 
applied.  Furthermore, predicted environmental concentrations (PECs) of detected 
ECs in soil were calculated to understand the potential output of these compounds 
by WWTPs.  Ciprofloxacin, diphenhydramine, norethindrone, prednisone, and tris(2-
butoxyethyl) phosphate had the highest PECs in soil. 
8.2  Introduction 
 Prolific use of chemicals by modern society has led to the presence of 
emerging contaminants (ECs) in the wastewater treatment (WWT) process.  Such 
compounds, which can include pharmaceuticals and personal care products 
(PPCPs), plasticizers, food additives, pesticides, fire retardants, etc., are often not 
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fully removed by treatment processes [80].  Removal efficiencies of ECs can be 
dependent on several factors, including the treatment systems employed by 
individual wastewater treatment plants (WWTPs), the physiochemical properties of 
individual compounds, as well as influent compound concentrations [9].  This inability 
to completely remove ECs can result in WWT systems acting as a source of such 
contaminants to the environment, whether through the discharge of effluent to local 
water bodies or through the land application of treated sludge, or biosolids. 
ECs have been well documented in wastewater biosolids.  For example, 
pharmaceuticals such as diclofenac, a nonsteroidal anti-inflammatory drug, and 
carbamazepine, an anticonvulsant and mood stabilizer, were detected as high as 
4,240 and 11,060 ng/g, respectively, in dewatered sludge from Chinese WWTPs 
with their estimated discharges to the environment via the disposal of sludge as high 
as 1,023 and 494 g/day, respectively [191].  The antidepressants citalopram, 
amitriptyline, and venlafaxine were detected at peak concentrations of 1,033, 768, 
and 833 ng/g, respectively, in Canadian biosolids [192].  Armstrong et al. (2017) 
found average concentrations of the plasticizer bis(2-ethylhexyl) phthalate (DEHP) in 
biosolids from a large municipal WWTP in the Mid-Atlantic region of the United 
States to be 66,700 ng/g for Class A biosolids and 25,000 ng/g for Class B biosolids 
[55].  Furthermore, temporal studies have demonstrated that concentrations of some 
compounds have remained continuous in biosolids over time.  For instance, Andrade 
et al. (2015) found that while the polybrominated diphenyl ether (PBDE) congeners 
BDE-47 and BDE-99 decreased in limed biosolids samples over a 7-year period, 
BDE-209 concentrations were unchanged during the study period.  Additionally, the 
same study revealed that the antimicrobial triclosan also did not decrease in 
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concentration during this time period, further emphasizing that biosolids, if land 
applied, can act as a steady source of certain ECs to the environment.  [21] 
 While there are numerous benefits to the land application of biosolids, such 
as increases in nutrient levels, improved water holding capacity, recovery of 
disturbed landscapes, etc. [133], concerns regarding the practice exist as well.  
These worries are often related to the ECs associated with the biosolids and include 
concerns surrounding microbial resistance issues [193,194], endocrine disrupting 
capabilities of some ECs [195], indirect human exposure via groundwater infiltration 
and crop or animal uptake [196], toxicity [197], etc.  Furthermore, a 3-year study on 
the fate of numerous PPCPs in outdoor mesocosms demonstrated that compounds 
can persist in soils well after biosolids application.  PPCPs such as 
diphenhydramine, fluoxetine, and triclocarban demonstrated no observable 
degradation over the 3-year period, whereas the half-lives of various other 
compounds could be as high as 2,310 days (ciprofloxacin) [198].  Moreover, the half-
lives of five perfluorinated compounds in a similar mesocosm study were determined 
to be as high as 866 days (perfluoroheptanoic acid) and compound loss was 
theorized to be due to ecological mobility via leaching, vegetative uptake, and/or 
volatilization rather than degradation [199].  One such way to prevent or diminish the 
negative effects of ECs during the beneficial reuse of wastewater sludge via land 
application is to reduce the concentrations of ECs present in the material in the first 
place.  To do so, further understanding of how different wastewater treatment 
technologies can influence concentrations of this broad classification of compounds 
in sludge is needed. 
 To accomplish this, the presence and fate of 27 ECs during final solids 
treatment was explored at six WWTPs located in the Mid-Atlantic region of the 
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United States.  Solids treatments at the study facilities include aerobic, such as 
sequencing batch reactor and membrane bioreactor, or anaerobic (including 
conventional and advanced) processes.  Grab samples from each facility were 
collected pretreatment, post treatment, and after final solids dewatering to 
understand how each phase of treatment impacts compound concentrations.  
Furthermore, predicted environmental concentrations of detected compounds in soils 
after a single biosolids application, as well as their estimated risk quotient were 
calculated to gain insight into the environmental implications of detected ECs in final 
solids from each study WWTP. 
8.3  Materials and Methods 
8.3.1  Target Analytes 
 All samples were analyzed for 27 commonly utilized ECs.  The compounds 
analyzed as well as their physiochemical properties and usages are provided in 
Table 8-1.  Analytical standard suppliers and compound purities are provided in 
Table SI-F1, located in the Supplemental Information. 
8.3.2  Sample Collection and Handling 
 Wastewater and final solids samples were collected from six different 
municipal WWTPs in the Mid Atlantic region of the United States.  The WWTPs 
sampled employ a variety of different treatment configurations (aerobic and/or 
anaerobic) and are situated in rural and metropolitan settings.  Specifications of the 
study WWTPs are provided in Table 6-1 [200]. 
 As this study concentrates on EC concentrations in final solids and the 
influence that treatment has on EC concentrations in final solids, the solids treatment 
processes at each facility were the sampling focus.  At WWTPs #1, 2, 3, and 4, grab 
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Compound Usage log Kow Solubility (mg/L) log Koa log Koc 
Pharmaceuticals and Personal Care Products (PPCPs) 
Betaxolol Beta Blocker 2.98 451 14.0 2.60 
Bisoprolol Beta Blocker 1.84 2240 14.8 1.52 
Carbamazipine Anticonvulsant/Mood Stabilizer 2.25 17.7 10.8 3.59 
Ciprofloxacin Antibiotic 0.00 11,480 17.0 1.55 
n,n-Diethyl-3-methylbenzamide (DEET) Insect repellent 2.26 666 8.25 2.73 
Diltiazem Calcium channel blocker 2.79 12.3 17.2 3.98 
Diphenhydramine Antihistamine 3.11 363 10.1 3.92 
Fluconazole Antifungal 0.25 336 11.6 4.72 
Irbesartan Angiotensin II receptor blocker 5.31 0.0599 18.1 7.91 
Norethindrone Steroid Hormone 2.99 118 10.6 3.43 
Oxybenzone UV Stabilizer/Absorber 3.52 68.6 10.0 3.10 
Prednisone Corticosteroid 1.59 312 9.40 1.56 
Resperidone Antipsychotic 3.49 2.76 17.5 6.65 
Testosterone Hormone 3.27 67.8 10.2 3.15 
Venlafaxine Antidepressant 3.28 267 12.4 3.17 
Pesticides 
Chlorpyrifos Insecticide 4.66 0.357 8.88 3.83 
Emamectin Benzoate Insecticide 5.00 93.0 NA 5.42 
Flubendiamide Insecticide NA NA NA NA 
Pendimethaline Herbicide 2.62 89.7 18.8 4.05 
Fire Retardants 
Tris(1-chloro-2-propyl) phosphate (TCPP) Fire retardant NA NA NA NA 
Triphenyl phosphate Fire retardant 4.70 1.03 8.46 3.72 
Tris(2-butoxyethyl) phosphate Fire retardant 3.00 1.96 13.1 5.67 
Food Additives 
Aspartame Artificial Sweetener 0.07 565 16.1 1.79 
Surfactants 
Perfluorohexanoic acid (PFHxA) Surfactant NA NA NA NA 
Perfluorononanoic acid (PFNA) Surfactant 7.27 0.00188 5.98 5.09 
Perfluorooctanoic acid (PFOA) Surfactant 6.30 0.260 5.73 4.43 
Perfluorooctanesulfonic acid (PFOS) Surfactant NA NA NA NA 
NA = not available 
Source of chemical properties: US EPA EPI Suite 
 
Table 8-1:  Compounds Analyzed and Their Physiochemical Properties 
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samples were collected prior to anaerobic digestion, after anaerobic digestion, and 
after final solids dewatering.  At WWTP #3, samples were collected prior to thermal 
hydrolysis, after thermal hydrolysis, from the anaerobic digestion tank (via the 
digested solids recycle line), and after final solids dewatering.  As WWTPs #5 and #6 
are very small and employ only a single treatment process (both aerobic), samples 
were collected prior to aerobic treatment, after aerobic treatment, and after final 
solids dewatering.  Samples were collected in January and February 2017.  After 
collection, all samples were stored at -20°C until analysis.  Further descriptions of 
the collection process can be found elsewhere (Chapter 6). 
8.3.3  Extraction Method 
 Prior to extraction, all samples (wastewater and final solids) were lyophilized.  
The liquid and solids faction of wastewater samples were extracted together.  Each 
sample was extracted in duplicate.  A modification of a previously established 
method [201] was utilized for compound extraction.  Approximately 0.15 g of sample 
was placed into a 50 mL centrifuge tube.  Fifteen (15) milliliters of phosphate buffer 
(pH ~2) was added to the tubes and vortexed for 5 minutes.  Twenty (20) milliliters of 
acetonitrile (ACN) was added to each centrifuge tube and the mixture vortexed 
briefly.  Next, all tubes were sonicated for 20 minutes then centrifuged for 5 minutes.  
Supernatants were then decanted into 250 mL round bottom flasks and the 
extraction process was repeated.  Afterwards, 15 mL of an ACN/diethyl ether mixture 
(80:20 v/v) was added to each centrifuge tube, vortexed briefly, sonicated for 20 
minutes and centrifuged for 5 minutes.  Supernatants for each sample were 
combined with those from the previous two extraction steps.  This extraction 
sequence was then repeated once.  Combined sample extracts were evaporated 
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using a rotary evaporator at 40°C until approximately 20 to 30 mL of extract 
remained.  Approximately 500 g of ethylenediaminetetraacetic acid and 200 mL of 
organic-free water (H2O) were added to each round bottom flask and swirled to mix.   
Sample extracts were then loaded onto Oasis® HLB solid phase extraction 
(SPE) cartridges (Waters Corporation, Milford, MA, USA) (200 mg, 6 mL) that were 
previously conditioned with 20 mL methanol (MeOH), 7.5 mL of H2O, and 7.5 mL of 
acidified H2O (pH ~2).  Cartridges were washed with 5 mL of H2O after sample 
loading and allowed to dry under vacuum.  Target compounds were eluted from the 
SPE cartridges using 15 mL MeOH and 15 mL of a MeOH/acetone mixture (50:50 
v/v).  Eluates were evaporated gently under nitrogen at 55°C and reconstituted for 
instrumental analysis in 1.5 mL of a 0.1% formic acid in MeOH solution. 
8.3.4  Instrumental Analysis 
 Sample extracts were analyzed using a Shimadzu Nexera X2 Ultra High 
Performance Liquid Chromatograph (UHPLC) linked to a Shimadzu 8040 triple 
quadrupole mass spectrometer (MS/MS) (Shimadzu North America, Columbia, MD, 
USA).  A mobile phase of 0.1% formic acid/0.1 mM ammonium acetate in 
H2O:MeOH (95:5 v/v) (Solvent A) and 0.1% formic acid/0.1 mM ammonium acetate 
in MeOH (Solvent B) [202] was run at a gradient to obtain chromatographic 
separation of compounds.  Gradient conditions began at 65% Solvent B and 
increased to 90% Solvent B over a 4-minute period.  Solvent B was then decreased 
back to 65% by 4.2 minutes, where it was maintained at this percentage for a minute 
– total run time of 5.2 minutes.  Solvent flow began at 0.42 mL/min and was 
increased to 0.55 mL/min at 1.5 minutes, where it was maintained for the rest of the 
run.  A Phenomenex Synergi™ Polar-RP column (2.5 µm, 100 Å, 2.0 x 100mm) 
(Phenomenex Inc., Torrance, CA, USA) was utilized and maintained at a 
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temperature of 45°C.  The mass spectrometer was operated using an electrospray 
ionization (ESI) source with a source temperature of 350°C, a heat block 
temperature of 400°C, and desolvation line temperature of 250°C.  Multiple reaction 
monitoring was utilized for compound acquisition.  Further details regarding MS/MS 
parameters, such as precursor/product masses, collision energies, etc., are provided 
in Table SI-F1 of the Supplemental Information. 
8.3.5  Quality Assurance/Quality Control 
 A single grab sample was collected into amber glass jars from each sample 
point at each WWTP from an area in each process where sufficient mixing has 
occurred.  Samples were extracted, in duplicate, in batches of 12 samples or less.  
Each extraction batch consisted of a laboratory-grade sand method blank and a 
sample spiked with all target compounds for recovery determination.  Each sample 
was spiked with 13C6-carbamazipine, d6-methyl chlorpyrifos, 13C4-ciprofloxacin, d6-
DEET, 13C3-fluconazole, 13C6-oxybenzone, 13C5-PFHxA, 13C9-PFNA, 13C8-PFOA, 
13C8-PFOS, and d6-venlafaxine as surrogate standards.   
During instrumental analysis, standards and solvent blanks were injected 
every 10 samples as a means of validating instrument stability.  A curve of seven 
standards (10, 25, 50, 100, 250, 500, and 1000 ng/mL; linearity correlations r2 ≥ 
0.99) was used for UHPLC-MS/MS calibration   Method detection limits (MDLs), 
determined using US Environmental Protection Agency protocols [98], limits of 
quantification (LOQs), defined as two times the MDL, and compound recoveries are 
provided in Table SI-F2 of the Supplemental Information.  GraphPad Prism 7 




8.4  Results and Discussion 
8.4.1  Pharmaceuticals and Personal Care Products (PPCPs) 
 Of the fifteen PPCP compounds analyzed, ten were detected above the LOQ 
in at least one sample.  The beta blockers betaxolol and bisprolol, carbamazepine, 
an anticonvulsant and mood stabilizer, resperidone, an antipsychotic, and 
venlafaxine, an antidepressant, were not detected in samples collected from any of 
the six sampled WWTPs.  Concentrations of detected PPCPs during each individual 
stage of treatment from the six WWTPs, as well as the percent change between 
each treatment step, are provided in Table SI-F3 of the Supplemental Information.  
Overall changes in detected PPCP compound concentrations (changes between 
treatment influent and final solids) are provided in Table 8-2. 
 The antibiotic ciprofloxacin was detected in all six WWTPs.  Concentrations 
are displayed in Figure 8-1a.  Overall, the compound was poorly removed during 
both anaerobic and aerobic wastewater treatment processes.  Concentrations of 
ciprofloxacin were only significantly changed between treatment influent and final 
solids in WWTP #4, where an 82.6% decrease (Tukey’s multiple comparisons test, P 
= 0.0005) was observed. 
 The assorted treatment systems had a varied effect on n,n-diethyl-3-
methylbenzamide (DEET), an insect repellent, as demonstrated in Figure 8-1b.  
WWTP #1-3, and #6 did not cause significant changes in concentrations between 
influent and final solids samples.  Anaerobic treatment at WWTP #4, however, 
resulted in a 28.5% increase in DEET overall (Tukey’s multiple comparisons test, P = 
0.0126) while the aerobic sequencing batch reactor employed by WWTP #5 caused 
concentrations to decrease by 77.6% (Tukey’s multiple comparisons test, P = 
0.0003).  While concentrations of DEET did not change overall at WWTP #3, a 
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Overall Change - 76.9% - 100% NS - 77.6% NS - 100% 
P-value a 0.0162 < 0.0001 > 0.9999 0.0002 > 0.9999 0.0013 
Chlorpyrifos 
Overall Change - 53.4% NS - 71.8% - 81.0% - 100% NS 
P-value a 0.0075 0.0787 0.0036 < 0.0001 0.0004 > 0.9999 
Ciprofloxacin 
Overall Change NS NS NS - 82.6% NS NS 
P-value a 0.6494 0.2612 0.6969 0.0005 0.5327 0.0744 
DEET 
Overall Change NS NS NS + 28.5% - 77.6% NS 
P-value a 0.9690 0.0557 0.9613 0.0126 0.0003 0.9882 
Diltiazem 
Overall Change - 65.4% - 57.4% - 100% - 60.3% - 26.7% NS 
P-value a 0.0018 0.0003 0.0084 < 0.0001 0.0121 0.0798 
Diphenhydramine 
Overall Change NS + 473% NS NS NS + 1496% 
P-value a 0.6909 0.0276 0.7819 0.4418 0.4680 0.0063 
Fluconazole 
Overall Change NS NS NS NS - 88.2% + 83.1% 
P-value a 0.2271 0.5852 0.6995 0.3360 0.0010 0.0036 
Irbesartan 
Overall Change NS - 97.8% + 95.2% NS - 32.3% NS 
P-value a 0.2728 0.0098 0.0234 0.0644 0.0459 0.0710 
Norethindrone 
Overall Change - 89.0% NS - 95.4% - 95.4% - 95.7% - 67.4% 
P-value a 0.0004 0.7108 0.0005 < 0.0001 0.0002 0.0080 
Oxybenzone 
Overall Change NS - 93.9% - 97.2% - 49.3% - 96.1% - 67.4% 
P-value a 0.0552 0.0020 0.0005 0.0139 < 0.0001 0.0110 
Pendimethaline 
Overall Change - 27.1% NS - 56.4% - 45.0% NS NS 
P-value a 0.0118 0.1035 < 0.0001 0.0004 0.3914 0.9078 
PFOS 
Overall Change NS NS + 187% NS + 135% + 156% 
P-value a 0.9639 0.6046 0.0011 0.1196 0.0033 0.0010 
Prednisone 
Overall Change - 73.8% NS - 92.2% - 79.7% + 13.4% NS 
P-value a 0.0251 0.8700 0.0118 0.0007 0.0110 0.7764 
Testosterone 
Overall Change - 100% NS - 100% NS - 100% NS 
P-value a 0.0002 > 0.9999 0.0012 0.3519 0.0008 > 0.9999 
Triphenyl phosphate 
Overall Change NS NS NS - 40.4% - 53.4% - 65.2% 
P-value a 0.5735 0.0503 0.5730 0.0004 0.0185 0.0102 
Tris(2-butoxyethyl) 
phosphate 
Overall Change NS NS + 128% + 376% - 72.2% - 61.5% 
P-value a 0.4309 0.1536 0.0068 0.0012 < 0.0001 0.0298 
NS = change in concentration not significant and, thus, not calculated; a Tukey's multiple comparisons test 
Table 8-2:  Overall Changes in Detected PPCP Compound Concentrations 
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Figure 8-1:  Concentrations of Detected PPCPs in Each WWTP Treatment Stage.  * indicates that concentration at that stage of treatment is 
significantly different than the previous stage. (n = 2) 
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significant increase of 176% (Tukey’s multiple comparisons test, P = 0.0189; Table 
SI-3) during thermal hydrolysis was observed, followed by a significant decrease in 
concentrations during anaerobic digestion (Tukey’s multiple comparisons test, P = 
0.0137; Table SI-F3) by 88.9%.Diltiazem, used to treat hypertension, was 
consistently degraded during anaerobic digestion (Figure 8-1c).  The anaerobic 
treatment systems employed by WWTPs #1 – 4 all resulted in significant decreases 
in concentrations, with overall removal rates ranging from 57.4% to 100%.  
Diltiazem concentrations decreased by 26.7% at WWTP #5 (Tukey’s multiple 
comparisons test, P = 0.0121), a reduction that was due to the dewatering process, 
not the aerobic SBR.  No significant overall change occurred during treatment at 
WWTP #6.   
 Concentrations of diphenhydramine (Figure 8-1d), an antihistamine, did not 
change significantly during treatment at WWTPs #1 and #3 - 5.  However, anaerobic 
digestion treatment at WWTP #2 resulted in a 473% increase in concentrations 
(Tukey’s multiple comparisons test, P = 0.0276) and the aerobic membrane 
bioreactor (MBR) treatment at WWTP #6 increased diphenhydramine concentrations 
by 1,496% (Tukey’s multiple comparisons test, P = 0.0063). 
 Concentrations of fluconazole (Figure 8-1e), an antifungal agent, were not 
impacted overall by the anaerobic processes at WWTPs #1 – 4.  WWTP #5, the 
facility with starting concentrations approximately an order of magnitude higher than 
the other WWTPs, was able to significantly decrease fluconazole during aerobic 
treatment with and overall decrease of 88.2% during treatment (Tukey’s multiple 
comparisons test, P = 0.0010).  Conversely, aerobic MBR treatment at WWTP #6 
resulted in an increase of 83.1% in fluconazole (Tukey’s multiple comparisons test, P 
= 0.0036). 
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 The influence of treatment processes on concentrations of irbesartan, 
prescribed for the treatment of hypertension, widely differed amongst the six 
WWTPs (Figure 8-1f).  Overall, concentrations did not change at WWTP #1 while as 
the anaerobic system at WWTP #2 significantly reduced irbesartan levels between 
influent and final solids by 97.8% (Tukey’s multiple comparisons test, P = 0.0098).  
Conversely, WWTPs #3 and 4, the facilities with more advanced anaerobic systems, 
saw concentrations increase during anaerobic treatment.  Irbesartan levels 
significantly increased between influent and final solids by 95.2% in WWTP #3.  
While there was no significant change in overall concentrations in WWTP #4, 
irbesartan did increase significantly during the anaerobic digestion stage of 
treatment (Tukey’s multiple comparisons test, P = 0.0006; Table SI-F3) before 
decreasing during the dewatering process (Tukey’s multiple comparisons test, P = 
0.0004; Table SI-F3).   
 The treatment systems employed at the study WWTPs were generally quite 
effective at degrading norethindrone, a steroid hormone (Figure 8-1g).  Anaerobic 
digestion treatments at WWTPs #1, 3, and 4 significantly reduced overall 
norethindrone levels by 89.0%, 95.4%, and 95.4%, respectively.  Furthermore, the 
thermal hydrolysis stage of treatment at WWTP #3 reduced concentrations by 35.4 
% (Tukey’s multiple comparisons test, P = 0.0205; Table SI-F3).  Aerobic treatments 
at WWTPs #5 and 6 reduced overall norethindrone levels by 95.7% and 67.4%, 
respectively. 
 Oxybenzone, a UV stabilizer and absorber, was effectively degraded under 
anaerobic and aerobic conditions (Figure 8-1h).  Anaerobically, oxybenzone was 
removed by 93.9%, 97.2%, and 49.3% at WWTPs #2 – 4, respectively.  Additionally, 
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the compound was readily degraded under aerobic conditions as well, with 96.1% 
and 67.4% removal at WWTPs #5 and 6, respectively. 
 Generally, the corticosteroid prednisone was effectively removed under 
anaerobic conditions while aerobic treatments appeared unable to degrade the 
compound (Figure 8-1i).  Treatment at WWTP #1 was able to significantly degrade 
prednisone by 73.8% Tukey’s multiple comparisons test, P = 0.0251) while WWTPs 
#3 and 4 reduced levels by 92.2% and 79.7% (Tukey’s multiple comparisons test, P 
= 0.0118 and 0.0007), respectively.  Treatment at WWTP #2 could not significantly 
change concentrations of the compound.  While the aerobic SBR at WWTP #5 
reduced prednisone levels by 20.2% (Tukey’s multiple comparisons test, P = 0.0033; 
Table SI-F3), overall concentrations increased by 13.4% (Tukey’s multiple 
comparisons test, P = 0.0110) between treatment influent and final solids.  
Concentrations did not change significantly during treatment at WWTP #6. 
 Testosterone (Figure 8-1j) was degraded to concentrations below LOQ during 
anaerobic treatment in WWTP #1 and 3.  The compound was not significantly 
removed by treatment at WWTP #4.  WWTP #5’s aerobic SBR reduced testosterone 
levels by 89.9% (Tukey’s multiple comparisons test, P = 0.0011; Table SI-F3) with 
overall concentrations being reduced to below the compound LOQ.  The compound 
was not detected at or above the LOQ from WWTPs #2 or 6. 
8.4.2  Pesticides 
 Of the four pesticides analyzed, two (emamectin benzoate and 
flubendiamide) were not detected at or above the LOQ from the six WWTPs.  
Concentrations of chlorpyrifos and pendimethalin, the detected pesticides, during 
each individual WWTP treatment stages and the percent change between each 
treatment step, are provided in Table SI-F3 of the Supplemental Information.  Overall 
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changes in concentrations between treatment influent and final solids are provided in 
Table 8-2. 
 Both anaerobic and aerobic treatments were generally able to degrade the 
insecticide chlorpyrifos in the six study WWTPs (Figure 8-2a).  In WWTP #1, 
chlorpyrifos was not significantly reduced during anaerobic digestion but, rather,  
 
 
Figure 8-2:  Concentrations of Detected Pesticides in Each WWTP Treatment Stage.  * 
indicates that concentration at that stage of treatment is significantly different than the previous 
stage. (n = 2) 
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during the dewatering process (52.5%, Tukey’s multiple comparisons test, P = 
0.0083; Table SI-F3).  Concentrations were not significantly changed during 
treatment at WWTP #2.  Chlorpyrifos levels were reduced by 71.8% (Tukey’s 
multiple comparisons test, P = 0.0036) during the treatment process at WWTP #3, 
with a 35.5% reduction occurring due to thermal hydrolysis (Tukey’s multiple 
comparisons test, P = 0.0453; Table SI-F3).  The treatment system at WWTP #4 
was also able to degrade the insecticide (81.0%, Tukey’s multiple comparisons test, 
P = < 0.0001).  Aerobic treatment at WWTP #5 reduced chlorpyrifos to levels below 
the LOQ (Tukey’s multiple comparisons test, P = 0.0004) while the insecticide was 
not detected at or above the LOQ in any samples collected from WWTP #6. 
 Influences of the different treatment systems on concentrations of the 
herbicide pendimethalin were varied (Figure 8-2b).  In WWTPs #1 and 2, 
concentrations increased by 21.6% and 49.5% [Tukey’s multiple comparisons test, P 
= 0.0224 (WWTP #1), P = 0.0149 (WWTP #2); Table SI-F3], respectively, during the 
anaerobic stage of treatment.  The treatment process employed at WWTP #3 
reduced concentrations by 56.4% (Tukey’s multiple comparisons test, P = < 0.0001) 
with significant decreases occurring during both thermal hydrolysis treatment and 
anaerobic digestion treatment.  Anaerobic digestion treatment also significantly 
degraded pendimethalin at WWTP #4 (Tukey’s multiple comparisons test, P = 
0.0004; Table SI-F3).  However, the aerobic processes employed by WWTPs #5 and 
6 were not able to significantly change concentrations during treatment. 
8.4.3  Fire Retardants 
 The flame retardants triphenyl phosphate and tris(2-butoxyethyl) phosphate 
were detected at all six WWTPs whereas tris(1-chloro-2-propyl) phosphate was not 
detected at or above the LOQ in any samples.  Overall changes in concentrations of 
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triphenyl phosphate and tris(2-butoxyethyl) phosphate between treatment influent 
and final solids are provided in Table 8-2, while concentrations and percent change 
associated with individual treatment steps are provided in Table SI-F3 of the 
Supplemental Information.   
  
 
Figure 8-3:  Concentrations of Detected Flame Retardants in Each WWTP Treatment 
Stage. * indicates that concentration at that stage of treatment is significantly different than 
the previous stage. (n = 2) 
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Triphenyl phosphate levels (Figure 8-3a) were not significantly changed 
during treatment at WWTPs #1 and 2.  At WWTP #3, concentrations were not 
significantly different between treatment influent and final solids.  However, the 
thermal hydrolysis stage of treatment resulted in a significant increase in triphenyl 
phosphate by 87.1% (Tukey’s multiple comparisons test, P = 0.0006) while 
anaerobic digestion caused a 45.8% decrease (Tukey’s multiple comparisons test, P 
= 0.0006).  Treatment at WWTP #4 was able to decrease overall concentrations by 
40.4% (Tukey’s multiple comparisons test, P = 0.0004).  The aerobic treatments 
utilized by WWTPs #5 and 6 were also able to significantly reduce triphenyl 
phosphate concentrations by 53.4% and 65.2%, respectively.  
 As with triphenyl phosphate, concentrations of tris(2-butoxyethyl) phosphate 
(Figure 8-3b) were not significantly changed during the treatment processes at 
WWTPs #1 and 2.  The anaerobic digestion stage of treatment at WWTPs #3 and 4 
resulted in large and significant increases in tris(2-butoxyethyl) phosphate: 509% 
and 215%, respectively [Tukey’s multiple comparisons test, P = 0.0006 (WWTP #3), 
P = 0.0062 (WWTP #4); Table SI-F3].  Aerobic processes, however, were able to 
effectively degrade the fire retardant.  The treatment processes at WWTP #5 was 
able to remove tris(2-butoxyethyl) phosphate by 72.2% overall (Tukey’s multiple 
comparisons test, P = < 0.0001) while those at WWTP #6 degraded the compound 
by 61.5% (Tukey’s multiple comparisons test, P = 0.0298). 
8.4.4  Food Additives 
 The artificial sweetener aspartame was readily removed by anaerobic and 
aerobic treatment processes (Figure 8-4a).  Concentrations were significantly 
reduced due to aerobic processes by 76.9% at WWTP #1 (Tukey’s multiple 
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comparisons test, P = 0.0162), below levels of LOQ at WWPT #2 (Tukey’s multiple 
comparisons test, P = < 0.0001), and by 77.6% at WWTP #4 (Tukey’s multiple 
comparisons test, P = 0.0002).  Aerobic MBR treatment at WWTP #6 also reduced 
aspartame concentrations to below the LOQ (Tukey’s multiple comparisons test, P = 
0.0013).  The artificial sweetener was not detected at or above the LOQ at WWTPs 
# 3 and 5. 
 
Figure 8-4:  Concentrations of Detected a) Food Additives and b) Surfactants in Each WWTP 
Treatment Stage.  * indicates that concentration at that stage of treatment is significantly 
different than the previous stage. (n = 2) 
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8.4.5  Surfactants 
 Perfluorohexanoic acid (PFHxA), perfluorononanoic acid (PFNA), and 
perfluorooctanoic acid (PFOA) were not detected at or above the LOQ in all 
samples.  The treatment processes employed by the study WWTPs were unable to 
remove PFOS and, in some cases, resulted increases concentrations of the 
compound (Figure 8-4b).  The anaerobic digestion stage of treatment at WWTP #3 
resulted in a 92.5% increase in PFOS (Tukey’s multiple comparisons test, P = 
0.0098; Table SI-F3) while concentrations increased an additional 30.4% due to the 
dewatering process (Tukey’s multiple comparisons test, P = 0.0467; Table SI-F3).  
The aerobic treatment processes employed by WWTPs #5 and 6 resulted in a 135% 
and 156% increase, respectively, [Tukey’s multiple comparisons test, P = 0.0033 
(WWTP #5), P = 0.0010 (WWTP #6)] in PFOS concentrations. 
8.4.6  Predicted Environmental Concentrations in Soil 
 In order to fully assess the ecological implications of the detected ECs, 
predicted environmental concentrations (PECs) of the compounds in soil after a 
single biosolids application from each WWTP were calculated using Equation 1: 




The initial compound concentration in soil (Csoil) was assumed to be zero, indicating 
no prior biosolids application.  The concentrations of ECs in final solids samples 
(provided in Table SI-F3) were used as the assumed concentrations in biosolids 
(Cbiosolids).  The application rate (AR) was assumed to be 6,950 dry kg/ha for Class A 
biosolids (WWTP #3) and 9,420 dry kg/ha for Class B biosolids (WWTPs #1, 2, and 
4) and landfilled final solids (WWTPs #5 and 6) [55].  The soil density (D) was 
assumed to be 1.35 g/cm3 [55] and the depth of the soil (SD) was set at 7.6 cm as a 
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means of simulating no till biosolids application [34].  The calculated PECs are 
provided in Table 8-3.  Ciprofloxacin, diphenhydramine, norethindrone, prednisone, 
and tris(2-butoxyethyl) phosphate had the highest PECs in soil at 27.9 ng/g (WWTP 
#6), 13.1 ng/g (WWTP #6), 12.1 ng/g (WWTP #2), 93.1 ng/g (WWTP #2), and 7.74 
ng/g (WWTP #4), respectively.   
 














Aspartame 0.0869 NC NC 0.160 NC NC 
Chlorpyrifos 0.114 0.136 0.0385 0.174 NC NC 
Ciprofloxacin 20.9 4.21 2.98 2.96 9.71 27.9 
DEET 0.788 0.589 0.612 0.820 0.645 0.964 
Diltiazem 0.238 0.247 NC 0.232 0.250 0.429 
Diphenhydramine 4.10 6.02 2.38 5.59 0.982 13.1 
Fluconazole 0.852 0.810 0.603 0.815 1.23 1.62 
Irbesartan 0.0883 0.0200 0.336 0.125 0.321 0.421 
Norethindrone 7.20 12.1 3.68 3.23 1.87 4.03 
Oxybenzone 0.217 0.0786 0.201 0.776 0.636 0.917 
Pendimethalin 1.55 1.26 0.813 1.09 1.45 0.740 
PFOS 0.295 0.317 0.772 0.501 0.499 0.982 
Prednisone 45.6 93.1 5.80 38.9 58.8 26.3 
Testosterone NC NC NC 0.731 NC NC 
Triphenyl phosphate 3.37 0.825 4.40 3.36 1.00 0.884 
Tris(2-butoxyethyl) 
phosphate 
2.09 3.21 4.27 7.74 1.78 6.61 
 NC = compound not detected at or above the LOQ in final solids samples, thus PEC not calculated 
 
The presence of ECs in soils after biosolids applications can have varying 
effects on the local environment, such as microbial and biotic toxicity, plant uptake, 
mobilization into other environmental compartments, etc.  In a study focusing on the 
impact of PPCPs on mosquito development, it was found that a PPCP mix that 
included norethindrone and ciprofloxacin delayed pupation time of Culex 
Table 8-3:  PECs in Soil for Detected ECs 
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quinquefasciatus.  Additionally, when the mosquito larva were exposed to both 
Bacillus thuringiensis subspecies israelensis (Bti), a bacterial insecticide used for 
mosquito population control, and the PPCP mixture or antibiotic-only mixture 
(comprised of lincomycin, oxytetracycline, and ciprofloxacin), a significantly higher 
mortality rate was observed when compared to those exposed only to Bti treatments.  
Finally, exposure to the PPCP mixture, the antibiotic-only mixture, or a hormone 
mixture (consisting of norethindrone, 17β estradiol, and 17α ethynylestradiol) 
resulted in an alteration of the mosquito microbiome [203].  Furthermore, the 
presence of ciprofloxacin in soil has been demonstrated to not only negatively 
impact the activity of natural microbial populations but to persist within soils with 
retention of biologically active properties [204].  Pot studies performed by Eggen et 
al. (2011) indicated the ability of plants to uptake a fraction of ciprofloxacin into their 
roots, with root accumulation factors estimated to be 0.26 and 0.059 for barley and 
carrot, respectively.  Moreover, the antibiotic negatively impacted the growth and 
development of carrots at concentrations of 6 – 10 mg/kg in the soil [205]. 
 Column experiments conducted on a silty clay loam and a sandy loam soils 
resulted in half-lives of 20.1 days and 13.3 days, respectively, for norethindrone 
[206].  Laboratory studies of three agricultural soil types (loam, sandy loam, and clay 
loam) showed the ability of diphenhydramine to persist with and without liquid 
municipal biosolids (LMB) supplementation.  The average 50% time of dissipation of 
the antihistamine during the experiments ranged from 88 days (clay loam, no LMB 
supplementation) to 335 days (loam, no LMB supplementation) [207].  Furthermore, 
a study of contaminants in rainfall-runoff from biosolids amended fields performed by 
Gray et al. (2017) demonstrated that rain events have the ability to mobilize 
numerous compounds and spread them from agricultural plots to other ecological.  
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One such compound was the flame retardant tris(2-butoxyethyl) phosphate, which 
demonstrated a high frequency of detection and an elevated concentration in runoff 
when compared to other analyzed compounds [208].  
8.5  Conclusions 
 This paper outlines the impact that solids treatment systems at 6 WWTPs had 
on various ECs.  Specifically, anaerobic digestion (both conventional and advanced) 
and aerobic digestion treatment systems were studied.  Of the 27 compounds 
analyzed, 16 were detected at or above the LOQ in at least one sample.  Impact of 
anaerobic and aerobic treatments on compound concentrations varied widely and 
was compound-specific.  Additionally, PECs were calculated to estimate the impact 
that land application of biosolids from the study WWTPs would have on soil 
concentrations of the detected ECs.  The ECs with the highest PECs in soil were 
ciprofloxacin, diphenhydramine, norethindrone, prednisone, and tris(2-butoxyethyl) 
phosphate.  Based on the results of this study, further research should focus on the 
transformation products of compounds that increased and/or decreased during the 
treatment processes to better understand the dynamics of the compound groups and 
the pathways of how individual treatment processes specifically influence a parent 
compound and its metabolites. 
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Chapter 9:  Conclusions and Future Work 
9.1  Conclusions 
 The study of the fate of various anthropogenic pollutants of concern during 
wastewater treatment both on-site and in laboratory simulations has allowed for a 
better understanding regarding the presence of these compounds and their 
transformation products in wastewater, how new treatment technologies influence 
compound concentrations and transformation product levels, and how altering 
already established treatment technologies can help to improve upon compound 
degradation.  Overall, the research presented in Chapters 2 through 8 can be 
summarized as: 
1) Increases in temperature, hydraulic retention time (HRT), and sludge 
retention time (SRT) during activated sludge treatment improved TCS and 
TCC degradation while substantial formation of methyl triclosan (MeTCS), 
a TCS metabolite, occurred during most treatment conditions.  While 
removal of TCS is desirable, formaiton of MeTCS is not due to its 
persistence and endocrine disrupting properties. 
2) Degradation of TCS during nitrification treatment was more efficient at pH 
range of 8.5 - 9.5 than at a range of 6.5 - 7.5.  MeTCS was formed in both 
pH ranges, but formation occurred more rapidly during the higher 
range.   Again, while improvement of TCS is desireable during treatment, 
the formation of MeTCS is not.  Concentrations of TCC and 2,4-
dichlorophenol (2,4-DCP), a TCS degradation product, did not significantly 
change during any nitrification treatment conditions.  
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3) sludge treatment via CambiTHP and anaerobic digestion increased 
concentrations of TCS, MeTCS, and 2,4-DCP in biosolids, when 
compared to lime treatment of sludge.  This was due to concentration via 
solids reduction during digestion. TCC concentrations decreased by over 
95% during CambiTHP pretreatment.  
4) Levels of four phthalate plasticizers in increased due to 
CambiTHP/anaerobic digestion treatment, when compared to treatment of 
sludge via liming.  Increases were not solely due to solids reduction during 
digestion.  It is theorized that transformation of metabolites during 
treatment added to increases in concentrations.  
5) Comparison of solids treatment at six different WWTPs showed that the 
plasticizer di(2-ethylhexyl) phthalate (DEHP) was readily degraded during 
aerobic treatments while anaerobic digestion resulted in either no 
significant change in concentrations or an increase in concentration, in the 
case of more advanced anaerobic processes.   Impacts of the various 
treatment systems on concentrations of the remaining three plasticizers 
were more varied – anaerobic digestion led to significant decreases, 
increases, or no significant change for these compounds, depending on 
the treatment facility.  
6) Comparison of anaerobic treatment with and without CambiTHP showed that 
TCS and MeTCS increased during anaerobic digestion with no significant 
impact when pretreated via CambiTHP while concentrations of TCC 
increased more rapidly when sludge was not pretreated and 2,4-
dichlorophenol levels increased at a faster rate with CambiTHP 
pretreatment.  Anaerobic digestion and CambiTHP pretreatment had a 
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more varying effect on plasticizers with DEHP decreasing, diisononyl 
phthalate levels remaining steady, and benzyl butyl phthalate 
concentrations increasing with pretreatment and decreasing 
without.  Plasticizer metabolites generally increased during the course of 
the experiments; and  
7) a method utilizing sonication/solid phase extraction and analysis via ultra 
high performance liquid chromatography/mass spectrometry was 
developed for 27 compounds.  Sixteen of the 27 compounds were 
detected in solids samples from 6 WWTPs, a majority of which were 
PPCPs.  Concentrations of compounds 
increased/decreased/remained unchanged depending on the individual 
treatment system and compound chemistry. 
9.2  Future Work 
 Based on the results of this research project, the following questions have 
arisen and should be addressed with future research: 
1. What are additional triclosan and triclocarban transformation products and 
what is their fate/formation rates under various treatment processes? 
2. What are additional PAE transformation products and what is their 
fate/formation rates under various treatment processes? 
3. How can an effective and efficient analytical method for TCS, TCC, and PAE 
transformation products be developed in complex matrices such as sludge 
using currently available instrumentation? 
4. What additional PAE conjugates/metabolites are present in wastewater and 
what are their fate during anaerobic and aerobic treatment?  Do these 
compounds explain the patterns of PAE formation observed in this thesis? 
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5. What are the transformation products/metabolites formed from compounds 





Chapter 10:  Supplemental Information 
10.1  Supplemental A:  Degradation of Triclosan and Triclocarban and 




10.1.1  Instrumental Analysis 
 
10.1.1.1  TCC and TCS HPLC-MS/MS conditions 
 
The LC column temperature was maintained at 50 °C. The initial solvent 
management was 55% solvent A (70-1% formic acid:30 methanol)  and 45% solvent 
B (methanol) and these conditions were changed by linear gradient to 50:50 (A:B) in 
15 minutes whereupon the instrument is returned to initial settings in one minute and 
maintained there for 4 min for equilibration to the initial conditions. Total run time 
was 20 min. The flow rate was maintained at 0.3 ml min-1. The injection volume was 
Figure SI-A1:  BioFlo® 115 Benchtop Bioreactors Set-up Prior to Covering in Aluminum Foil 
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10 µl. Source parameters were as follow: capillary voltage is set at 2.93 kV; cone 
voltage at 22 V; extractor voltage is set at 1 V; rf lens at 0.1 V; source and 
desolvation temperatures are 140 and 400 °C, respectively. A nitrogen generator is 
used to supply the nebulizer and desolvation gas (flow rates were approximately 60 
and 600 L h-1, respectively). Both quadrupoles were set at a resolution of 12.0. 
Analytes concentrations were determined by isotope dilution methods using 13C12-
TCC and 13C12-TCS as an internal standard to quantitate the unlabeled triclosan and 
triclocarban. Peak integration and quantification was performed automatically using 
the MassLynx v4.0 software (Micromass Ltd., Machester, UK). 
10.1.1.2  Transformation Products UHPLC-MS/MS conditions 
 
 A Shimadzu Nexera X2 UHPLC coupled with a Shimadzu 8040 triple 
quadrupole MS was used to qualitatively scan for 2,4-DCP, DCC, MCC, NCC, 4-
chlorocatechol, and 4-CA.  A mobile phase of 10 mM ammonium acetate in 
MeOH:acetonitrile:H2O was run through a Supelco Ascentis® Express C18 column 
(2.7 µm, 50 x 2.1 cm) at a rate of 0.5 mL/min.  The column over was maintained at 






Q1 (V) CE (eV) Q3 (V) 
4-CA ESI+ 128.4 ---  10 18 --- 
4-
Chlorocatechol 
ESI+ 145.6  ---  12 18 --- 
2,4-DCP ESI- 161.1 125.05 10 18 24 
DCC ESI- 278.9 125.95 25 15 13 
MCC ESI- 245.1 126.05 16 11 24 
NCC ESI- 211.1 92.1 13 13 18 
10.1.1.3  MeTCS GC-MS conditions 
 
 GC operating parameters were as follows: helium carrier gas flowing at 1 
ml/min through column, injection inlet temperature was 250 °C, 2 µl of sample was 
injected at 14 kPa in splitless mode. The column temperature was programmed as 
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follow: initial setting was 70 °C (held for 5 min), then ramped at different rates as 
follows: first 20°C/min to 100 °C then 10 °C/min to 160 °C, next 1 °C/min to 169 °C 
and finally 18 °C/min to 325 °C. The interface to the detector was 280 °C. The MS 
detector was operated in electron impact ionization mode (EI, 70 eV) with the ion 
source temperature at 230 °C. The acquisition mode was single ion monitoring (SIM) 
and for quantification, the mass fragment 302.0 and 306.0 was used for MeTCS and 
314.0 and 316.0 for 13C12-MeTCS. The analyte concentrations were determined by 
isotope dilution methods using 13C12-MeTCS as an internal standard to quantitate the 
unlabeled MeTCS. Peak integration and quantification was performed automatically 
using the MSD ChemStation software (Agilent Technologies). 










Figure SI-A3:  Soluble COD Concentrations for Each Reactor Run at 21°C and 30°C 







Figure SI-A5:  Volatile Total Suspended Solids Concentrations for Each Reactor Run at 21°C 
and 30°C 




10.2  Supplemental B:  Fate of Triclosan, Triclocarban, and their 
Transformation Products in Wastewater Under Nitrifying Conditions 
 
Compound Purity Supplier 
TCS > 97% Wellington Labs 
TCC > 97% Wellington Labs 
MeTCS > 97% Wellington Labs 
13C12-TCS ≥ 99% Wellington Labs 
13C13-TCC ≥ 99% Wellington Labs 
13C12-MeTCS ≥ 99% Wellington Labs 
DCC N/A Oakwood Chemicals 
MCC N/A Sigma Aldrich 
NCC 98% Sigma Aldrich 
2,4-DCP ≥ 97% Sigma Aldrich 
d3-2,4-DCP 98% Cambridge Isotope 
TCS-o-sulf N/A Toronto Research Chemicals 
 
 
Figure SI-A7: Volatile Total Solids Concentrations for Each Reactor Run at 21°C and 30°C 
Table SI-B1:  Standard Suppliers and Purities 
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TCS MeTCS 2,4-DCP TCS-O-Sulf 
Water (ng/L) 7.9 15.8 82.3 ± 11.8 8.5 17.0 68.1 ± 7.6 49.3 98.6 68.0 ± 11.2 53.9 107.8 64.9 ± 12.5 
Sludge (ng/g) 14.4 28.8 87.5 ± 4.1 16.7 33.4 70.1 ± 5.2 14.5 29.0 77.4 ± 10.7 29.2 58.4 65.3 ± 16.1 
  TCC DCC MCC NCC 
Water (ng/L) 2.7 5.4 70.8 ± 3.5 58.9 117.8 73.4 ± 6.9 53.3 106.6 69.5 ± 6.4 60.7 121.4 72.7 ± 7.8 
















Figure SI-B2:  Microbial Activity During Nitrification Treatment 




Figure SI-B4:  Solids Concentrations During Nitrification Treatment 
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10.3  Supplemental C:  Influence of Thermal Hydrolysis-Anaerobic Digestion 
Treatment of Wastewater Solids on Concentrations of Triclosan, Triclocarban, 
and their Transformation Products in Biosolids 
10.3.1  Sample Extraction 
10.3.1.1  TCC, TCS, MeTCS, TCS-O-Sulf, DCC, MCC, NCC, & 2,4-DCP 
Samples were extracted using a Dionex Accelerated Solvent Extraction 
(ASE) #300 system (Dionex Corporation, Sunnyvale, CA, USA) with a 20:80 (v/v) 
blend of water:isopropyl alcohol (IPA).  The ASE was run at a pressure of 2001 psi 
and a temperature of 120°C.  The heat cycle was set for 6 minutes followed by a 
static cycle of 10 minutes and a purging of 200 seconds.  Three extraction cycles in 
total were performed for each sample. 
Sample cleanup was performed using Oasis® HLB solid phase extraction 
(SPE) cartridges (6 mL, 200 mg, 30 um) (Waters Corporation, Milford, MA, USA).  
Cartridges were conditioned with 25 mL dichloromethane (DCM):diethyl ether (DEE) 
(80:20 v/v). ASE extracts were mixed with 100 mL of phosphate buffer (pH ~7) and 
loaded on to the cartridges under vacuum.  After sample loading, Oasis® HLB 
cartridges were washed with 10 mL of deionized water and left under vacuum for 20 
minutes until dryness.  A cartridge with 4 g of Na2SO4 on top of 1 g Florisil® was 
placed under the Oasis® HLB cartridges.  Target analytes were then eluted with 3 x 
10 mL DCM:DEE (80:20 v/v).  Eluates were evaporated with a rotary evaporator and 
reconstituted in 1.5 mL methanol (MeOH) for instrumental analysis.  
10.3.2.  Instrumental Analysis 
10.3.2.1  TCC, TCS, DCC, MCC, NCC, & 2,4-DCP 
Instrument:  Shimadzu Nexera X2 UHPLC w/ Shimadzu 8040 triple quadrupole MS 
Mobile Phase:  10 mM Ammonium acetate in MeOH:ACN:H2O (60:15:25 v/v) (0.5 
mL/min) 
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Column:  Supelco Ascentis® Express C18 reverse phase column (2.7 μm, 50 x 2.1 
mm) 





m/z Q1 (V) CE (eV) Q3 (V) 
TCC ESI- 313.00 160.00 19.0 13.0 30.0 
13C13-TCC ESI- 326.00 165.95 20.0 15.0 30.0 
TCS ESI- 287.00 34.95 17.0 9.0 13.0 
13C12-TCS ESI- 299.10 34.95 17.0 9.0 13.0 
2,4-DCP ESI- 161.10 125.05 10.0 18.0 24.0 
d3-2,4-DCP ESI- 164.00 126.95 15.0 18.0 23.0 
DCC ESI- 278.90 125.95 25.0 15.0 13.0 
MCC ESI- 245.10 126.05 16.0 11.0 24.0 
NCC ESI- 211.10 92.10 13.0 13.0 18.0 
 
10.3.2.2  TCS-O-Sulf 
Instrument:  Shimadzu Nexera X2 UHPLC w/ Shimadzu 8040 triple quadrupole MS 
Mobile Phase:  0.2% Formic acid in MeOH (0.55 mL/min) 
Column:  Supelco Ascentis® Express C18 reverse phase column (2.7 μm, 50 x 2.1 
mm) 





m/z Q1 (V) CE (eV) Q3 (V) 
TCS-O-Sulf ESI- 366.90 286.90 15.0 15.0 30.0 
13C12-TCS ESI- 299.00 35.05 27.0 10.0 12.0 
 
10.3.2.3  MeTCS 
Instrument:  Agilent 7890B gas chromatograph (GC) w/ Agilent 5977A mass 
selective detector (MSD) 
Carrier gas:  Helium (1 mL/min) 
Column:  DB-5-MS (length: 15 m; diameter: 0.25 mm; and film thickness: 0.1 μm) 
Mode:  Splitless 
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Injection temperature:  250°C 
Chromatographic conditions:  The initial setting was 70 °C (held for 5 min), ramped 
20°C/min until 100 °C, then 10 °C/min to 160 °C, next 1 °C/min to 169 °C and finally 
18 °C/min to 325 °C. The interface to the detector was 280 °C.  
MS Conditions:  The MS detector was run in electron impact ionization mode (EI, 70 
eV) with an ion source temperature of 230 °C. The acquisition mode was single ion 
monitoring (SIM) and for quantification, the mass fragment 302.0 and 306.0 was 
used for MeTCS and 314.0 and 316.0 for 13C12-MeTCS. 
10.3.2.4  4-CA & 3,4-DCA 
Instrument:  Agilent 7890B gas chromatograph (GC) w/ Agilent 5977A mass 
selective detector (MSD) 
Carrier gas:  Helium (1 mL/min) 
Column:  DB-5-MS (length: 15 m; diameter: 0.25 mm; and film thickness: 0.1 μm) 
Mode:  Splitless 
Injection temperature:  250°C 
Chromatographic conditions:  The initial setting was 40 °C (held for 5 min) and 
ramped 22°C/min until 290 °C (held for 10 min). The interface to the detector was 
325 °C.  
MS Conditions:  The MS detector was run in electron impact ionization mode (EI, 70 
eV). The acquisition mode was single ion monitoring (SIM) and for quantification, the 
mass fragment 127.0 was used for 4-CA, 161.0 for 3,4-DCA, and 163 for d2-3,4-
DCA. 
10.4  Supplemental D:  Effect of Cambi Thermal Hydrolysis Process-Anaerobic 







Table SI-D1:  Structures and log Kow Values of Compounds Studied 
 
























a log Kow value estimated using US EPA EPI Suite™ KOWWIN v 1.67 









(msec) Q1 (V) CE  Q3 (V) 
DEHP 
391.2 148.95 100 -27 -22 -25 
391.2 113.15 100 -27 -10 -21 
d4-DEHP 
395.1 153.05 100 -10 -21 -29 
395.1 170.95 100 -10 -14 -30 
DiNP 
419.3 71.1 100 -27 -22 -26 
419.3 85.25 100 -27 -18 -15 
DiDP 
447.3 85.2 100 -29 -21 -15 
447.3 71.1 100 -29 -21 -27 
BBP 
313.25 91.1 100 -19 -21 -15 
313.25 148.95 100 -19 -14 -14 
d4-BBP 
317.1 91.1 100 -14 -22 -16 
317.1 153 100 -14 -15 -27 
 
** Settings in italics indicate those used for quantitation 
 
Nebulizing gas flow:  3 L/min 
Drying gas flow:  15 L/min 
DL temperature:  150°C 
Heat block temperature:  350°C 
 
Column oven temperature:  50°C 
 
Table SI-D2:  Method Detection Limits and Recoveries for Phthalate Plasticizers 
 
  DEHP DiNP DiDP BBP 
 
MDL (ng/L) 22.3 27.2 20.9 14.6 




10.5  Supplemental E:  Effect of Cambi Thermal Hydrolysis Process-Anaerobic 





Table SI-E1:  Solids Data During Anaerobic Digestion 
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Figure SI-E2:  Biogas (Methane) Makeup 
 
 
Figure SI-E3:  Solids Concentrations During Anaerobic Digestion 
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10.6  Supplemental F:  Impact of Various Wastewater Treatment Conditions on 
Concentrations of 27 Emerging Contaminants and Their Estimated 















Table SI-F2:  Target Compound MDLs, LOQs, and Average Recoveries 
 
Compound MDL (ng/g) LOQ (ng/g) Recovery (%) 
Aspartame 1.15 2.30 91.1 ± 6.33 
Betaxolol 2.05 4.10 69.7 ± 4.39 
Bisoprolol 24.7 49.4 76.3 ± 8.04 
Carbamazipine 10.3 20.6 71.0 ± 3.96 
Chlorpyrifos 1.04 2.08 68.3 ± 6.17 
Ciprofloxacin 8.98 18.0 67.2 ± 12.1 
DEET 10.4 20.8 73.4 ± 9.88 
Diltiazem 7.83 15.7 82.5 ± 7.19 
Diphenhydramine 13.2 26.4 60.6 ± 3.42 
Emamectin Benzoate 6.17 12.3 74.8 ± 5.55 
Flubendiamide 18.7 37.4 93.4 ± 3.02 
Fluconazole 2.26 4.52 86.9 ± 4.11 
Irbesartan 0.524 1.05 71.2 ± 7.20 
Norethindrone 23.4 46.8 94.0 ± 5.06 
Oxybenzone 1.69 3.38 59.6 ± 9.82 
Pendimethalin 7.99 16.0 88.1 ± 3.57 
PFHxA 24.8 49.6 75.3 ± 10.5 
PFNA 13.8 27.6 69.4 ± 6.29 
PFOA 20.0 40.0 80.2 ± 4.90 
PFOS 6.87 13.7 106 ± 13.4 
Prednisone 16.6 33.2 93.5 ± 13.6 
Resperidone 43.1 86.2 57.3 ± 7.99 
TCPP 14.2 28.4 62.8 ± 3.91 
Testosterone 7.90 15.8 80.2 ± 5.31 
Triphenyl phosphate 5.71 11.4 90.1 ± 4.28 
Tris(2-butoxyethyl) phosphate 14.6 29.2 87.7 ± 8.23 
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